Exploring microbiological modulation possibilities for oral health by Loozen, Gitte
  
 
 
KU Leuven 
Group Biomedical Sciences  
Faculty of Medicine 
Department of Oral Health Sciences 
 
Ghent University 
Faculty Bioscience Engineering 
Department of Biochemical and Microbial Technology 
 
 
 
 
 
Exploring microbiological modulation possibilities for oral health 
Gitte Loozen  
 
 
 
Jury: 
 
Promoter KULeuven: Prof. Dr. Wim Teughels 
Promoter UGent: Prof. Dr. Ir. Nico Boon 
Jurymembers: Prof. Dr. Ir. Kristel Bernaerts, Prof. Dr. Lieve Vanmellaert, Prof. Dr. Joerg Meyle, Prof. 
Dr. Michel Brecx, Prof. Dr. Daisy Vanrompay  
 
 
 
 
Leuven, 2013 
  
  
 
 
DANKWOORD 
Nu de laatste hand aan mijn thesis gelegd is, neem ik even tijd om stil te staan bij de mensen die mij 
de afgelopen jaren hierbij geholpen hebben. 
Allereerst wil ik mijn promotoren Prof. Dr. Wim Teughels en Prof. Ir. Nico Boon bedanken. Bedankt 
voor het vertrouwen dat jullie in mij hebben gesteld en om me de kans te geven deze uitdaging aan te 
vatten. Verder wil ik jullie bedanken voor de goede begeleiding en de tijd die jullie altijd voor mij 
vrijmaakten. Jullie zijn beiden heel gepassioneerd bezig met onderzoek en dit heeft altijd aanstekelijk 
gewerkt.  
Ik bedank alle leden van de examencommissie voor het grondig nalezen van mijn werk en de 
verbeteringen die ze voorstelden. I would like to thank Prof. Dr. J. Meyle and Prof. Dr. M. Brecx for 
accepting to be a member of the doctoral committee. In het bijzonder wil ik Prof. Dr. K. Bernaerts en 
Prof. Dr. L. Vanmellaert bedanken voor hun begeleiding en tips als leden van mijn 
thesisbegeleidingscommissie. Een woordje van dank gaat ook naar het hoofd van de afdeling 
parodontologie Prof. Dr. M. Quirynen bedankt voor de ondersteuning en de mogelijkheid om dit 
onderzoek uit te voeren op het labo parodontologie. 
Mijn collega’s verdienen een speciaal dankwoordje. Martine, bedankt voor al je hulp met de 
experimenten, je getrainde ogen hebben mij meermaals geholpen als ik niet zeker was met welke 
bacteriën ik te maken had. Ik zal je geanimeerde verhalen over vanalles en nog wat missen. Jesica, ik 
ben heel blij dat ik al deze jaren een bureau heb kunnen delen met jou. Als er iets niet meteen lukte 
kon ik altijd bij jou terecht om frustraties te uiten en samen een oplossing te zoeken. Bedankt voor de 
leuke conversaties, de vrienschap en de steun. I will send an update of good movies for you to see 
every once in a while. De collega’s van het labo experimentele microbiologie, Jolien en Rita bedankt 
voor de steun en gezellige babbels. Rita bedankt voor de vele handige tips die je gegeven hebt in het 
labo en Jolien, als er nog eens een interessant concert op de agenda staat laat je het maar weten. 
Mededoctoraatstudenten Vera, Esteban, Laleh en Ladan wil ik danken voor hun interesse en steun. Als 
laatste wil ik graag al de andere collega’s van ons ‘samengestelde’ labo bedanken voor hun steun: 
Annemie en Katja van ziekenhuishygiëne en Sandra en Inge (en de rest van de crew) van 
kindergeneeskunde. 
Wim Coucke bedankt voor je statistische analyses en de tips die je gegeven hebt als ik vastzat met een 
statistisch probleem.  
Ook een woordje van dank aan alle medewerkers van de afdeling parodontologie op campus Sint-
Rafaël voor de staalnames en aan alle medewerkers van Biomat die altijd veel interesse hebben 
getoond in mijn onderzoek. Tim en Siska van Labmet wil ik ook bedanken voor hun expertise en hulp 
met de DGGE. 
Verder bedank ik al mijn vrienden en familie voor hun interesse en steun. Velen hebben ooit wel eens 
gevraagd: “Hoe is het nu? Vordert het een beetje?”. En ook al was het niet altijd eenvoudig om uit te 
leggen hoe het nu werkelijk zat, deze blijk van interesse door velen, zorgde voor motivatie! Ook 
bedankt voor de ontspannende momenten. 
 
In het bijzonder wil ik mijn mama en papa bedanken. Bedankt voor de mogelijkheden die jullie me 
gegeven hebben. Mama bedankt om altijd voor mij klaar te staan met advies en steun. Bedankt voor 
alles! Ten laatste, bedankt Raf voor het opvangen van mijn stressmomenten, voor je 
onvoorwaardelijke steun, je motiverende woorden en je hulp! 
  
 
 
  
  
 
1 
 
TABLE OF CONTENTS 
SUMMARY ............................................................................................................................................ 5 
SAMENVATTING ................................................................................................................................. 7 
ABBREVIATION LIST.......................................................................................................................... 9 
CHAPTER I: General introduction ....................................................................................................... 13 
1. PERIODONTAL DISEASES ....................................................................................................... 13 
1.1 Prevalence ............................................................................................................................. 14 
1.2 Aetiology ................................................................................................................................ 14 
1.2.1 Host and environment ................................................................................................... 16 
1.2.2 Presence of pathogenic species ..................................................................................... 18 
1.2.3 Absence of beneficial species ........................................................................................ 19 
1.3 Pathogenesis .......................................................................................................................... 20 
2. CURRENT TREATMENT OPTIONS ......................................................................................... 22 
3. EXPLORING ALTERNATIVE TREATMENT OPTIONS ......................................................... 22 
3.1 Exploration of the oral microbial ecosystem ......................................................................... 23 
3.2 Targeting the Gram-negative (pathogenic) component of the oral microbial ecosystem ..... 23 
3.2.1 Bdellovibrio ................................................................................................................... 24 
3.2.2 Growth and reproduction of Bdellovibrio ..................................................................... 24 
3.2.3 Bdellovibrio bacteriovorus as biological agent ............................................................. 26 
3.3 Boosting beneficial part of the oral microbial ecosystem ..................................................... 28 
3.3.1 Probiotics ....................................................................................................................... 28 
3.3.2 Prebiotics ....................................................................................................................... 29 
3.4 Development of essential research tools in periodontal research ........................................ 29 
4. AIMS ............................................................................................................................................. 31 
CHAPTER II: Inter-bacterial correlations in subgingival biofilm: a large-scale retrospective analysis33 
1. INTRODUCTION ......................................................................................................................... 33 
2. MATERIAL AND METHODS .................................................................................................... 35 
2.1 Sample population ................................................................................................................. 35 
2.2 Microbiological assessment .................................................................................................. 35 
2.3 Statistical analysis ................................................................................................................. 37 
3. RESULTS ...................................................................................................................................... 38 
3.1 Presence (%) of bacterial species in relation to probing pocket depth ................................. 38 
3.2 Abundance of bacterial species in relation to pocket depth .................................................. 38 
3.3 Correlation between bacterial species and pocket depth ...................................................... 39 
3.4 Inter-bacterial relationships between tested oral bacteria based on abundance data ......... 41 
  
 
2 
 
3.5 Inter-bacterial relationships between tested oral bacteria based on prevalence .................. 48 
4. DISCUSSION ............................................................................................................................... 50 
5. REFERENCES .............................................................................................................................. 54 
CHAPTER III: Effect of Bdellovibrio bacteriovorus HD100 on multispecies oral communities ........ 59 
1. INTRODUCTION ......................................................................................................................... 59 
2. MATERIALS AND METHODS .................................................................................................. 61 
2.1 Strains and culturing conditions ........................................................................................... 61 
2.2 DNA extraction and quantitative PCR .................................................................................. 62 
2.3 Denaturing gradient gel electrophoresis (DGGE) ................................................................ 63 
2.4 Community models ................................................................................................................ 63 
2.4.1 Dual species model ........................................................................................................ 63 
2.4.2 Six species model .......................................................................................................... 64 
2.4.3 Ex vivo model ................................................................................................................ 64 
2.5 Predation specificity of B. bacteriovorus HD100 ................................................................. 65 
2.6 Alternative electron acceptors for Bdellovibrio .................................................................... 65 
2.7 Statistics ................................................................................................................................ 65 
3. RESULTS ...................................................................................................................................... 66 
3.1 Predation efficiency of B. bacteriovorus HD 100 in dual species model .............................. 66 
3.2 Predation efficiency of B. bacteriovorus HD 100 on in vitro bacterial communities ........... 67 
3.3 Effect of Bdellovibrio bacteriovorus HD 100 on ex vivo clinical samples ............................ 68 
3.4 Effect of Bdellovibrio bacteriovorus HD 100 on ex vivo clinical samples assessed with 
DGGE ………………………………………………………………………………………………72 
3.5 Changing the predation specificity of B. bacteriovorus HD100 ........................................... 74 
3.6 Alternative electron acceptors for Bdellovibrio .................................................................... 76 
4. DISCUSSION ............................................................................................................................... 77 
5. REFERENCES .............................................................................................................................. 81 
CHAPTER IV: Do probiotics offer opportunities to manipulate the periodontal oral microbiota? ...... 85 
1. INTRODUCTION ......................................................................................................................... 85 
2. POSSIBLE MECHANISMS OF PROBIOTIC ACTION (Narrative Review) ............................. 89 
2.1 Search strategy ...................................................................................................................... 89 
2.2 Results ................................................................................................................................... 89 
2.2.1 Immune modulation ...................................................................................................... 90 
2.2.2 Antimicrobial substances produced by probiotics ......................................................... 91 
2.2.3 Competitive exclusion ................................................................................................... 92 
2.3 Adverse effects and safety ...................................................................................................... 93 
  
 
3 
 
3. CLINICAL EFFECTS OF ORAL PROBIOTICS ON PERIODONTAL HEALTH (Systematic 
Review) ................................................................................................................................................. 95 
3.1 Materials and methods .......................................................................................................... 95 
3.1.1 Focused question ........................................................................................................... 95 
3.1.2 Search strategy .............................................................................................................. 95 
3.1.3 Search terms .................................................................................................................. 95 
3.1.4 Inclusion criteria ............................................................................................................ 96 
3.1.5 Exclusion criteria ........................................................................................................... 96 
3.1.6 Data extraction .............................................................................................................. 96 
3.2 Results ................................................................................................................................... 97 
3.2.1 Microbiological changes ............................................................................................... 98 
3.2.2 Changes in plaque index ................................................................................................ 99 
3.2.3 Changes in gingivitis index ......................................................................................... 100 
3.2.4 Bleeding upon probing ................................................................................................ 100 
3.2.5 Probing pocket depth (PD) and clinical attachment level (CAL) ................................ 101 
3.2.6 Inflammatory markers ................................................................................................. 109 
3.2.7 Other effects ................................................................................................................ 110 
4. DISCUSSION ............................................................................................................................. 111 
5. REFERENCES ............................................................................................................................ 114 
CHAPTER V: β-methyl-D-galactoside, a potential prebiotic against periodontal diseases? .............. 125 
1. INTRODUCTION ....................................................................................................................... 125 
2. MATERIALS AND METHODS ................................................................................................ 128 
2.1 Strains and culturing conditions ......................................................................................... 128 
2.2 Growth on different energy sources .................................................................................... 128 
2.3 In vitro effect of β-methyl-D-galactoside on periodontopathogens ..................................... 129 
2.4 Influence of pH on effect of β-methyl-D-galactoside ........................................................... 130 
2.5 Statistical analysis ............................................................................................................... 130 
3. RESULTS .................................................................................................................................... 131 
3.1 Growth stimulation to different energy sources .................................................................. 131 
3.2 In vitro effect of β-methyl-D-galactoside on periodontopathogens ..................................... 134 
3.3 Influence of pH on effect of β-methyl-D-galactoside ........................................................... 137 
4. DISCUSSION ............................................................................................................................. 138 
5. REFERENCES ............................................................................................................................ 143 
6. ADDENDUM .............................................................................................................................. 146 
CHAPTER VI: Live/dead real-time PCR to assess new therapies against dental plaque related 
pathologies .......................................................................................................................................... 151 
  
 
4 
 
1. INTRODUCTION ....................................................................................................................... 151 
2. MATERIALS AND METHODS ................................................................................................ 153 
2.1 Strains and culture conditions ............................................................................................. 153 
2.2 Stress conditions .................................................................................................................. 153 
2.3 Mixtures of viable and dead cells ........................................................................................ 153 
2.4 EMA/PMA cross-linking ...................................................................................................... 153 
2.5 DNA extraction and quantitative PCR ................................................................................ 154 
2.6 Statistics .............................................................................................................................. 154 
3. RESULTS .................................................................................................................................... 155 
3.1 Effectiveness of EMA and PMA on heat-killed bacterial suspensions ................................ 155 
3.2 Effect of bacterial concentration ......................................................................................... 156 
3.3 Effect of EMA and PMA on viable cells .............................................................................. 157 
3.4 Effects of PMA on mixtures of viable and heat-killed cells ................................................. 158 
3.5 Influence of amplicon size ................................................................................................... 159 
4. DISCUSSION ............................................................................................................................. 161 
5. REFERENCES ............................................................................................................................ 164 
CHAPTER VII: General discussion .................................................................................................... 167 
REFERENCE LIST ............................................................................................................................. 178 
CURRICULUM VITAE ..................................................................................................................... 192 
 
  
  
 
5 
 
SUMMARY 
Periodontitis is a frequently encountered infectious disease that affects about 80% of the adults. 
Approximately 10 to 15% of these adults suffer from a severe form, in which the accompanied 
inflammatory process will result in the destruction of the supporting tissues of the teeth. When left 
untreated, periodontitis can lead to loosening and subsequent loss of teeth. Periodontitis is considered 
to be a polymicrobial infection. The mouth is very densely populated with a complex microbiota 
forming community biofilms on the tooth surface called dental plaque. It is this biofilm that can give 
rise to periodontitis, however in contrast with early theories other factors also contribute to the onset 
of disease. The current view on the aetiology of the periodontal diseases considers three factors to be 
crucial in disease development:  a susceptible host (and environment), the presence of pathogenic 
species and reduction or absence of “beneficial bacteria”. According to this theory the oral cavity and 
its microbiota are regarded as an oral ecosystem that is in equilibrium with the host and the 
environment under healthy conditions, however a change in one of the three aforementioned factors 
could lead to periodontal disease. Conventional treatment for periodontitis is still based on older 
theories since one tries to remove the whole bacterial threat by mechanical subgingival debridement 
and leaves the subsequent recolonization up to chance. This protocol does not always succeed in 
arresting and controlling periodontitis. Additionally the increase in resistance towards antimicrobial 
agents warrants the development of new treatments.   
The recognition that this therapy also removes the beneficial part of the microbiota may result in new 
treatment options focusing on protecting or restoring this beneficial microbiota. The search for 
alternative treatment options was the main aim of this research by modulating the oral microbiota.  In 
a first study described in the manuscript a closer look was given to the microbial shift that occurs 
when going from a healthy situation to periodontitis. Past research on this topic has always been 
conducted on a relatively small study population, the innovative aspect of this study was that data 
from more than 6000 untreated patients was analysed to investigate the microbiological shifts as 
function of disease severity and to correlate the outgrowth of pathogenic bacteria, associated with 
periodontitis, with suppression of beneficial bacteria. Digging deeper into the bacterial relations and 
interactions that occur when going from health to disease can be very useful as in that way it will 
allow us to predict shifts in the community species composition and thus changes from oral health 
towards oral disease. In the second part the quest for new treatment options was started focusing 
primarily on the balance between beneficial and pathogenic species in the oral environment. One 
option is to attack the Gram-negative pathogenic bacteria (periodontopathogens) present in 
periodontitis using biological agents. Bdellovibrio bacteriovorus, is a small, very motile Gram-
negative, delta Proteobacterium, that is able to predate, enter and kill other Gram-negative bacteria. As 
most periodontopathogens are Gram-negative bacteria, the use of B. bacteriovorus against those 
bacteria would be a possible treatment option. Previous tests with this predator were conducted on 
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single species communities or single species biofilms and in this study the action of this predatory 
bacterium against Gram-negative bacteria in multispecies models was tested. In the third and fourth 
study the other side of the balance was considered: the number of beneficial species. One approach 
that can lead to a boost in beneficial bacteria is the use of pre- and probiotics. In the third chapter a 
systematic review of the literature on probiotics in the oral cavity was performed in order to get a 
better idea of the mechanisms of action of probiotics and their clinical effects on oral health and more 
specifically on periodontitis. The systematic review showed that in most studies concerning probiotics 
and periodontal diseases lactobacilli were the probiotics of choice. However, instead of using extra-
oral probiotics it would be more logical to directly refill low concentrations of indigenous beneficial 
bacteria. These indigenous beneficial bacteria have some advantages over other probiotic bacteria. 
They are already incorporated in the oral ecosystem and biofilm structure in this way they don’t have 
to compete for binding sites to remain viable in the mouth. Theoretically, prebiotics could enhance the 
growth of beneficial bacteria already present in the mouth. In the fourth chapter, the aim was to screen 
for and select potential prebiotics that specifically stimulate indigenous beneficial species in the oral 
environment and to assess whether this stimulation can cause a reduction of pathogenic bacteria. The 
last chapter was dedicated to the assessment of a new technique to distinguish between live and dead 
bacteria using ethidium monoazide (EMA) and propidium monoazide (PMA) in combination with 
real-time quantitative polymerase chain reaction (qPCR). The existence of such technique is very 
useful in the dental field as for the moment DNA of both live and dead bacteria is quantified with 
qPCR. This makes it very difficult to establish whether a treatment protocol against periodontitis is 
effective, without using culturing techniques. The aim of this study was to test the effectiveness of this 
technique on Prevotella intermedia, Streptococcus mutans and Aggregatibacter 
actinomycetemcomitans, three pathogenic bacteria implicated in different oral pathologies. This 
technique could form the base for all future research concerning periodontitis-associated bacteria and 
treatments. 
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SAMENVATTING 
Parodontitis is frequent voorkomende infectie die circa 80% van alle volwassenen treft. Ongeveer 10 
tot 15% van deze volwassenen worden getroffen door een ernstige vorm, waarbij de bijbehorende 
inflammatoire reactie leidt tot de afbraak van de ondersteunende weefsels van de tand. Wanneer dit 
onbehandeld blijft, kan parodontitis leiden tot tandverlies. Parodontitis wordt gezien als een 
polymicrobiële infectie. De mond is zeer dicht bevolkt met een complexe microbiota die biofilms 
vormt op het tandoppervlak, ook tandplak genoemd. Het is deze biofilm die aanleiding kan geven tot 
parodontitis, maar in tegenstelling tot eerdere theoriën  dragen andere factoren ook bij tot het ontstaan 
van de ziekte. Volgens de huidige etiologie omtrent parodontale ziekten zijn er 3 factoren cruciaal in 
de ziekteontwikkeling: een vatbare gastheer (en omgeving), de aanwezigheid van pathogene soorten 
en een reductie of afwezigheid van beneficiële bacteriën. Deze theorie stelt de orale caviteit en de 
aanwezige microbiota voor als een oraal ecosysteem, dat in balans is met de gastheer en de omgeving 
in gezondheid. Deze theorie impliceert ook dat een verandering in één van de drie bovengenoemde 
factoren kan leiden tot parodontitis. Huidige behandelingsmethoden voor parodontitis zijn nog steeds 
gebaseerd op eerdere hypothesen, aangezien zij de hele microbiota trachten te verwijderen door 
mechanische subgingivale debridering. Hierdoor laten ze de rekolonisatie aan het toeval over, 
waardoor de behandeling niet altijd slaagt in het controleren van parodontitis. Daarnaast is er ook een 
stijgende resistentie voor antimicrobiële middelen, waardoor er vraag is naar nieuwe 
behandelingsopties. De erkenning dat de huidige therapie ook het beneficiële gedeelte van de 
microbiota verwijdert, kan leiden tot nieuwe behandelingen die focussen op het beschermen of 
herstellen van deze beneficiële microbiota. 
De zoektocht naar alternatieve behandelingsopties door het moduleren van de orale microbiota was het 
hoofddoel van dit onderzoek. In de eerste studie werd dieper ingegaan op de microbiële shift die 
plaatsvindt wanneer we gaan van een gezonde situatie naar parodontitis. Eerder onderzoek op dit 
onderwerp werd steeds uitgevoerd op een relatief kleine populatie. Het innoverende aan deze studie 
was dat gegevens van meer dan 6000 onbehandelde patiënten werden geanalyseerd om de microbiële 
shifts in functie van de ernst van de ziekte in kaart te brengen en de uitgroei van pathogene bacteriën, 
geassocieerd met parodontitis, te correleren met een onderdrukking van de beneficiële bacteriën. Het 
onderzoeken van de bacteriële relaties en interacties die plaatsvinden in de transitie van gezond naar 
ziekte, kan zeer interessant zijn omdat dit het mogelijk maakt om shifts in de compositie van de 
bacteriële gemeenschap te voorspellen. In het tweede gedeelte begon de zoektocht naar nieuwe 
behandelingsopties, waarbij hoofdzakelijk werd gefocust op de balans tussen beneficiële en pathogene 
bacteriën in de orale omgeving. Een optie is om de Gram-negatieve pathogene bacteriën 
(paropathogenen) aanwezig bij parodontitis, te bestrijden met behulp van biologische middelen. 
Bdellovibrio bacteriovorus is een kleine, zeer motiele Gram-negatieve, delta Proteobacterie, die in 
staat is om andere Gram-negatieve bacteriën aan te vallen en te doden. Omdat de meeste 
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paropathogenen Gram-negatieve bacteriën zijn, kan het gebruik van B. bacteriovorus een mogelijke 
behandelingsoptie zijn. Eerdere studies met deze predator werden altijd uitgevoerd op 
gemeenschappen en biofilms gebouwd met één enkele soort, en in deze studie werd het effect van B. 
bacteriovorus op Gram-negatieve bacteriën in multispecies gemeenschappen getest. In het derde en 
vierde hoofdstuk werd de andere kant van de balans bekeken: de beneficiële bacteriën. Eén aanpak die 
kan leiden tot een boost in de aantallen van beneficiële bacteriën is het gebruik van pre- en probiotica. 
In het derde hoofdstuk werd er een systematische review van de literatuur over probiotica uitgevoerd, 
om een beter idee te krijgen van de actiemechanismen van probiotica in de mond en hun klinische 
effecten op de orale gezondheid en meer specifiek parodontitis. De review toonde aan dat in de meeste 
studies lactobacilli werden gebruikt als probiotica. Nochtans zou het logischer zijn om, in plaats van 
extra-orale probiotica te gebruiken,  de lage concentraties van beneficiële bacteriën die reeds deel 
uitmaken van de orale microbiota direct te verhogen. Deze orale beneficiële bacteriën hebben enkele 
voordelen, ze zijn reeds opgenomen in het orale ecosysteem en in de biofilmstructuur en moeten 
hierdoor niet strijden voor kolonisatieplaatsen in de mond. In theorie zouden prebiotica de groei van 
deze inheemse beneficiële bacteriën kunnen stimuleren. Het onderzoek naar de effecten van prebiotica 
op de orale microbiota staat nog in zijn kinderschoenen. In het vierde hoofdstuk werd er een screening 
uitgevoerd voor potentiële prebiotica die specifiek de beneficiële bacteriën in de mond stimuleren. 
Verder werd gekeken of deze stimulatie kon leiden tot reducties in de aantallen van pathogene 
bacteriën. In het laatste hoofdstuk werd er een nieuwe techniek bekeken om een onderscheid te kunnen 
maken tussen levende en dode bacteriën door gebruik van ethidium monoazide en propidium 
monoazide in combinatie met kwantitatieve polymerasekettingreactie. Het bestaan van zo een techniek 
is heel bruikbaar in het orale onderzoeksgebied omdat met de huidige technieken DNA, van zowel 
levende als dode bacteriën, wordt gekwantificeerd met kwantitatieve polymerasekettingreactie. Dit 
bemoeilijkt de evaluatie van een behandeling, en er zou dan gebruik gemaakt moeten worden van 
kweektechnieken. Het doel van deze studie was om de effectiviteit van deze techniek te bekijken voor 
drie belangrijke spelers in de orale pathologie, Prevotella intermedia, Streptococcus mutans en 
Aggregatibacter actinomycetemcomitans. Deze techniek kan de basis vormen voor alle toekomstige 
onderzoek betreffende parodontitis-geassocieerde bacteriën en behandelingen.  
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CHAPTER I: General introduction 
1. PERIODONTAL DISEASES 
Periodontal diseases are infections of the supporting tissues of the teeth that can result in attachment 
loss and destruction of alveolar bone and eventually tooth loss (Figure 1). The 1999 American 
Academy of Periodontology (AAP) classification gives the most complete and detailed classification 
of these conditions. This system lists 7 major categories of periodontal diseases, with the most 
important being, gingival diseases, chronic periodontitis, and aggressive periodontitis (Highfield, 
2009). Gingivitis that is associated with dental plaque formation is the most common form of gingival 
disease. The disease is characterized by the presence of clinical signs of inflammation that are 
confined to the gingiva and is associated with teeth showing no attachment loss. Periodontitis on the 
other hand is an inflammation of the periodontal tissues often preceded by gingivitis, and accompanied 
by clinical attachment loss (Highfield, 2009; Savage et al., 2009). Chronic periodontitis is the most 
frequently encountered form of periodontitis, characterized by pocket formation and/or gingival 
recession. The disease can be localized or generalized, involving more than 30% of sites in the mouth. 
Chronic periodontitis may be described by severity as: slight, (1 to 2 mm), moderate (3 to 4 mm) or 
severe (≥ 5 mm) based on the amount of clinical attachment loss. Onset of the condition can occur at 
any age but is most commonly detected in adults. Its prevalence, however, increases with age. This is 
in contrast with aggressive periodontitis which usually affects young individuals during the first three 
decades of life. The condition differs primarily from chronic periodontitis by the rapid rate of 
progression seen in an otherwise healthy individual and the absence of large accumulations of plaque 
(Pihlstrom et al., 2005). Aside from the different oral symptoms of periodontitis, a number of other 
pathologies have been associated with periodontitis like coronary heart disease and atherosclerosis 
(Khader et al., 2004; Bahekar et al., 2007; Humphrey et al., 2008).  
 
 
 
 
 
 
 
 
 
Figure 1: Healthy vs periodontitis (http://nogalesdentallaser.com/periodontitis/ 2011) 
CHAPTER I: General introduction 
14 
 
1.1 Prevalence 
Periodontal diseases like periodontitis and gingivitis are detected in the vast majority of the 
population.  Prevalence of the disease differs between regions, recently the world health organization 
(WHO) reported that 10-15% of the world population suffers from severe periodontitis (Petersen & 
Ogawa, 2005). A Belgian survey on the prevalence of periodontal diseases has been conducted by ICE 
(Interuniversity Cell for Epidemiology) and commissioned by the RIZIV (Rijksinstituut voor ziekte- 
en invaliditeitsverzekering) between 2008 and 2010. Results showed that 32.99% of the population 
had a healthy periodontium, 18.38% presented with periodontitis (pockets ≥ 4 mm), of which 1.38% 
had severe periodontitis (pockets ≥ 6 mm). Recently, the centre for disease control (CDC) has reported 
on the prevalence of severe periodontitis in the US. They noticed a decline in the prevalence of 
periodontitis in the period of 1999-2004 compared to the years 1988 to 1994. The findings suggested a 
more than 50% decrease in the prevalence of pocket depths greater than 4 mm for adults between 20 
and 64 years of age in one decade. However, as such a study has not been performed in other parts of 
the world, it is difficult to state whether this is a general trend or not (Borrell et al., 2005; Petersen & 
Ogawa, 2005; Dye et al., 2007). In addition ethnical differences have been described concerning 
periodontitis. The clearest example found in epidemiological data is the observation that both localized 
and generalized forms of aggressive periodontitis occur about 10 times more frequently in African 
Americans compared to Caucasians (Borrell & Papapanou, 2005). This suggests that among others, 
genetic factors are also important in the aetiology of the disease.  
 
1.2 Aetiology 
There have been several theories concerning the exact role of host and bacterial factors in the 
aetiology of periodontal diseases. At first the focus laid on the bacterial factors. The mouth is very 
densely populated with a complex microbiota, forming communities on the tooth surface (Danser et 
al., 1994; Petit et al., 1994; Danser et al., 1996; von Troil-Lindén et al., 1996; Beikler et al., 2004). 
These communities are referred to as dental plaque, a biofilm of oral microorganisms embedded in a 
matrix of polymers of host and bacterial origin. Evidently this bacterial biofilm is an important player 
in the aetiology of periodontitis and can help to give rise to periodontitis. Initially one assumed that the 
disease was the outcome of the total amount of dental plaque. This theory was called ‘the non-specific 
plaque theory’ (Theilade, 1986). However, when research progressed it was noticed that a large 
amount of plaque was not always linked to the development of periodontitis. Patients having little 
plaque were also prone to the disease and vice versa. Consequently ‘the specific plaque hypothesis’ 
proposed that of the diverse microbiota present in the mouth, only a few species are actively involved 
in the disease (Loesche, 1976). Studies showed that certain bacterial species were present in higher 
concentrations in patients with periodontitis compared to healthy patients (Loomer, 2004; Quirynen et 
al., 2005). Although, certain species like Aggregatibacter actinomycetemcomitans and 
CHAPTER I: General introduction 
15 
 
Porphyromonas gingivalis have been associated with the disease, their presence does not necessarily 
imply presence or development of periodontitis. Only recently, the current view on the aetiology of 
periodontal diseases shifted. Nowadays the hypothesis behind it is slightly more complex, putting the 
emphasis more on the host and on environmental factors (Marsh, 1994). The theory, called ‘the 
ecological plaque hypothesis’ tries to unify the existing theories on the aetiology of oral diseases 
(Figure 2). The mouth can be regarded as an ecological niche and in a healthy situation the resident 
microorganisms live in a relatively stable and harmonious relationship with the host. Factors like the 
total amount of dental plaque and the specific microbial composition of plaque may both contribute to 
the transition from health to disease. In a healthy situation all factors are in a state of dynamic 
equilibrium. Disease-associated organisms are minor components of the oral microbiota in health, 
however changes in this delicate balance can cause an outgrowth of pathogenic bacteria. By 
outcompeting the commensal microbiota they can cause disease. In this ecological concept there are 
certain factors that can lead to a transition from health to disease. This theory also incorporates the 
influence of host and environmental factors like pH, the diet, oral hygiene, saliva flow and so on. The 
three most important factors for the onset of disease are: the host environment properties, the absence 
of beneficial bacteria and the presence of periodontal pathogens (periodontopathogens) (Slots & 
Rams, 1991; Socransky & Haffajee, 1992; Wolff et al., 1994).  
 
 
Figure 2: Ecological plaque hypothesis (Marsh et al. 2011): a dynamic relationship is present between the oral microbiota 
and the host environment. High biofilm levels lead to a host inflammatory response, which in turn, alters local environment 
conditions. These changes will make the community more proteolytic, which will further drive the inflammatory response, 
providing further selection pressure for a proteolytic microbiota that is better adapted to the new environment. Host risk 
factors such as smoking, defects in host defenses, can increase the risk for periodontal disease. GCF: gingival crevicular 
fluid. 
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1.2.1 Host and environment 
One should consider that host and environmental factors can be divided in modifiable and non-
modifiable factors. Lifestyle and oral health measures can be adjusted, whereas genetic predisposition 
cannot be controlled.  
 
1.2.1.1 Modifiable factors 
Oral health and physical factors 
Good oral hygiene measures are the base for a healthy oral cavity. When oral hygiene is not effective, 
biofilm levels increase, creating a more anaerobic environment favouring growth of 
periodontopathogens and leading to a stronger inflammatory response. Additionally there are several 
host environmental factors that can contribute to the actual onset of the disease, triggered by this 
biofilm build-up.  When inflammation is present, the local temperature will increase. Up to 2°C 
difference has been measured between healthy and diseased sites. Subgingival sites with higher 
temperatures have elevated proportions of the periodontopathogens: Prevotella intermedia, A. 
actinomycetemcomitans and P. gingivalis (Devine & Marsh, 2009). Another factor to take into 
consideration is the pH. Most oral microorganisms require a neutral pH for optimal growth. This pH is 
regulated by saliva that has a pH in the range of 6.75-7.25. The slightest change in pH can cause major 
bacterial shifts within the bacterial biofilm. Where excess sugar intake leads to a decrease in pH 
favouring growth of cariogenic bacteria, inflammation causes the pH to increase to 7.4 favouring the 
growth of periodontopathogens, like P. gingivalis. Both salivary flow and gingival crevicular fluid 
(GCF) flow contribute to the balance in the mouth. In healthy circumstances the flow of GCF is low 
and the flow of saliva is high. However, as inflammation increases the GCF flow increases. The 
composition of GCF will also change. It will contain more haemin which is an excellent growth factor 
for some periodontopathogens, turning them more virulent (Marsh & Devine, 2011). 
Lifestyle and health 
Evidence strongly indicates an adverse effect of smoking on periodontal health. It is a major risk 
factor for increasing the prevalence and severity of periodontal diseases (Kaldahl et al., 1996; Tonetti, 
1998; Johnson & Hill, 2004; Johnson & Guthmiller, 2007). On average, smokers are four times more 
likely to have periodontitis than non-smokers. A dose-response relationship exists between the amount 
of cigarettes smoked per day and the odds of having periodontitis. When smoking 9 or less cigarettes a 
day the odds decrease to 2.8, whereas people smoking 31 or more cigarettes a day were almost six 
times more prone to have periodontitis (Tomar & Asma, 2000). The exact mechanisms behind this 
increased risk are not fully understood, and studies focusing on these mechanisms have conflicting 
results. However, several studies showed increased prevalence of periodontopathogens, Tannerella 
forsythensis, P. gingivalis and Campylobacter rectus in smokers (Preber et al., 1992; Haffajee & 
Socransky, 2001; van Winkelhoff et al., 2001). Next to the microbiota, smoking also seems to have an 
CHAPTER I: General introduction 
17 
 
effect on the immune response. Tobacco products appear to have a detrimental effect on the action of 
neutrophils, leading to oxidative burst of these immune cells (Eichel & Shahrik, 1969; Kenney et al., 
1977). In general smoking seems to down-regulate the immune response to a bacterial challenge. The 
levels of antibody immunoglobulin G2, IgG2, against periodontopathogens have been reported to be 
reduced in smokers versus non-smokers with periodontitis (Tangada et al., 1997).  
Besides smoking, patients with a poorly managed type I or II diabetes are at increased risk for 
developing periodontal disease (Taylor, 2001). A large cross-sectional study by Grossi and coworkers 
(1994) observed that diabetic patients were twice as likely to have attachment loss compared to non-
diabetic individuals. Another study by Bridges et al. (1996) demonstrated that diabetes influenced 
several periodontal parameters including, bleeding scores, probing depth and loss of attachment. 
Smoking seems to further increase the risk of periodontitis in diabetic patients. Presumably, the altered 
immune response in diabetic patients is responsible for the onset of periodontal disease. The function 
of cells involved in this response, including neutrophils, monocytes and macrophages, is altered in 
many people with diabetes. The adherence, chemotaxis and phagocytosis of neutrophils often are 
impaired (Manouchehr-Pour et al., 1981). Neutrophils are the primary line of the host defense. 
Impairment of their function may inhibit efficient removal of bacterial cells in the periodontal pocket. 
Diabetes can be regarded as a modifiable factor, as the disease can be controlled and the relative risk 
to periodontitis can be normalized with good glycemic control (Gustke, 1999).  
 
1.2.1.2 Non-modifiable factors 
Host genetics  
Periodontitis can be regarded as a multifactorial disease and beside the bacterial factor it is widely 
accepted that genetic diversity and host susceptibility also contribute to the onset of the disease. An 
interplay between these factors and environmental and lifestyle factors can lead to periodontitis in one 
individual while others maintain perfect oral health. Studies on identical twins suggest that 50% of 
susceptibility to periodontal disease is due to host factors (Michalowicz et al., 2000). In most cases 
this host susceptibility comes down to an improperly regulated immune response to a certain bacterial 
threat. In the case of localized aggressive periodontitis overly active neutrophils have been proposed 
as mediators for the periodontal tissue destruction (Van Dyke & Serhan, 2003). In addition several 
genetic polymorphisms have been identified with a link to periodontal disease. Polymorphisms in the 
interleukin (IL)1, IL-6, and Toll-like receptor (TLR)4 genes have been associated with aggressive and 
chronic periodontitis. These genetic polymorphisms can result in alterations in immunity by changing 
an encoded protein or its expression thereby influencing disease outcome. Specific IL-1 genotypes 
have already been linked to the presence of more pathogenic microorganisms (Socransky et al., 2000; 
Laine et al., 2012). However, a positive association between a genetic polymorphism and disease 
within one population may not be necessarily extrapolated to other ethnic groups. 
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Systemic diseases 
Several systemic diseases can be related to periodontal disease, the underlying cause being an 
inadequate number or function of neutrophils (Nualart Grollmus et al., 2007). Primary neutrophil 
disorders include neutropenia, agranulocytosis (Scully et al., 1982), Chédiak-Higashi syndrome, while 
secondary neutrophil impairment is seen in people with Down syndrome (Cohen et al., 1961; Reuland-
Bosma & van Dijk, 1986; Cichon et al., 1998) and Papillon-Lèfevre syndrome (Firatli et al., 1996; 
Lundgren et al., 1998). The latter one is caused by a mutation in the cathepsin C gene. Cathepsin C is 
a key enzyme in the activation of peptidases in inflammatory cells, like neutrophils.  
 
1.2.2 Presence of pathogenic species 
Another essential factor in the aetiology of periodontal diseases is the presence of pathogenic bacteria 
in the oral cavity. The initial beneficial relationship between the host and its oral microbiota can 
collapse due to certain environmental and host factors leading to a microbial shift and eventually to 
periodontitis. Previously less abundant members of the oral microbiota can become dominant, 
resulting in a shift from a healthy oral microbiota consisting primarily of Gram-positive, saccharolytic, 
and facultative anaerobic bacteria to one consisting primarily of Gram-negative and obligate anaerobic 
species (Slots, 1977; Paster et al., 2001), of which many have a proteolytic metabolism (Marsh, 1994; 
Berezow & Darveau, 2011; Marsh & Devine, 2011). Several microorganisms have already been 
associated with periodontitis using traditional culturing techniques. A. actinomycetemcomitans has 
been strongly implicated in aggressive periodontitis whereas P. gingivalis, P. intermedia, T. 
forsythensis and Treponema denticola have been associated with chronic periodontitis (Mullally et al., 
2000; Noiri et al., 2001; Feng & Weinberg, 2006). As 50% of the oral microbiota is unculturable 
(Kroes et al., 1999; Aas et al., 2005), the traditional microbiological approaches gave an incomplete 
picture. Socransky and coworkers (1998) used whole- genomic DNA probes and checkerboard DNA-
DNA hybridization to group oral bacteria into distinguishable color-coded clusters associated with 
health or disease. Two complexes were clearly associated with periodontal disease, the orange 
complex consisting of P. intermedia, Fusobacterium nucleatum among others and the red complex 
harboring P. gingivalis, T. forsythensis and T. denticola. Subsequently, the list of potential pathogens 
was expanded using species-specific 16S primers for PCR amplification (Kumar et al., 2003). 
However, the oral ecosystem is very complex and periodontitis clearly has a polymicrobial aetiology. 
Past techniques did not provide an overview of the whole community and only focused on specific 
taxa. The development of metagenomic techniques and next-generation sequencing techniques makes 
it possible to study whole bacterial communities by analyzing the complete DNA pool from complex 
samples. Griffen et al. (2012) used pyrosequencing of 16S rRNA genes to map bacterial community 
differences between health and disease, data confirmed the association of specific species with 
periodontitis, like P. gingivalis, T. denticola and T. forsythensis. However, a large number of 
additional species also showed significant associations with the disease. Especially, Filifactor alocis, 
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and some other uncultivated species should be considered in future studies. Bacteria associated with 
periodontitis can contribute to the disease in different ways.  
Several periodontopathogens can adhere to and invade host tissues. P. gingivalis for example has 
fimbriae that can mediate binding of this bacterium to different types of bacterial cells (Feng & 
Weinberg, 2006). Periodontopathogens can alter immune responses by modulation of cytokines or 
chemokines. Others, including A. actinomycetemcomitans induce the secretion of inflammatory 
cytokines, such as IL-8 from gingival epithelial cells and fibroblasts (Uchida et al., 2001; Hasegawa et 
al., 2007; Ji et al., 2007). Furthermore, these bacteria express several proteases important in 
periodontal tissue destruction (Feng & Weinberg, 2006). 
 
1.2.3 Absence of beneficial species 
The oral cavity can harbor around 700 species (Chen et al., 2010; Dewhirst et al., 2010), which in 
healthy circumstances coexist with the host. Beside the periodontopathogens that can cause disease 
under certain conditions, the oral microbiota also contains some bacteria that can provide a benefit to 
the host (Roberts & Darveau, 2002). Biofilms from the healthy non-inflamed periodontal tissues 
consist mainly of Gram-positive, saccharolytic and facultative anaerobic bacteria. Culture studies by 
Moore et al. (Moore et al., 1987; Moore & Moore, 1994) associated several species with health 
including, Actinomyces, Streptococcus and Veillonella species. Culturing-independent techniques such 
as rRNA gene-based techniques helped to further characterize the health-associated microbiota. 
According to studies using this technique the genera showing the largest representation in a healthy 
oral cavity include: Streptococcus, Veillonella, Granulicatella, Actinomyces, Corynebacterium, 
Rothia, Fusobacterium, Prevotella, Capnocytophaga, Neisseria and Haemophilus (Aas et al., 2005; 
Jenkinson & Lamont, 2005; Zaura et al., 2009; Bik et al., 2010). However, these studies also indicate 
that significant inter-individual differences exist. Health-associated bacteria can affect the 
periodontopathogens in different ways and thus influence the disease process. These indigenous 
bacteria can occupy sites otherwise occupied by periodontopathogens, Teughels and coworkers 
showed that Streptococcus mitis, Streptococcus salivarius and Streptococcus sanguinis were able to 
inhibit epithelial colonization of A. actinomycetemcomitans (Teughels et al., 2007a, b).  
They can also prevent production of virulence factors by periodontopathogens. In addition beneficial 
bacteria can adversely affect the vitality or growth of a pathogen. Various in vitro and in vivo studies 
have shown that production of hydrogen peroxide by beneficial bacterial strains can inhibit growth of 
periodontopathogens (Hillman & Shivers, 1988). 
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1.3 Pathogenesis  
Periodontitis is a complex chronic inflammatory infection and many factors contribute to the aetiology 
of the disease. The actual clinical symptoms associated with periodontal disease are caused due to 
interplay between bacteria and the inflammatory response. The disease is initially started by oral 
bacteria that elicit an immune response in the susceptible host leading to inflammation and bone 
destruction. Plaque bacteria can induce tissue destruction either directly through invasion of the tissues 
and the production of harmful substances that induce cell death and tissue necrosis or indirectly 
through activation of inflammatory cells. Direct damage can be caused by the production of noxious 
agents such as ammonia (NH3), and hydrogen sulfide (H2S). These compounds can cause apoptosis in 
a wide range of immune cells (Newman, 2012a). Besides these agents, bacteria also produce proteases, 
breaking down the structural proteins of the periodontium such as collagen, elastin and fibronectin. 
The end products of this digestion are used as nutrients for the bacteria. The breakdown caused by the 
proteases promotes further microbial invasion (Baba et al., 2002; Potempa & Pike, 2009). Several 
periodontal pathogens have been reported to invade the gingival tissues, such as A. 
actinomycetemcomitans, P. gingivalis and F. nucleatum in vitro (Saglie et al., 1988; Hillmann et al., 
1998; Fives-Taylor et al., 1999; Edwards et al., 2006). Christersson and coworkers (1987) determined 
the gingival location of A. actinomycetemcomitans in periodontal lesions of juvenile periodontitis 
patients and showed with transmission electron microscopic examination that the gingival tissue in 
juvenile periodontitis lesions harbor this bacterium. Although the clinical signs of periodontitis are in 
part caused directly by the oral bacteria and their by-products, virulence factors, it is generally 
believed that most of the damage is the result of indirect host immune and inflammatory responses to 
the invading pathogens and their by-products. Next to the bacterial load itself and some bacterial 
proteases, the most important factor stimulating the inflammatory response is the microbial virulence 
factor lipopolysaccharides (LPS). LPS is a large molecule composed of a lipid component (lipid A) 
and a polysaccharide component. These molecules can be found in the outer membrane of Gram-
negative bacteria. LPS is a strong activator of the innate immune system by stimulating the TLR4 
(Darveau et al., 2004; Dixon & Darveau, 2005). 
The host defense mechanism against the bacterial load and accompanying virulence factors involves 
both the innate and adaptive elements of the immune system. However, before the immune system is 
activated, some primary defenses have to be breached (Kornman et al., 1997).  Saliva is a primary 
defense. Besides the fact that a good saliva flow prevents attachment of oral bacteria to the tissues in 
the mouth, human saliva also contains numerous molecular components that contribute to host 
defenses against periodontitis. Some induce cell death (e.g. lysozyme), or inhibit adherence to oral 
surfaces (e.g. mucins), while others inhibit specific virulence factors (e.g. histatin) (Giannobile et al., 
2009). Epithelial tissues are another primary defense, as they are the main site of initial interaction 
between plaque bacteria and the host. The epithelium acts as a barrier against bacteria and their 
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products. However, certain periodontopathogens, like P. gingivalis are able to migrate through the 
basement membrane of epithelial cells and invade the connective tissues in vitro (Schroeder & 
Listgarten, 1997; Lamont & Jenkinson, 2000). When these primary defenses fail to prevent bacterial 
colonization, cells of the innate immunity are activated, particularly the neutrophils and the 
complement system. The adaptive immune system is triggered when the innate immune system does 
not succeed in clearing the infection, the effector cells of the adaptive immune system are the 
lymphocytes.  
 
The most important mediators of the immune system are cytokines and matrix metalloproteinases 
(MMPs) (Seymour & Taylor, 2004). Cytokines are produced by a large number of cell types such as 
neutrophils, macrophages and lymphocytes but also by epithelial cells (Seymour & Taylor, 2004). 
They mediate connective tissue and alveolar bone destruction by inducing fibroblasts and osteoclasts 
to produce proteolyctic enzymes (Birkedal-Hansen, 1993; Gemmell et al., 1997; Takashiba et al., 
2003; Taylor et al., 2004). Some key cytokines involved in periodontitis are IL-1 and tumor necrosis 
factor (TNF)-α. MMPs are proteolytic enzymes, degrading extracellular matrix molecules such as 
collagen, gelatine and elastin (Birkedal-Hansen, 1993; Tervahartiala et al., 2000). They are produced 
by a wide range of cell types including neutrophils, macrophages, fibroblasts and epithelial cells. In 
figure 3 an overview is given of the pathogenesis in periodontitis. In summary, the microbial challenge 
will lead to an upregulated host immune-inflammatory response in the periodontal tissues, which 
causes the periodontal tissue breakdown.  
 
 
Figure 3: Pathogenesis of periodontitis: The upregulated immune response due to the microbial challenge will lead to 
periodontal tissue breakdown, including alveolar bone resorption via activation of osteoclasts. Process can be modified by 
other environmental or genetic risk factors. (Carranza’s clinical periodontology: Chapter 21) 
CHAPTER I: General introduction 
22 
 
2. CURRENT TREATMENT OPTIONS 
The primary goal of treatment is to eliminate inflammation and reduce pockets, basically to bring the 
oral cavity in a state of health. Conventional treatment combines subgingival mechanical debridement 
with oral hygiene improvement and is in some cases supplemented with antiseptics or antibiotics.  
Subgingival mechanical debridement is a non-surgical measure and consists of scaling and root 
planing. Scaling involves the removal of dental calculus from the teeth. Root planing is the removal of 
bacteria and rod cement from the tooth root. Studies showed that mechanical debridement alone does 
not guaranty a successful treatment. Although the total number of colony-forming units can decrease 
by two log values after treatment, this shift towards a less pathogenic microbiota is only temporary. 
Bacteria less strongly implicated as periodontal pathogens reappear within weeks, and re-
establishment of a more pathogenic microbiota occurs within months (Magnusson et al., 1984; Harper 
& Robinson, 1987). The ineffectiveness of this approach can be explained by the unfavourable 
anatomy of the periodontal pocket, the incomplete removal of dental plaque, the existence of an 
intraoral microbial translocation or the fact that pathogens can invade periodontal tissues. Because of 
these reasons the subgingival mechanical debridement is occasionally supplemented with application 
of antiseptics or antibiotics to further suppress periodontal pathogens (Quirynen et al., 2002). 
However, the beneficial effects of the application of antiseptics or antibiotics are sometimes limited in 
part because these antimicrobial agents are not effective for the treatment of biofilms. Additionally the 
increase in resistance towards antimicrobial agents warrants the development of new treatments 
(Quirynen et al., 2002; Devine & Marsh, 2009). If these non-surgical measures fail, surgical treatment 
is available: flap surgery for example allows better cleaning of the root surfaces and removal of 
residual pockets. However, the recognition that above mentioned therapy also removes the beneficial 
part of the microbiota may result in new treatment options focusing on protecting or restoring this 
beneficial microbiota. 
3. EXPLORING ALTERNATIVE TREATMENT OPTIONS   
In the past, treatment procedures focused on the removal of the whole oral microbiota to regain a 
healthy situation in the oral cavity. Current treatment protocols often lead to a recolonization with a 
more aggressive oral microbiota, and often retreatment is needed. So there is still room for 
improvement and an urge for new methods. New insights into the aetiology of periodontal diseases 
have been a source of inspiration in that aspect. The ecological plaque hypothesis claims that all 
microorganisms in the oral cavity work together in one microbial ecosystem (Marsh, 1994). This 
microbial ecosystem interacts with the host to maintain health or cause periodontal disease. Two main 
routes can be taken in the search for alternative treatment options: the host factor, including the 
inflammatory response can be targeted or the microbial ecosystem can be balanced out. In this thesis 
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the focus was put on the microbial ecosystem, underlying this ecosystem is a complex network of 
bacterial species that can interact with each other in different ways.  
Besides an exploration of this microbial ecosystem to further define periodontitis- and health- 
associated bacteria, two main options were investigated with regard to restoring the equilibrium in the 
oral cavity: (a) reduction of pathogenic bacteria and (b) increasing the concentration of beneficial 
bacteria. The main goals of this thesis (3.1-3.4) are elaborated in more detail below. 
3.1 Exploration of the oral microbial ecosystem  
The complexity of the microbial ecosystem has been recognized for a long time. More than 700 
species can reside in the oral cavity and this number keeps on increasing with the development of new 
bacterial identification techniques (Paster et al., 2001; Aas et al., 2005). The oral microbiota can 
consist of three types of bacteria: pathogenic bacteria, beneficial bacteria and neutral or commensal 
bacteria. This nomenclature can be confusing as several species with commensal or beneficial 
properties in the oral cavity can also be pathogenic elsewhere in the body and vice versa.  S. sanguinis 
for example has been shown to exhibit beneficial properties in the oral cavity, however the bacterium 
has also been associated with infective endocardititis (Douglas et al., 1993). S. mitis can also express 
defined virulence characteristics and contribute to disease (Mitchell, 2011). Which bacterial species 
belong to which group is still under debate, although there seems to be an association between the 
concentration of Gram-negative bacteria and periodontitis (Slots, 1977; Paster et al., 2001). Presence 
of high numbers of Gram-positive bacteria on the other hand is correlated with a healthy situation. All 
three types of bacteria can live in symbiosis with each other in a healthy situation in which the 
pathogenic bacteria are outnumbered by the beneficial and commensal bacteria. However, a shift 
towards a more pathogenic microbiota can lead to periodontitis. In the past several research groups 
have already attempted to define specific bacteria associated with periodontitis and those associated 
with health (Socransky et al., 1998). Nevertheless past research on this topic has always been 
conducted on a relatively small study population.  
A first aim of this project was to conduct an elaborate exploration of subgingival biofilm communities. 
Microbial data of over 6000 untreated patients was assessed to investigate the microbiological shifts as 
function of disease severity and to correlate the outgrowth of pathogenic bacteria associated with 
periodontitis, with suppression of beneficial bacteria. 
3.2 Targeting the Gram-negative (pathogenic) component of the oral microbial ecosystem 
As the classical key pathogenic bacteria are primarily represented by Gram-negative bacteria, an 
attempt was made to lower this component by using Bdellovibrio, a predator of Gram-negative 
bacteria. The second aim of this project was to evaluate the effect of this predator on multispecies 
models of oral bacteria. 
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3.2.1 Bdellovibrio  
Predation is pervasive at all levels of live and predation between bacteria has been known for a long 
time (Beebe, 1941). The process of predation is of major importance in controlling species diversity, 
distribution and abundance in ecological communities. The most studied predatory microorganisms 
are the Bdellovibrio. These obligate predatory bacteria are accidentally discovered by Hans Stolp 
(1963) while attempting to isolate bacteriophages from soil. After their initial discovery, Bdellovibrio 
were isolated from various habitats and found to be widely distributed in aquatic and terrestrial 
environments (Jurkevitch & Ramati, 2000). They are Gram-negative delta-proteobacteria that require 
other Gram-negative prey cells to invade and utilize as substrate for their growth and reproduction 
(Figure 4). After the discovery of the genus Bdellovibrio, the group of phenotypically similar 
organisms increased and is currently referred to as the Bdellovibrio and like organisms (BALOs). 
Different phylogenetic analyses of BALOs have been performed. Based on the 16S rRNA sequences, 
Davidov and Jurkevitch (2004) proposed a classification of BALOs into two different families: the 
Bdellovibrionaceae and the Bacteriovoraceae. The Bdellovibrionaceae family only contains one 
species: Bdellovibrio bacteriovorus. The Bacteriovoraceae consist of the species Bacteriovorax stolpii 
and Peredibacter starrii. Although discovered in 1962, the predominantly predatory nature of BALOs 
hindered molecular genetic studies. In 2004 the complete genomic sequence of Bdellovibrio 
bacteriovorus HD100 was determined, which made it easier to understand the predator-prey 
relationships (Rendulic et al., 2004; Sockett & Lambert, 2004). 
 
 
Figure 4: Electron micrographs showing replication of Bdellovibrio within prey (Sockett, 2009). 
3.2.2 Growth and reproduction of Bdellovibrio 
The life cycle of Bdellovibrio is biphasic, comprising a free-living attack phase and an intra-
periplasmic growth phase taking place in the periplasm of the prey cell (Figure 5). Free-swimming 
attack phase cells are capable of attaining speeds of up to 160 µm per second and are propelled by a 
single polar flagellum. In the absence of prey cells Bdellovibrio will rapidly lose viability. This is due 
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to their rapid motility during the search for prey, leading to a high endogenous rate of respiration and 
thus high energy consumption (Hespell et al., 1973). However, it is also this motility that enables 
Bdellovibrio to collide with prey bacteria. The method that Bdellovibrio use to scout for prey bacteria 
is still under debate. Collisions between prey and predator appear to be random, however it has been 
shown that certain strains of Bdellovibrio exhibit a chemoattraction towards soluble nutrients such as 
amino acids and other organic compounds (Straley & Conti, 1977; Straley et al., 1979; Lambert et al., 
2003). In low-moisture environments Bdellovibrio even seem to use slow gliding motility to encounter 
prey bacteria (Lambert et al., 2011).  
The attachment of Bdellovibrio to its prey following initial collision proceeds in two stages. Initial 
attachment is reversible and nonspecific, in this recognition period Bdellovibrio identifies its prey by 
mechanisms still unknown, but there is evidence that it involves the core polysaccharide of the prey 
lipopolysaccharide (Severin et al., 1981; Chemeris et al., 1984).  After this the second stage of 
attachment is entered which is irreversible and specific. After this point a highly orchestrated confined 
secretion of enzymes that cause a local breakdown of the outer membrane and the cell wall of the prey 
takes place. This pallet of enzymes includes lipopolysaccharides, glucanases (solubilizing 10% of N-
acetyl glucosamine during attachment), deacetylases (deacetylates the peptidoglycan) and proteases 
(Rendulic et al., 2004). Upon degradation of the outer membrane and cell way of the prey invasion 
starts. Burnham et al. suggested that flagellar motility was essential to generate the forces required to 
invade the prey cell, proposing that motile drilling of Bdellovibrio was necessary for prey entry 
(Burnham et al., 1968). This statement was attenuated in a study by Lambert et al. working with 
mutated flagellin genes. Their results showed that although the flagellar motility of Bdellovibrio is 
important for prey location and collision in liquid cultures, it is not necessary for actual invasion of 
prey bacteria (Lambert et al., 2006). These results are strengthened by the fact that irreversible 
predator- prey attachment is always achieved at the non-flagellated pole. Instead the action of type IV 
pili seems to pull Bdellovibrio in the prey periplasm (Evans et al., 2007). After entering the periplasm 
of the prey bacterium Bdellovibrio reshapes and reseals the outer membrane of the prey cell. Inside the 
periplasm the predator starts to grow utilizing macromolecules of the prey as building blocks, due to 
the destruction of the structural components in the periplasmic space the prey cell loses its rigidity, 
and is converted into a spherical structure called a bdelloplast (Sockett, 2009). Once the resources of 
the prey are all consumed, the growth phase is completed and Bdellovibrio septate into individual 
cells. The progeny develops a flagellum to gain motility after which the remaining prey membrane is 
breached and the Bdellovibrio are released to reinitiate their lifecycle (Kessel & Shilo, 1976; Núñez et 
al., 2003). Depending on the prey and environment, this life cycle takes roughly 3 to 4 hours. 
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Figure 5: Biphasic life cycle of Bdellovibrio (Socket et al., 2004). 
 
3.2.3 Bdellovibrio bacteriovorus as biological agent 
Several studies have been published concerning the use of BALOs as biological control agents in 
environmental as well as medical microbiological settings. Many human pathogens are being predated 
on by Bdellovibrio, including Escherichia coli, Pseudomonas and Legionella species (Matin & 
Rittenberg, 1972; Tomov et al., 1982; Kadouri & O’Toole, 2005). One study examined the lysis of E. 
coli and Salmonella species on stainless steel surfaces by Bdellovibrio concluding that these predatory 
bacteria could potentially be used to remove bacteria from food processing equipment to reduce 
incidence of food poisoning (Fratamico & Cooke, 1996). The use of Bdellovibrio in the treatment of 
gastrointestinal diseases has also been assessed. Bdellovibrio was effective in reducing numbers of 
Campylobacter jejuni and Helicobacter pylori, two microorganisms implicated in gastrointestinal 
infections (Markelova, 2010). 
The Gram-negative oral pathogens causing periodontal diseases also are an attractive target for 
BALOs. A selective reduction of these pathogens in the oral cavity could favour the beneficial 
microbiota thereby promoting health. In order to use BALOs as a biological agent against periodontal 
disease one important criterium had to be fulfilled. Bdellovibrio should be able to attack 
microorganisms organized in a biofilm, like dental plaque. The action of these predatory bacteria on 
biofilms of E. coli already rendered positive results, a reduction in biofilm biomass was observed as 
early as 3 h after exposure to the predator (Kadouri & O’Toole, 2005). With this in mind research was 
started by our group testing the predation capacities of B. bacteriovorus on several 
periodontopathogens (Van Essche et al., 2009, 2011). In a first study both planktonic cultures of A. 
actinomycetemcomitans as single species biofilms of this periodontopathogen were preyed upon by B. 
bacteriovorus. A recent study explored the potential antimicrobial activity of a range of predatory 
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bacteria against several key periodontopathogens, revealing that B. bacteriovorus HD100 was the most 
versatile predator decreasing the viability of A. actinomycetemcomitans, P. intermedia, Eikenella 
corrodens and F. nucleatum. Furthermore, the predation was not inhibited in the presence of a decoy 
bacterium (Van Essche et al., 2011). A study by Dashiff and Kadouri (2011)  working with B. 
bacteriovorus 109J strain confirmed the action of the predator on biofilms of A. 
actinomycetemcomitans and E. corrodens however no effect was observed for other 
periodontopathogens like P. intermedia and F. nucleatum. These studies prove that BALOs have 
potential as biological agents against periodontal diseases, however as bacteria in dental plaque are 
organized in a complex biofilm further experiments have to be carried out testing these predatory 
bacteria on multispecies biofilms. Additional information regarding BALOs can be found in the 
textbox below.  
 
 
 
 
Safety aspects 
Different safety aspects should be considered when applying a non-indigenous micro-organism to the human body. As Bdellovibrio are 
Gram-negative bacteria with an outer membrane consisting of LPS, they could potentially elicit toxic responses. However, the 
lipopolysaccharide layers of BALOs were found to be unique as the structure of the lipid A was devoid of any negatively charged 
groups (Schwudke et al., 2003). Consequently, their binding affinity to the LPS receptors in human cells is significantly lower.  
Finally, the interaction of BALOs with the Gram-negative commensal microbiota should be examined. The Gram-negative commensal 
organisms are important for intestinal health (Tlaskalová-Hogenová et al., 2004). Studies by Westergaard and Kramer (1977) showed 
that BALOs do not have a lytic effect in the gastro-intestinal environment. They could however by readily isolated from the gastro-
intestinal system of cattle, poultry and humans (Edao, 2001). In a recent study by Atterbury and coworkers, B. bacteriovorus was used 
to dose poultry with a normal gut microbiota or poultry predosed with a Salmonella strain. No adverse effects on their growth and well-
being were observed (Atterbury et al., 2011). 
 
Prey resistance 
It seems that BALOs do not completely eradicate their prey despite excessive predator prey ratios (Alexander, 1981; Sockett & 
Lambert, 2004). However, studies indicate that resistance to Bdellovibrio predation is due to a plastic phenotype response rather than a 
permanently encoded one (Shemesh & Jurkevitch, 2004).  
 
Aerobicity 
One limiting factor concerning the use of BALOs in the oral cavity is their oxygen requirement. Their inability to prey in an oxygen-
limited environment was previously reported (Schoeffield et al., 1996). This can be a disadvantage as periodontitis is characterized by 
anaerobic bacteria located deep within the low oxygen environment of the periodontal pocket. However, BALOs may still be an 
efficient strategy to reduce periodontopathogens such as F. nucleatum and A. actinomyctemcomitans; these bacteria can be detected 
throughout the whole oral cavity. Furthermore, these predatory bacteria could be employed to prevent recolonization of the periodontal 
pocket after periodontal therapy (Dashiff & Kadouri, 2011). Solutions can also be found in the genome of Bdellovibrio. Genome 
analysis of B. bacteriovorus HD100 identified an alternative cytochrome oxidase complex that facilitates microaerophilic respiration. 
In addition nitrite reductase and nitric oxide reductase genes have been discovered indicating that other electron acceptors can be used 
to make anaerobic respiration possible (Sockett & Lambert, 2004).  
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3.3 Boosting beneficial part of the oral microbial ecosystem 
Here the focus was put on the beneficial component of the oral microbial ecosystem, in order to boost 
the beneficial bacteria both the use of pro- and prebiotics was investigated. Probiotics have been 
employed before in the periodontal field and the commercial exploitation of probiotics followed 
claiming their beneficial effects on periodontal health. However, it is important to make sure this is 
based on solid clinical evidence. Therefore the aim of this part was to carry out a systematic review of 
the literature on probiotics in the oral cavity. 
 
The theory of prebiotics, stimulating beneficial bacteria, has never been analysed in the dental field, 
therefore the objective was to screen different compounds for their ability to stimulate growth of 
beneficial oral bacteria and investigate their indirect effect on pathogenic oral bacteria. This will help 
to unravel the bacterial networks and interactions at the base of the disease. 
 
3.3.1 Probiotics  
The use of microorganisms to promote health can be traced back to the end of the 19th century. The 
first to demonstrate an association between microorganisms and health was Albert Döderlein in 1892. 
His research illustrated that vaginal bacteria producing lactic acid were able to prevent or inhibit 
growth of pathogenic bacteria (Döderlein, 1892). In 1899 Tissier identified bifidobacteria and 
suggested to use them therapeutically for treating infant diarrhea. Later on in 1906 this scientist 
reported a successful modulation of the gut microbiota in infants suffering of intestinal infections by 
the displacement of the pathogenic bacteria with bifidobacteria (Teughels et al., 2008). Around the 
same time the work of Eli Metchnikoff, a Ukrainian-born Nobel Prize winner working at the Pasteur 
Institute, provided a scientific rationale for the use of live microorganisms in the prevention and 
treatment of infections. In his book “The prolongation of life” published in 1907 he proposed that the 
lactic acid-producing strain Lactobacillus bulgaricus (contained in Bulgarian yoghurt) was able to 
displace the pathogenic intestinal microbiota. He claimed that some of the bacterial organisms present 
in the large intestine were a source of toxic substances that contributed to illness and aging. The 
consumption of fermented milk products, containing beneficial lactic acid bacteria would lower the 
intestinal pH thereby inhibiting the growth of proteolytic bacteria (Metchnikoff & Mitchell, 1907). In 
order to test his hypothesis further Metchnikoff drank sour milk every day until his death. After this 
the discovery of antibiotics slowed down further research on beneficial bacteria and apart from the 
launch of Yakult® in Japan in the 1930s the concept of microbial therapy got little attention, until 1965 
when the term ‘probiotics’ was first introduced by Lilly and Stillwell as ‘substances secreted by one 
organism which stimulate the growth of another’ (Lilly & Stilwell, 1965). After nine years, Parker 
(1974) described probiotics as “organisms and substances which contribute to intestinal balance, since 
then several definitions of probiotics have been proposed (Salminen et al., 2005). The current 
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definition of a probiotic organism as defined by the world health organization is “a live microorganism 
that when administered in an adequate amount confers a health benefit on the host” 
(http://www.who.int/foodsafety/fs_management/ en/probiotic_guidelines.pdf). Most of the research 
performed on probiotics was related to diseases of the gastrointestinal tract. In the past few years the 
use of probiotics to enhance oral health has gained more interest (Teughels et al., 2008). Health-
associated oral biofilms consist for the most part of Gram-positive bacteria, like Streptococcus and 
Lactobacillus species. A shift towards a pathogenic Gram-negative microbiota is related with disease. 
Restoring those reduced numbers of Gram-positive beneficial bacteria via probiotics might be valuable 
in the treatment of periodontal diseases.  
 
3.3.2 Prebiotics 
Prebiotics have recently be redefined as a selectively fermented ingredient that allows specific 
changes, both in the composition and/or activity in the gastrointestinal biota, that confer benefits upon 
host well-being and health (Roberfroid, 2007). Prebiotics were introduced for the first time by Gibson 
and Roberfroid (1995). The major mechanism of action of prebiotics is assumed to be indirect, by 
stimulating indigenous beneficial bacteria. Research on this topic has been mainly focused on the 
gastrointestinal microbiota (Gibson et al., 2005). Human milk for example can be considered as the 
original prebiotic for gut microbiota management and has been shown to be a powerful stimulator for 
bifidobacteria (Salvini et al., 2011). As a result the gut biota of a breast-fed child is high in 
bifidobacteria and these infants therefore experience fewer gastrointestinal problems compared to 
bottle-fed infants. Some other examples of prebiotics are inulin, fructo-oligosaccharides, galacto-
oligosaccharides and lactulose (Gibson & Roberfroid, 1995; Buddington et al., 1996; Kleessen et al., 
1997; Tuohy et al., 2001; Guigoz et al., 2008). Fructo-oligosaccharides are naturally occurring 
carbohydrates that support the growth of bifidobacteria. Besides indirect effects prebiotics can also 
exert some direct effects on the host, for example by stimulating expression of IL-10 or enhancement 
of IgA secretion (Forchielli & Walker, 2005; Kleessen & Blaut, 2005). When employing prebiotic 
compounds to combat gastrointestinal disorders, they should fulfill certain criteria, which include 
resistance to gastric acidity, to hydrolysis by mammalian enzymes and to gastrointestinal absorption. 
The use of prebiotics in the oral cavity has been discussed although in most cases just as a supplement 
to probiotic strains rather than favouring the endogenous, resident microorganisms.  
 
3.4 Development of essential research tools in periodontal research 
Treatment protocols nowadays aim at complete eradication of the oral microbiota. However, as 
alternative treatment options focus especially on particular components of this oral microbiota new 
research tools are essential. There are a variety of microbiological diagnostic tests available for the 
identification and quantification of oral bacteria. Culture methods were considered as the gold 
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standard for a long time (Loomer, 2004). Different culture media, selective and non-selective, exist for 
the identification of a range of oral bacteria. This technique can also be used in combination with 
biochemical tests. Although cultivation techniques possess one advantage, namely assessment of 
antibiotic sensitivity, they also have some limitations. First of all, the majority of the 
periodontopathogens require anaerobic growth conditions. Therefore when working with culture 
methods problems of sampling, transport and incubation have to be considered. In addition the 
technique is unable to detect low levels of microorganisms, has a high cost and is labor intensive 
(Jervøe-Storm et al., 2005). Several bacterial species with a role in periodontitis, like T. denticola and 
other spirochetes, have proven to be difficult to culture which poses an extra problem (Chan et al., 
1993). Alternative methods include enzymatic assays, immunoassays or nucleic acid probes. However, 
real-time quantitative polymerase chain reaction (qPCR) seems to be the best alternative (Boutaga et 
al., 2006). Where standard PCR lacks the ability for precise quantification, qPCR overcomes this 
problem by direct monitoring of the increasing amount of PCR products throughout the assay. A 
qPCR assay has already been established for several oral bacteria, including periodontopathogens. 
Boutaga and colleagues (2003, 2006) developed a real-time Taqman PCR assay for P. gingivalis, A. 
actinomycetemcomitans, P. intermedia and Fusobacterium spp. and concentrations of T. denticola and 
T. forsythensis can also be quantified with real-time PCR (Sakamoto et al., 2001; Yoshida et al., 
2004). Although this technique has many benefits, one disadvantage is that DNA from dead bacterial 
cells is also quantified. This is a problem as the true effect of treatment protocols will be masked by 
the presence of these dead bacteria. New techniques should be developed especially for validating the 
effect of new upcoming treatment options for periodontitis.  
In this part of the project the goal was to develop a new technique to distinguish between live and dead 
oral bacteria using real-time PCR. 
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4. AIMS 
The aim of this project was the search for alternative treatment options for periodontitis. The focus 
was put primarily on two factors, which are considered crucial for disease development: the presence 
of pathogenic species and the reduction or absence of beneficial bacteria. Instead of targeting the 
whole microbiota, an attempt was made to influence these specific factors thereby restoring or 
maintaining the natural balance of the oral microbiota. This aim was realized through the following 
objectives: 
 
 
 
 
 
1. An elaborate exploration of the oral subgingival biofilm communities was conducted. The 
dental microbial community of more than 6000 untreated periodontitis and healthy patients 
were assessed (i) to investigate the microbiological shifts that occurs as a function of disease 
severity and (ii) to correlate the outgrowth of pathogenic bacteria associated with 
periodontitis, with suppression of beneficial bacteria. This information will help to unravel 
bacterial relationships and interactions. 
2. The use of Bdellovibrio bacteriovorus to reduce oral pathogenic bacteria was investigated. 
Specifically, the action of this predator against oral pathogenic bacteria was assessed in 
bacterial multispecies communities, to include the polymicrobial character of the oral 
microbiology. 
3. A systematic review on the effect of probiotics on the periodontal oral microbiota was carried 
out. Several studies have already been completed on probiotics in the dental field and the 
commercial exploitation of probiotics followed claiming beneficial effect on periodontal 
health. However, as most studies are testing different probiotic bacteria and using different 
set-up and methods, a review was necessary to investigate the true effect of probiotics on 
periodontal health. 
4. Screening and selection of potential prebiotics that specifically stimulate indigenous beneficial 
species in the oral environment and to assess whether this stimulation can cause a reduction of 
pathogenic oral bacteria. 
5. Assessment of a new technique to distinguish between live and dead oral bacteria using 
ethidium monoazide (EMA) and propidium monoazide (PMA) in combination with real-time 
PCR.  
Although the host factor is also important in the ecology of periodontitis, this aspect was not explored 
in this project. 
Figure 6: Balance in oral cavity: aspects investigated in thesis are indicated. 
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1. INTRODUCTION 
Periodontal diseases are difficult to treat, in part because the aetiology is difficult to define. In contrast 
to many other diseases, periodontal diseases are not caused by one single bacterium. Currently, they 
are considered as polymicrobial infections but for a long time the presence of several key pathogenic 
bacteria was considered crucial in the onset of periodontitis. Aggregatibacter actinomycetemcomitans 
has been associated with aggressive periodontitis whereas Porphyromonas gingivalis, Prevotella 
intermedia, Tannerella forsythensis and Treponema denticola have been associated with chronic 
periodontitis (Mullally et al., 2000; Noiri et al., 2001; Feng & Weinberg, 2006). Furthermore, it was 
assumed that the start of periodontitis was accompanied by a shift from a healthy oral microbiota, 
consisting primarily of Gram-positive, saccharolytic, and facultative anaerobic bacteria to one 
consisting primarily of Gram-negative and obligate anaerobic species (Slots, 1977; Paster et al., 2001). 
The studies of Socransky and coworkers (1998) have strengthened this train of thought, with the 
introduction of color-coded complexes to group oral bacteria into distinguishable clusters associated 
with health or disease. Two complexes were clearly associated with periodontal disease, the red 
complex consisting of P. gingivalis, T. forsythensis and T. denticola and the orange complex harboring 
P. intermedia, Fusobacterium nucleatum, Prevotella nigrescens and Peptostreptococcus micros. Other 
complexes, harboring Gram-positive bacteria like streptococcal species and Actinomyces species, were 
correlated with health.  
Although Gram-negative bacteria could play a role in the onset of disease, the presence of these 
species does not imply a certainty that disease will occur. Healthy periodontal tissues have been shown 
to harbor these pathogenic microorganisms, albeit in low numbers (Marsh, 2003). Consequently, other 
microorganisms could also be implicated in disease. These observations have led to new ideas 
concerning the aetiology of periodontal infections. New theories consider the oral cavity as an 
ecosystem, in which the host, the environment and bacteria all contribute to the onset of disease 
(Marsh, 2003; Darveau, 2010). According to this ecological plaque hypothesis in healthy 
circumstances a symbiotic balance exists between the host and all microorganisms. However, a change 
in the number of pathogenic or beneficial bacteria and their balance, or a change/activation in/of the 
host response could lead to the onset of periodontitis. For this 2-way interaction, it is unclear if it is the 
dysbiosis which leads to the inflammatory destruction of the periodontal tissues or whether it is the 
inflammatory response which leads to a dysbiosis.  Recent molecular techniques allow focusing on 
this ecological concept via microbiomic and metagenomic techniques. These latter techniques attempt 
to capture/analyse the whole community instead of focusing on specific taxa. They can discover new 
microorganisms implicated in periodontitis since the oral 
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ecosystem is not formed by just a few players. Griffen et al. (2012) used pyrosequencing of 16S rRNA 
genes to map bacterial community differences between periodontitis and health. Data confirmed the 
association of specific Gram-negative species with periodontitis, like P. gingivalis, T. denticola and T. 
forsythensis. However, a large number of additional species also showed significant associations with 
the disease. Especially, Filifactor alocis, a Gram-positive bacterium and some other yet uncultivated 
species seemed to be associated with periodontal disease. Several microorganisms showed to be 
correlated with health under which the Streptococcus, Acinetobacter, Actinomyces and Moraxella 
species were the most important ones. 
 
Although the complexity of the oral ecology and the ecological differences between health and disease 
are well accepted, a clear view on the dynamics in relation to disease severity or progression is 
lacking. The ecological changes in relation to disease progression are difficult to study longitudinally 
since it is impossible to determine in advance which subjects will develop disease and once disease 
starts to develop, it is unethical not to intervene. Despite these problems, a few studies have attempted 
to follow the microbiological changes occurring during the transition from health to disease 
(MacFarlane et al., 1988; Machtei et al., 1997; Papapanou et al., 1997; Tanner et al., 1998).  Machtei 
and coworkers (1997) established that presence of T. forsythensis, P. intermedia and P. gingivalis was 
a prognostic factor for further periodontal breakdown. Whereas data from Tanner and coworkers 
(1998) suggested that T. forsythensis, Campylobacter rectus and Selenomonas noxia were major 
species characterizing sites converting from periodontal health to disease. However, because of above 
mentioned reasons most data concerning ecological changes in relation to disease progression are 
derived from cross-sectional studies (Socransky et al., 1998; Haffajee et al., 2008). In these studies, 
microbiological differences between healthy, gingivitis, moderate or severe periodontitis patients or 
between shallow, moderate and deep pockets are used to describe the microbial dynamics from health 
to disease. However, in order to understand the ecological dynamics within periodontal pockets in 
relation to disease progression, it is necessary to study microbial changes in relation to increasing 
periodontal pocket depths (PD). Since longitudinal studies are considered unethical and seeing the 
wide variety of possible probing PDs, cross-sectional studies need to incorporate large numbers of 
patients in order to provide sufficient power. The associated costs with microbial analyses often 
hamper analyzing large numbers of patients.  
The limited number of patients that can be analysed also hampers the possibility to study the effect of 
the outgrowth of one member of the ecology on the other members of this ecology. Such analysis 
could potentially provide valuable information regarding inter-species interactions and associations 
within the dynamic microbial ecology. Therefore, the aim of this study was to analyse the microbial 
changes within the subgingival microbial ecology in relation to probing pocket depth and in relation to 
individual species numbers based on a set of 6308 unique subgingival plaque samples which were 
analysed for 20 species on a commercial basis.   
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2. MATERIAL AND METHODS 
2.1 Sample population 
A blinded microbiological database for the years 2007 through 2009, provided by Advanced Dental 
Diagnostics B.V. (ADD) (Malden, Netherlands), was screened and analysed in this cross-sectional, 
retrospective study. The database was constructed based on commercial microbiological analyses of 
patient samples provided by oral healthcare workers in the Netherlands, Belgium and Germany. Next 
to the pooled sample, clinical patient and sample related information based on standard questionnaire 
forms was provided. These forms contained information regarding PD, gender, date of birth, smoking 
behavior, oral hygiene, and treatment stage.  The sample population consisted of patients from 
Western Europe, predominantly the Netherlands and Germany. If the questionnaire did not provide the 
primarily required patient/sample information, the patient/sample was excluded from further analysis. 
When the questionnaire provided patient or sample information that was questionable or contradictory 
(e.g. a sample designated as both before initial therapy and after initial therapy) the sample was also 
excluded from further analysis. Based on the provided information, the average PD, maximum PD, 
number of pooled sites and patient age at the moment of sample taking were determined. Since 
samples in this database were derived from pooled samples, the PD and associated standard error of 
the mean (SEM) of each participating individual was determined as an intra-subject average over the 1 
to 5 registered pocket depths at the sampling sites. Patients with PD-values over 12 mm were excluded 
from analysis. As such the population consisted of 12.884 patients. For further analysis the sample 
population was divided into two main groups: patients/samples before initial therapy (abbreviated as 
BIT; n=6308) and patients/samples after initial therapy but before surgery (abbreviated as AIT; 
n=6576). In this study only the group of patients/samples before initial therapy were considered (BIT; 
n=6308).  The population was arbitrarily divided in 8 PD-categories: ≤ 3 (equal or smaller than 3 mm); 
>3 (larger than 3 mm); >4; >5; >6; >7; >8; >9.  
2.2 Microbiological assessment  
Subgingival plaque samples were taken by dental clinicians with access to case history, radiographs 
and clinical data. Clinicians had a choice to take between 1 and 5 samples using sterile paper points 
with each one at a different site. These paperpoints were deposited into marked eppendorf tubes and 
sent to the company (ADD) at room temperature for molecular microbiological assessment. DNA 
from the samples was obtained by using the QuickExtract™ DNA Extraction Solution (Epicentre 
Biotechnologies, Madison, USA) according to the manufacturer’s instructions. The polymerase chain 
reaction (PCR) was performed in a total volume of 20 µl using 0.2 ml PCR reaction tubes (Greiner 
bio-one, Frickenhausen, Germany). The PCR reaction mixture contained 18.8 µl of PCR MasterMix 
(Parocheck20® kit Greiner, Frickenhausen, Germany) , 1.25 units of Taqpolymerase (Promega, 
Madison, WI, USA) and 1 µl of bacterial DNA (2-10 ng/l). The negative control contained ultrapure 
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water in place of bacterial DNA. Amplification was performed on a GeneAmp 9700 (Perkin Elmer, 
Fremont, USA). Assay conditions consisted of an initial minute at 94°C, followed by 45 cycles of 
95°C for 20 s, 60°C for 20 s and an elongation step at 72°C for 1 min. Afterwards samples were kept 
at 22°C. Heating ramp was set to 1°C/s and the temperature of the lid was 105°C. This assay allowed 
for the amplification of parts of the specific 16S rRNA gene in the presence of fluorescently-labeled 
primers. 30 µl of Hybridization buffer (Parocheck20® kit Greiner, Frickenhausen, Germany) was 
mixed in a reaction tube with the PCR product (5 µl) at room temperature. After which the suspension 
was mixed for 2 min at 95°C in a heating block and cooled down for 30 s. Of the hybridization mix, 
25 µl was transferred into each well of the Parocheck20® DNA chip (Greiner Bio-one, Frickenhausen, 
Germany) using an 8-channel multipipette. This chip contained specific probes for the 20 different 
periodontal species as outlined in table 1. By doing so, each probe was spotted with pathogen specific 
single stranded 16S rRNA encoding gene. Subsequently, this chip was incubated for 10 min at 60°C in 
a steam-saturated atmosphere, washed for 10 s in a preheated washing buffer at 60°C, for 20 s in a 
washing buffer at 60°C and for 10 s at room temperature. Excessive liquid was removed from the chip 
surface. Chips were analysed on an Axon Genepix4000 scanner (Molecular Devices, Sunnyvale, 
USA). Photomultiplier gain was adjusted to 600 (Cy3) and 700 (Cy5), respectively. The start 
resolution was set to 10 µm. Analysis was possible if controls (hybridization control, PCR control and 
orientation control) had been passed. Values were plotted as signal to noise ratios (SNR). The average 
of 5 spots represented one microbe. These average SNR values were then translated into bacterial 
amounts with the help of a standard curve. Such curves (SNR values versus bacterial amounts) were 
available for all 20 strains. 
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Table 1: 20 periodontal bacteria detectable with Parocheck® kit 
 Abbreviation (as used in 
figures and tables) 
Aggregatibacter actinomycetemcomitans Aa 
Actinomyces odontolyticus Ao 
Actinomyces viscosus Av 
Tannerella forsythensis Tf 
Campylobacter concisus Cc 
Campylobacter gracilis Cg 
Campylobacter rectus Cr 
Capnocytphaga (gingivalis/sputigena/ochracea) species Cs 
Eikenella corrodens Ec 
Eubacterium nodatum En 
Fusobacterium nucleatum Fn 
Peptostreptococcus micros Pm 
Porphyromonas gingivalis Pg 
Prevotella intermedia Pi 
Prevotella nigrescens Pn 
Streptococcus constellatus group (constellatus,intermedius,anginosus) Scg 
Streptococcus gordonii group or ‘mutans’ group 
(gordonii,salivarius,cricetus,mutans,uberis) 
Sgg 
Streptococcus mitis group (mitis,oralis,sanguinis,parasanguinis) Smg 
Treponema denticola Td 
Veillonella parvula Vp 
 
2.3 Statistical analysis 
Multiple tables were created from the dataset to be able to allow for constrained ordination and 
correlations. Microbial data were available in terms of counts of the 20 test species. PDs were 
considered as a variable discontinuous factor. PDs were classified in 8 categories. Bacterial numbers 
were log transformed. Before correlation assessment, data were displayed by use of cumulative 
histograms. The relationship between the number of bacteria and the PD was assessed with the 
Spearman correlation coefficient. Significance of the correlation was assessed with Chi-square test and 
correction for multiple comparisons was carried out. The relation between the PD and the absence or 
presence of a certain bacterium was evaluated by means of a generalized linear model, from which a 
coefficient was calculated. In both cases a positive value of the correlation coefficient represents a 
positive relation, a negative value depicts a negative relation. Afterwards the relation between the 
different bacteria was assessed. Spearman rank correlations were calculated and significance of the 
correlation was evaluated with Chi-square test and correction for multiple comparisons was carried 
out. All assessments were done based on the whole dataset and based on the data without zero values 
(data not shown). Finally, an evaluation was made based on the degree on which bacteria appear 
together. Phi was calculated as a measure of association of presence (0: no association; 1: strong 
association). P-value was calculated with the Chi-square test. Significance level was set at p<0.05. 
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3. RESULTS 
3.1 Presence (%) of bacterial species in relation to probing pocket depth 
Figure 1 shows that for P. gingivalis, T. forsythensis, T. denticola, P. intermedia, Peptostreptococcus 
micros and Eubacterium nodatum the prevalence increased with increasing pocket depth whereas the 
opposite was true for A. actinomycetcomitans, Prevotella nigrescens, Campylobacter gracilis, 
Eikenella corrodens, Capnocytophaga species, Campylobacter concisus, Streptococcus mitis group, 
Streptococcus gordonii group, Streptococcus constellatus group, Actinomyces odontolyticus and 
Actinomyces viscosus. These bacteria showed a higher prevalence in shallow (≤ 3 mm) and 
intermediate pockets (3-6 mm). Detection percentages of F. nucleatum, Campylobacter rectus and 
Veillonella parvula remained relatively stable between the various PDs.  
 
Figure 1: Presence of bacterial species in relation to pocket depth (PD): Detection percentages (%) are displayed for each 
bacterium in function of the specific pocket depth category. PDs are divided in 8 categories (mm). 
3.2 Abundance of bacterial species in relation to pocket depth 
P. gingivalis, T. forsythensis, T. denticola, E. nodatum, P. micros and P. intermedia showed a clear 
increase in abundance with increasing PD (Figure 2). However, the majority of the investigated 
bacteria (A. actinomycetemcomitans, P. nigrescens, E. corrodens, Capnocytophaga species, C. 
gracilis, C. concisus, S. mitis group, S. constellatus group, S. gordonii group, A. odontolyticus, A. 
viscosus and V. parvula) showed a decrease in abundance with increasing PDs. For two 
microorganisms F. nucleatum and C. rectus, the abundance remained stable when going from a 
healthy to a diseased pocket.  
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Figure 2: Numbers of bacterial species in relation to pocket depth (PD): Bacterial numbers are displayed for each 
bacterium in function of the specific pocket depth category. PDs are divided in 8 categories. Error bars represent standard 
errors of the mean (n=6308).  
3.3 Correlation between bacterial species and pocket depth 
Table 2 demonstrates the correlation coefficient between the bacterial species and the PD based on the 
abundance of the bacteria as well as the detection frequencies of the bacteria in relation to PD. The 
strongest correlation was observed for T. forsythensis and T. denticola. Looking at detection 
frequency, these bacteria showed a strong positive correlation with PD and a weak positive correlation 
for abundance. This clearly indicates that the prevalence of these two bacteria, as well as their 
abundance to a lesser extent, increases with increasing pocket depth. A. viscosus on the other hand 
displayed a moderate negative correlation with PD for both prevalence and abundance. V. parvula also 
showed a moderate negative association with PD when looking at detection frequency, however this 
was only a weak negative association when looking at abundance. For most other bacteria weak 
correlations were observed for abundance as well as detection frequency. For A. 
actinomycetemcomitans, P. intermedia, C. rectus, P. micros and P. nigrescens only very weak 
correlations were demonstrated.  
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Table 2: Correlation coefficient bacterial species and PD: Coefficients are displayed in two categories: correlation 
between abundance of species and PD and correlation between detection frequency and PD. Correlations were divided in 
categories based on their strength. Between 0-0.1: none to very weak correlation (no color); 0.1-0.3: weak positive 
correlation (yellow); 0.4-0.6: moderate correlation (orange); 0.7-1: strong correlation (red); -0.1-0.3: weak negative 
correlation (green) (Dancey & Reidy, 2004). All values in bold represent significant correlations (p<0.05). 
 Abundance Detection frequency 
Aa -0,066 -0.103 
Tf 0,327 0,731 
Td 0,302 0,719 
Pi 0,019 0,048 
Pg 0,126 0,180 
Fn -0,011 0.176 
Cc -0,163 -0,328 
Ec -0,250 -0,321 
Sgg -0,297 -0,343 
Ao -0,181 -0,262 
Vp -0,260 -0,424 
Cs -0,319 -0,312 
Smg -0,283 -0,254 
Scg -0,291 -0,327 
Cr -0,007 0,012 
Av -0,376 -0,476 
Cg -0,229 -0,257 
Pm 0,037 0,019 
Pn -0,097 -0,107 
En 0,162 0,211 
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3.4 Inter-bacterial relationships between tested oral bacteria based on abundance data 
Relationships between bacteria were assessed with correlation matrices based on Spearman 
correlations. Table 3 indicated the different positive or negative correlations between the different 
bacteria. Several correlations could be observed and most correlations were significant (bold). Strong 
positive correlations exist between T. forsythensis and T. denticola and between all three streptococcal 
groups. Furthermore, A. viscosus showed a strong positive correlation with the S. mitis group and S. 
gordonii group. All significant weak, moderate and strong correlations were selected and displayed in 
figures 3-7. In these graphs the concentration of each species was gradually increased to observe the 
inter-bacterial shifts. The histograms showed that T. forsythensis and T. denticola decreased when the 
concentration of A. viscosus, S. constellatus group, S. gordonii group, S. mitis group, Capnocytophaga 
species or E. corrodens increased, and, vice versa. Furthermore, an increase in A. viscosus also led to 
decreases in C. rectus, whereas an increase in the S. mitis group was accompanied with a decrease in 
P. gingivalis. Higher concentrations of F. nucleatum, A. odontolyticus and C. concisus led to higher 
concentrations of all bacteria shown in the histogram. P. nigrescens was positively correlated with P. 
intermedia, but its increase also led to decreases in E. nodatum. C. gracilis and C. concisus were 
positively correlated with all streptococci and A. viscosus among others. However, they also showed a 
positive correlation with C. rectus. 
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Figure 3: Inter-bacterial relationships: Effect of categorical increase in A. actinomycetemcomitans, E. corrodens, 
Capnocytphaga species and F. nucleatum on other bacteria. Bars indicate the correlation degree: weak correlation, moderate 
correlation. Error bars represent the standard error of the mean (n=6308). 
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Figure 4: Inter-bacterial relationships: Effect of categorical increase in P. nigrescens, V. parvula, P. gingivalis and T. 
forsythensis on other bacteria. Bars indicate the correlation degree: weak correlation, moderate correlation, strong correlation. 
Error bars represent the standard error of the mean (n=6308). 
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Figure 5: Inter-bacterial relationships: Effect of categorical increase in T. denticola, P. intermedia, C. gracilis and C. 
rectus on other bacteria. Bars indicate the correlation degree: weak correlation, moderate correlation, strong correlation. Error 
bars represent the standard error of the mean (n=6308). 
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Figure 6: Inter-bacterial relationships: Effect of categorical increase in C. concisus, P. micros, E. nodatum and A. viscosus 
on other bacteria. Bars indicate the correlation degree: weak correlation, moderate correlation, strong correlation. Error bars 
represent the standard error of the mean (n=6308). 
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Figure 7: Inter-bacterial relationships: Effect of categorical increase in S. mitis S. gordonii and S. constellatus group and 
A. odontolyticus on other bacteria. Bars indicate the correlation degree: weak correlation, moderate correlation, strong 
correlation. Error bars represent the standard error of the mean (n=6308). 
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3.5 Inter-bacterial relationships between tested oral bacteria based on prevalence 
In table 4 an overview is given of the significant correlations between bacteria based on prevalence.  It 
was observed that several bacteria increased in detection frequency when another bacterium was 
present.  P. gingivalis showed an increase in detection percentage when T. forsythensis and T. 
denticola were present, whereas no effect of the presence of P. gingivalis on detection percentages of 
T. forsythensis and T. denticola was observed. It was also clear that T. forsythensis and T. denticola 
were dependent of each other, percentages increased when they were present together. The 
dependence on the other bacteria was slightly more pronounced for T. forsythensis. Presence of T. 
denticola also caused an increase in detection of P. micros, P. intermedia and C. rectus, vice versa no 
effect was shown. Such a one-sided influence was also seen for the S. constellatus group and A. 
odontolyticus, and the S. constellatus group and V. parvula. The detection percentage of this 
Streptococcus group clearly increased when A. odontolyticus and V. parvula were present. 
Additionally A. viscosus seemed to be dependent on presence of V. parvula. For the rest of the 
correlations in table 4, dependence was observed in two directions. Detection of the S. mitis group for 
instance increased when bacteria from the S. constellatus group were present and similarly the latter 
group increased when bacteria from the S. mitis group were present. 
  
CHAPTER II: Inter-bacterial correlations in subgingival biofilm: a large-scale retrospective analysis 
49 
 
Table 4: Correlation based on detection: Phi value (value between 0-1 that depicts the association of two bacteria based on 
appearance) and Chi square (p-value) was calculated for all bacterial combinations. Those bacterial combinations that 
showed a significant p-value (<0.05) and a difference of factor 0.2 between the percentages in A- B+ and A+ B+ or B- A+ and 
B+ A+ are displayed in the table. Four detection percentages are shown: B- A+: detection percentage of A when B is absent; A- 
B+: detection percentage of B when A is absent, A+ B+: detection percentage of B when A is present, B+ A+: detection 
percentage of A when B is present. 
 
 Detection percentage (%) 
A B Phi value A+ B+ A-  B+ B+A+ B- A+ 
Aa Cs 0,1204 93,5 85,2 36,8 19 
Pg Tf 0,2497 99,5 90,3 67,4 9,4 
Pg Td 0,1486 99,7 95,6 66,1 11,1 
Tf Td 0,4483 99,4 68,5 97,4 31,5 
Tf En 0,1146 32,6 4,3 99,5 94,8 
Td Pm 0,1187 64,8 20,4 99,5 96,2 
Td Pi 0,1328 67,3 18,5 99,5 95,8 
Td Cr 0,1206 59,2 13 99,6 96,4 
Pm En 0,2658 40,8 15,1 82,8 55,3 
Pn Cs 0,1859 94,6 82,4 50 21,3 
Cg Cc 0,2394 20,5 3,5 90,3 56,4 
Cg Ec 0.3243 60,4 27,2 77,8 46,1 
Cr Cc 0.1549 18,4 7,5 77,5 55,4 
Ec Cs 0,2114 95,3 81,5 51,4 18,8 
Ec Cc 0,1738 20,2 8,2 69,2 44 
Ec Smg 0,2105 92,7 77,4 52 22,8 
Ec Av 0,2600 84,9 61,6 55,5 26,3 
Cs Vp 0,1958 99,2 91,2 88,9 40 
Smg Scg 0,4218 77,6 23,5 94,8 61,8 
Smg Av 0,315 78,6 39,6 91,6 66,1 
Sgg Scg 0,3735 76,3 26,7 94,6 66,4 
Sgg Av 0,3653 79,3 32,4 93,7 65,2 
Scg Ao 0,2328 96,7 83,5 72,3 31 
Scg Vp 0,1199 99,3 95,9 70 27,3 
Ao Av 0,2679 76 30,2 96,9 81,2 
Av Vp 0,1044 99,1 96 73,3 37,3 
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4. DISCUSSION 
Different microbial aetiologies have already been proposed with regard to periodontal diseases, 
ranging from the ‘non-specific plaque hypothesis’, to implication of specific bacteria (Hajishengallis 
& Lamont, 2012). Socransky and coworkers (1998) established a color-coded system, in which the so-
called “red complex” bacteria correlated with the disease. However, with the arrival of better 
molecular-based approaches it became apparent that the periodontal aetiology may be more complex. 
First, red complex bacteria have also been found in healthy circumstances and secondly as the oral 
microbiota can contain over 700 organisms, other bacteria could also play important roles. It is 
possible that the whole oral microbiota displays a polymicrobial synergy as suggested in current 
etiological hypotheses (Marsh, 2003; Darveau, 2010). Periodontitis could then be caused by a 
dysbiotic change in the complex oral microbiota, for instance a change in the relative abundance of 
certain members relative to their abundance in health. Such a change could disturb the host-microbe 
relationship leading to inflammation. In this study the prevalence and abundance of 20 oral bacteria 
was assessed in health and disease and more importantly a closer look was given to the inter-bacterial 
relationships in order to confirm a dysbiotic change in the microbiota during periodontitis. 
Furthermore, these inter-bacterial relationships could show possibilities of bacterial antagonism.  
First the prevalence and relative abundance of the microorganisms was examined in 6308 patients, 
presented with different gradations of periodontitis from healthy patients to patients with severe 
periodontitis (Figure 1 and 2). Furthermore, the correlation of prevalence and abundance of bacterial 
species with PD was assessed (Table 2). When comparing our results with the color-coded complexes 
described by Socransky and coworkers (1998) it was shown that the red complex bacteria also showed 
a clear association with disease in the current study. T. forsythensis, T. denticola and P. gingivalis 
showed a clear increase in prevalence and abundance with increasing PD and they displayed an 
apparent positive correlation with PD. Their correlation with disease has also been shown in other 
studies (Ximénez-Fyvie et al., 2000; Haffajee et al., 2008; Griffen et al., 2012; Wade, 2013). 
Additionally the current study also illustrated a disease-association for P. intermedia, P. micros and E. 
nodatum, based on their numbers and prevalence in deeper pockets. Except for P. micros they also 
showed a positive correlation with PD, although this was only a weak correlation. These bacteria were 
members of the orange complex in the study by Socransky (1998). This complex was strongly 
correlated with the red complex and with disease in that study. Several bacteria displayed a decrease in 
prevalence and abundance with an increase in PD and a clear negative correlation with PD in the 
current study under which Streptococcus, Capnocytophaga and Actinomyces species, V. parvula, E. 
corrodens and C. concisus. These species groups have already been associated with a healthy 
periodontium in earlier studies (Roberts & Darveau, 2002; Bik et al., 2010; Griffen et al., 2012). In the 
study of Socransky and coworkers (1998) they were also defined as non-disease associated, situated in 
the green, yellow or purple complexes. However, some discrepancies were also shown between the 
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current study and the analysis by Socransky and coworkers (1998). In the current study a decrease in 
prevalence and abundance was observed for both P. nigrescens and C. gracilis and a negative 
correlation with PD, whereas they were positioned in the orange disease-associated complex by 
Socransky and coworkers (1998). Furthermore, F. nucleatum and C. rectus, both defined as orange-
complex bacteria, showed a decrease in numbers and detection frequency with increase in PD in the 
current study, and a very weak correlation with PD was observed. Current results also showed that F. 
nucleatum had a high prevalence and abundance in all PD categories. This can be explained by the co-
aggregation capacities of this bacterium, which is able to form bridges between early and late 
colonizers (Kolenbrander et al., 2002). A. actinomycetemcomitans, in other studies often mentioned as 
an important player in aggressive periodontitis, also displayed a very weak negative correlation with 
PD. This bacterium was also positioned in a distinct complex in the study by Socransky et al. (1998). 
The fact that in the current study A. actinomycetemcomitans showed decreases in prevalence and 
abundance with increasing pocket depth could be explained by the presence of a less virulent serotype 
of this bacterium in the tested samples. It is known that certain serotypes of this bacterium are more 
virulent because of the expression of leukotoxin, a virulence factor (Curtis et al., 2011). 
 
After establishing which microorganisms were associated with disease or health, the inter-bacterial 
relationships were assessed. Correlation matrices (Table 3) illustrated that almost all microorganisms 
were in one way correlated to other species and most of these correlations were significant. 
Histograms (Figure 3-7) displayed the weak, strong and moderate correlations and showed clear 
microbial shifts. When observing the correlation between the streptococcal groups and other bacteria, 
it has to be kept in mind that these groups consist of several Streptococcus species. Especially the S. 
gordonii group is important here as it consists of earlier defined beneficial species such as S. salivarius 
as well as the cariogenic bacterium S. mutans. For example it is known that S. gordonii is able to 
coaggregate with P. gingivalis (Nobbs et al., 2009; Curtis et al., 2011). When looking at the 
correlation matrices a very weak negative correlation can be observed between the gordonii group and 
P. gingivalis. This may indicate a higher presence or higher numbers of other bacteria in this group, as 
S. salivarius already showed some antagonistic activity against P. gingivalis (Teughels et al., 2007; 
Sliepen et al., 2009). The most obvious negative correlations were observed between the disease-
associated bacteria T. forsythensis and T. denticola and some health-associated bacteria (Streptococcus 
groups, A. viscosus, V. parvula, E. corrodens and Capnocytophaga species). Studies concerning T. 
forsythensis and T. denticola are scarce as these bacteria are difficult to culture. However, it is known 
that the streptococci often produce bacteriocins, inhibiting pathogenic bacteria (Santagati et al., 2012). 
Hillman et al. (1985) already described a negative correlation between the viridians streptococci (S. 
sanguinis, S. uberis) and T. forsythensis. A study by Apolônio and coworkers (2007) also 
demonstrated that E. corrodens was able to produce antagonistic substances effective against several 
oral bacteria, such as P. gingivalis, a small negative correlation was also observed in this study.  
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Most correlations in the matrices were positive and several of the bacterial interactions displayed in 
the histograms have already been described in earlier studies. A mutual symbiotic relationship 
between T. denticola and P. gingivalis has been described, succinic acid a growth factor produced by 
T. denticola appears to be incorporated in the cell envelop of P. gingivalis (Grenier, 1992). The strong 
correlation between T. forsythensis and T. denticola has already been described in several studies 
(Bolstad et al., 1996; Ikegami et al., 2004). As F. nucleatum is considered a bridging species it 
displays a positive correlation with several oral bacteria. Aggregations have already been described 
between F. nucleatum and P. gingivalis (Kolenbrander & London, 1993; Kolenbrander et al., 2002; 
Periasamy & Kolenbrander, 2009), Gram-positive species (Kolenbrander et al., 1989; Kang et al., 
2005), Prevotella species (Okuda et al., 2012a), E. nodatum (George & Falkler, 1992), P. micros 
(Kremer & Van Steenbergen, 2000), T. forsythensis (Sharma et al., 2005), T. denticola (Kolenbrander 
et al., 1995) and Capnocytophaga species (Okuda et al., 2012b) among others. The strongest positive 
correlations were described between the streptococcal species, V. parvula, A. viscosus and E. 
corrodens. Streptococcus species and Veillonella species have already been found to occur often at the 
same site in the oral cavity, most probably because Veillonella utilizes short-chain acids such as lactate 
secreted by streptococci (Kreth et al., 2008). Ebisu and coworkers (1988) demonstrated coaggregation 
between E. corrodens and A. viscosus and S. sanguinis by means of a bacterial lectin-like substance. 
Whereas Weiss et al. (1987) showed co-aggregation between Capnocytophaga species and Gram-
positive species such as Actinomyces species and S. sanguinis.  
However, it was also observed that three bacteria, whose increase led to increases in the concentration 
of several health-associated bacteria such as the streptococcal species, and from which the 
concentration and prevalence decreased with increasing PD, also had a strong correlation with one or 
more disease-associated bacteria. P. nigrescens showed a positive correlation with P. intermedia and 
C. gracilis was closely related to C. rectus which may also explain why these bacteria were earlier 
defined as a member of the disease-associated orange complex. Furthermore, A. odontolyticus showed 
a positive correlation with both P. gingivalis and P. intermedia. The correlation between A. 
odontolyticus and P. intermedia was already described by Nesbitt and coworkers (1993). Besides 
correlations based on abundance, correlations were also presented based on detection frequencies, 
which illustrated that several bacteria are dependent on the presence of other bacteria, as was shown 
for P. gingivalis whose detection percentage increased when T. forsythensis or T. denticola were 
present, the relation between P. gingivalis and T. denticola was already mentioned before (Grenier, 
1992). 
This large-scale retrospective study was able to correlate several bacteria with disease and illustrated 
several bacterial interactions. However, a critical view on the used methodology is required. It has to 
be kept in mind that the method of data collection lent itself to a potential inter-(intra) observer 
variability due to participation of an unknown number of non-calibrated dental practitioners. However, 
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the extent of the sample population should compensate for this suspected variability. Microbiological 
analysis was carried out with a semi-quantitative technique and it would therefore maybe be better to 
validate results with quantitative PCR. However, this would be time-consuming and would increase 
costs. Additionally, analysis was done in a standardized manner, correct controls were included as 
well as a standard curve, and a limit of detection was determined for each bacterium.  
In conclusion, many significant inter-bacterial correlations were observed. Via which mechanisms 
these bacterial relationships work is unclear. However, this strengthens the hypothesis that the oral 
cavity can be seen as an ecological system, in which next to the host a delicate bacterial network exists 
where the slightest change in bacterial presence or abundance could lead to a shift from health to 
disease and vice versa. Furthermore, it has to be kept in mind that although a species seems to have no 
correlation with clinical factors its increase could indirectly lead to disease. In this study only a small 
array of oral bacteria was tested, in the future analysis could be performed working with the human 
microbe identification microarray (HOMIM). A study by Ahn et al. (2011) already compared 
hybridization based on HOMIM with pyrosequencing and demonstrated that both techniques were 
highly correlated on both phylum and genus level. Samples can also be taken from different sites in 
the mouth as it has already been shown that differences exist in the bacterial composition between 
supra- and subgingival plaque or saliva and subgingival plaque (Aas et al., 2005).  Another option 
would be to combine information about PD with information about bleeding on probing, as this is 
considered a measure for inflammation. However, current knowledge on bacterial correlations and 
relations already paves the way for possible new treatment options not focusing on removal of the 
whole oral microbiota, but focusing on restoring the shifted balance.  
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CHAPTER III: Effect of Bdellovibrio bacteriovorus HD100 on multispecies 
oral communities 
1. INTRODUCTION 
Plaque induced periodontal diseases are inflammatory conditions of the periodontium. The prevalence 
is high, 10-15% of the world population suffers from severe periodontitis (Petersen & Ogawa 2005). 
In severe cases periodontitis is characterized by destruction of periodontal tissues, resulting in 
attachment losses which lead to loss of teeth. The disease has a polymicrobial aetiology and is initiated 
by the presence of a complex biofilm, called dental plaque, residing on the tooth (Marsh, 1994). 
Although this biofilm can also be present in healthy individuals, disease-associated dental plaque can 
be distinguished by the presence of high proportions of Gram-negative micro-organisms (Slots, 1977; 
Slots & Rams, 1991; Paster et al., 2001).  
Several Gram-negative microorganisms have been associated with periodontitis; Aggregatibacter 
actinomycetemcomitans for example has been implicated in aggressive forms of periodontitis (Fine et 
al., 2007; Schacher et al., 2007). Furthermore, Socransky and coworkers (1998) used whole- genomic 
DNA probes and checkerboard DNA-DNA hybridization to group oral bacteria into distinguishable 
clusters associated with health or disease. Two complexes were clearly associated with periodontal 
disease, one consisting of Prevotella intermedia, Fusobacterium nucleatum among others and the 
other harboring Porphyromonas gingivalis, Tannerella forsythensis and Treponema denticola 
(Socransky et al., 1998; Noiri et al., 2001; Feng & Weinberg, 2006). Although recent studies using 
pyrosequencing indicated that other microorganisms like the Gram-positive Filifactor alocis and some 
uncultivated species could also play a role in the disease, they also confirm the association of the 
above mentioned Gram-negative species with periodontitis (Griffen et al., 2012). Current treatment 
options against periodontitis do not succeed in completely eradicating the Gram-negative micro-
organisms from the oral cavity. Additionally, treatment protocols primarily focus on removal of the 
complete oral microbiota and leave recolonization up to chance, while it has been demonstrated that 
several species in dental plaque have protective features and are therefore better left unharmed 
(Roberts & Darveau, 2002).  
Recently, Bdellovibrio and like organisms (BALOs) received some attention as possible biological 
agents against periodontitis-related biofilms. BALOs are delta-proteobacteria with high motility that 
predate solely on Gram-negative bacteria. Various studies have supported the fact that BALOs are no 
threat to general health (Dwidar et al., 2012). These predatory bacteria have been readily isolated from 
the gastro-intestinal system of cattle and poultry, without evidence of harmful effects on the intestinal 
microbiota (Westergaard & Kramer, 1977; Atterbury et al., 2011). In addition, Schwudke and 
colleagues (2003) demonstrated that BALOs have low immunogenicity in part because of a 
significantly lower binding affinity to the LPS receptors in human cells. Their life cycle consists of a 
free-living attack phase followed by an intraperiplasmic growth phase. When multiplied, the predator 
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shatters the remains of the prey cell, releasing its progeny into the environment (Sockett & Lambert, 
2004). Compared to bacteriophages BALOs display a very non-specific predation of their host cells. 
They have been shown to attack Gram-negative bacteria from very distinct genera: Escherichia, 
Pseudomonas, Salmonella, Campylobacter (Kadouri & O’Toole, 2005; Markelova, 2010). The most 
studied strain of the BALO group is Bdellovibrio bacteriovorus. Previous research has demonstrated 
that Bdellovibrio bacteriovorus HD100 had the widest prey spectrum and was able to predate on a 
range of oral pathogens, can infiltrate and attack surface attached bacteria and even reduce 
Aggregatibacter actinomycetemcomitans biofilm formation (Van Essche et al., 2009, 2011; Dashiff & 
Kadouri, 2011). Furthermore, this predation efficiency was not inhibited in the presence of a Gram-
positive decoy bacterium.  
However, in order to use B. bacteriovorus as a biological agent against periodontal disease the 
polymicrobial nature of the disease should be considered. BALOs should be able to attack oral 
pathogens organized in planktonic communities and complex biofilms and up till now most studies 
have been performed on single species cultures or single species biofilms. Therefore the aim of this 
study was to reveal the effect of B. bacteriovorus HD100 on communities of oral bacteria. First the 
effect of the predator was assessed in a dual species experiment, containing A. actinomycetemcomitans 
together with another target Gram-negative oral pathogen or with a non-target Gram-positive or Gram-
negative decoy. Later on the effect of Bdellovibrio on in vitro communities of 6 oral microorganisms 
was evaluated and finally ex vivo clinical samples from periodontitis patients were used. A closer look 
was also given to the predation specificity of B. bacteriovorus HD100 to establish whether BALOs 
have a preference for certain prey bacteria and whether this preference can be guided into a certain 
direction.  
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2. MATERIALS AND METHODS 
2.1 Strains and culturing conditions 
Prevotella intermedia ATCC 25611, Aggregatibacter actinomyctemcomitans ATCC 43718, 
Porphyromonas gingivalis ATTCC 33277, Fusobacterium nucleatum ATCC 10953, Streptococcus 
mitis ATCC 49456, Actinomyces naeslundii ATCC 52655, Pseudomonas fluorescens ATCC 13525 
and Campylobacter jejuni ATCC 33560 were used as model organisms for in vitro experiments. 
Escherichia coli ML35 ATCC 43827 was used as prey bacterium for Bdellovibrio bacteriovorus 
HD100. Bacterial strains were grown on blood agar plates (Blood Agar Base II; Oxoid, Basingstoke, 
UK) supplemented with 5 µg/ml haemin (Sigma Chemical Co, St. Louis, MO), 1 µg/ml menadion and 
5% sterile horse blood (Biotrading, Keerbergen, Belgium). Bacteria were collected from blood agar 
plates and transferred to 10 ml brain heart infusion broth (BHI) (Difco Laboratories, Detroit, MI). P. 
intermedia, P. gingivalis, A. naeslundii and F. nucleatum were incubated overnight at 37°C in an 
anaerobic atmosphere, A. actinomycetemcomitans and S. mitis were incubated overnight at 37°C in a 
5% CO2 environment, E. coli and P. fluorescens were incubated aerobically at 37°C and C. jejuni was 
incubated in microaerophilic conditions (Anoxomat™ system, Mart Microbiology, The Netherlands). 
Bacterial concentration was adjusted by measuring optical density (OD) at 600 nm. For in vitro 
experiments selective agar plates were prepared for each bacterium. P. intermedia and P. gingivalis 
were cultured on CDC anaerobe 5% sheep blood agar (Becton Dickinson, Franklin Lakes, NJ) , A. 
actinomycetemcomitans on Tryptic soy serum bacitracin vancomycin agar (TSBV): Brain Heart 
Infusion Agar (Oxoid, Basingstoke, UK) supplemented with 5 g yeast extract (Oxoid, Basingstoke, 
UK), 1.5 g sodium fumarate (Sigma Chemical Co, St. Louis, MO), 1 g sodium formiate (Sigma 
Chemical Co, St. Louis, MO) and 0.009 g Vancomycin (Sigma Chemical Co, St. Louis, MO) per l. F. 
nucleatum on crystal violet erythromycin (CVE) agar, per l: 10 g Trypticase (Becton Dickinson, 
Franklin Lakes, NJ), 5 g yeast extract (Oxoid, Basingstoke, UK), 5 g sodiumchloride (Sigma Chemical 
Co, St. Louis, MO), 2 g dextrose (Sigma Chemical Co, St. Louis, MO) and 0.2g L-Tryptophan (Sigma 
Chemical Co, St. Louis, MO) and 15 g agar (Becton Dickinson, Franklin Lakes, NJ) supplemented 
with 5% sterile horse blood (Biotrading, Keerbergen, Belgium), 0.005 g crystal violet (Sigma 
Chemical Co, St. Louis, MO) and 0.004 g erythromycin (Sigma Chemical Co, St. Louis, MO). S. mitis 
on mitis salivarius (MS) agar (Becton Dickinson, Franklin Lakes, NJ) and A. naeslundii on cadmium 
sulfate fluoride acridine trypticase (CFAT) agar. These plates contained per l: Trypticase soy broth 30 
g (Becton Dickinson, Franklin Lakes, NJ), 5 g glucose (Sigma Chemical Co, St. Louis, MO), 13 mg 
cadmium sulfate (Sigma Chemical Co, St. Louis, MO), 80 mg sodium fluoride (Sigma Chemical Co, 
St. Louis, MO), 1.2 mg neutral acriflavin (Sigma Chemical Co, St. Louis, MO), 2.5 mg potassium 
tellurite (Becton Dickinson, Franklin Lakes, NJ), 0.25 mg basic fuchsin (Sigma Chemical Co, St. 
Louis, MO), 15 g agar (Becton Dickinson, Franklin Lakes, NJ) supplemented with 5% sterile horse 
blood (Biotrading, Keerbergen, Belgium). Anaerobic and aerobic growth was determined on blood 
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agar plates (Blood Agar Base II; Oxoid, Basingstoke, UK). B. bacteriovorus HD 100 was kindly 
donated by Prof. E. Jurkevitch of the Hebrew University of Israel and was maintained on double layer 
HM agar plates containing their prey organisms (Van Essche et al., 2011; Jurkevitch, 2006). For the 
preparation of broth cultures of B. bacteriovorus, E. coli ML 35 was suspended in HM medium, 
containing HEPES (25 mM), calcium (3 mM) and magnesium (2 mM) at pH 7.6, to a concentration of 
5 x108 colony forming units (CFU)/ml and inoculated with an adequate amount of B. bacteriovorus to 
obtain a fresh lysate after 18 h of aerobic incubation at 30°C under continuous shaking. Before 
harvesting the predatory bacteria, cultures were examined with phase contrast microscopy. B. 
bacteriovorus cells were separated from the remaining prey by filtration over a 1.2 µm Acrodisk filter 
(Millipore Filter Corporation, Bedford, MA, USA) and 2 additional filtrations over 0.45 µm Acrodisk 
filters. 
 
2.2 DNA extraction and quantitative PCR 
The DNA was extracted with a DNeasy Tissue Kit (QIAGEN, Maryland, USA) in accordance with the 
manufacturer’s instructions. DNA was extracted after treatment with propidium monoazide (PMA), to 
remove DNA from dead bacterial cells as described in Loozen et al. (2011). The amounts and quality 
of DNA extracted were estimated by electrophoresis on a 1% agarose gel. A vitality quantitative 
polymerase chain reaction (qPCR) assay was performed on a CFX96 Real-Time System (BioRad, 
Hercules, CA). The Taqman 5’ nuclease assay PCR method was used for detection and quantification 
of bacterial DNA. Primers and probes were targeted against the 16S rRNA gene for P. 
intermedia (forward (F): 5’-CGGTCTGTTAAGCGTGTTGTG-3’, reverse (R): 5’-CACCATGAAT 
TCCGCATACG-3’, probe: 5’-TGGCGGACTTGAGTGCACGC-3’), A. actinomycetemcomitans (F: 
5’-GAACCTTACCTACTCTTGACATCCGAA-3’, R: 5’-TGCAGCACCTGTCTCAAAGC-3’, 
Probe: 5’-AGAACTCAGAGATGGGTTTGTGCCTTAGGG-3’), P. gingivalis (F: 5’- GCGCTCAA 
CGTTCAGCC-3’, R: 5’-CACGAATTCCGCCTGC-3’, Probe: 5’- CACTGAACTCAAGCCCGGCA 
GTTTCAA-3’), F. nucleatum (F:5’-GGATTTATTGGGCGTAAAGC-3’, R: 5’-GGCATTCCTACAA 
ATATCTACGAA-3’, Probe: 5’- CTCTACACTTGTAGTTCCG-3’) and B. bacteriovorus HD100 
(Van Essche, 2009). Taqman reactions contained 12.5 µl qPCR Mastermix Plus (Eurogentec, Seraing, 
Belgium), 4.5 µl sterile H2O, 1 µl of each primer and probe and 5 µl template DNA. Primers and 
probes were used at different concentrations depending on the organism. Assay conditions for all 
primer/probe sets consisted of an initial 2 min at 50°C, followed by a denaturation step for 10 min at 
95°C, followed by 45 cycles of 95°C for 15 s and 60°C for 60 s. Quantification was based on a 
plasmid standard curve.  
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2.3 Denaturing gradient gel electrophoresis (DGGE) 
PCR was performed with bacterial primers targeting the 16S rRNA gene. The nucleotide sequences of 
the primers are as follows: forward (P338F): 5’-CAGGCCTAACACATGCAAGTC- 3’; reverse 
(P518R): 5’-ATTACCGCGGCTGCTGG-3’. For the forward primers a 5’-GC clamp was added for 
DGGE analysis. The final concentrations of the different components in the mastermix were: 0.2 µM 
of each primer, 200 µM of each deoxynucleotide triphosphate, 1.5 mM MgCl2, 1X Taq DNA 
Polymerase 10X Reaction Buffer (MgCl2-free), 1.25 u/50µl of Taq DNA Polymerase (Promega, 
Madison, WI, USA), 400 ng/µl of bovine serum albumin (Hoffmann-La Roche, Basel, Switzerland), 
and DNase and RNase free filter sterilized water (Sigma-Aldrich Chemie, Steinheim, Germany). 1 µl 
of extracted DNA was added to 24 µl of PCR mastermix. Before each PCR run, the temperature was 
held at 95°C for 10 min, followed by 30 cycles of  denaturation; 1 min at 94°C, annealing: 1 min at 
53°C, elongation: 2 min at 72°C. After each run the temperature was kept at 72°C for 12 min. 
Amplification products were analysed by electrophoresis on 1% agarose gels. DGGE (Denaturing 
Gradient Gel Electrophoresis), based on the protocol of Muyzer and colleagues (1993), was performed 
using the Bio-Rad D Gene System (Bio-Rad, Hercules, CA, USA). The PCR products were loaded 
onto 8% (w/v) polyacrylamide gels in 1xTAE (20 mM Tris, 10 mM acetate, 0.5 mM EDTA pH 7.4). 
The polyacrylamide gels were made with denaturing gradient ranging from 45 to 60 % (where 100% 
denaturant contains 7 M urea and 40% formamide). The electrophoresis was run for 16 hours at 60°C 
and 38 V. After the electrophoresis, the gel is stained for 20 min in 200 ml 1xTAE  and 16 µl SYBR 
Green I (Invitrogen, NY, USA).  The stained gel is visualized immediately with UV transillumination. 
The processing of the DGGE gels was done with the Bionumerics software 2.0 (Applied Maths, Sint-
Martens-Latem, Belgium). 
2.4 Community models 
2.4.1 Dual species model 
A dual species model was used to assess the predation efficiency of B. bacteriovorus HD100 towards 
A. actinomyctemcomitans in the presence of other target microorganisms, P. intermedia, P. gingivalis, 
F. nucleatum and a non-target microorganism, S. mitis. Overnight stationary cultures of all 
microorganisms in BHI were centrifuged (10 min, 6000xg) and washed with HM medium. 
Subsequently, bacterial density was determined at 600 nm and suspensions were prepared for A. 
actinomycetemcomitans containing approximately 1x107 CFU/ml, for all other target and non-target 
microorganisms three suspensions were prepared of 1x106 CFU/ml, 1x107 CFU/ml and 1x108 
CFU/ml. B. bacteriovorus HD100 filtered cultures were centrifuged (20 min; 27,000xg) and 
resuspended in HM medium to an OD600 of 1 (10 log10 cells/ml). 67 µl of the A. 
actinomycetemcomitans suspension was mixed with 67 µl of a decoy microorganism, so that different 
prey: decoy ratios were established of approximately 1:10, 1:1 and 1:0.1. To this mixture 67 µl of B. 
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bacteriovorus HD100 suspension was added. A mixture of A. actinomycetemcomitans and B. 
bacteriovorus HD 100 without decoy was included as positive control, as negative control both A. 
actinomycetemcomitans alone and A. actinomycetemcomitans with decoy was included without 
presence of Bdellovibrio. Viability of prey and decoy was monitored hourly over a 3 h period with 
selective microbial plating. Experiments were performed 3 times at different days.  
 
2.4.2 Six species model 
An in vitro community was set-up using 6 periodontitis-associated model organisms: P. intermedia, A. 
actinomyctemcomitans, P. gingivalis, F. nucleatum, S. mitis, and A. naeslundii. Cultures were 
prepared as described above and the concentration of these planktonic bacteria was adjusted to an 
OD600 of 1x107 CFU/ml, 125 µl of each bacterium was added to reach a suspension of 750 µl. After 
filtration two concentrations of B. bacteriovorus HD100 were prepared OD600=1 and OD600=2. 250 µl 
of Bdellovibrio suspension (OD=1 or OD=2) was added to the 750 µl bacterial mixture, HM medium 
without Bdellovibrio was used as a negative control. Microbiological changes in these communities 
were monitored via microbiological plating over 3 hours. Experiments were repeated 5 times at 
different days. 
 
2.4.3 Ex vivo model 
Saliva and subgingival samples were retrieved from 8 periodontitis patients visiting the Department of 
Periodontology at the University Hospital of Leuven. Patients were informed about the purpose of the 
research and gave their written consent for the analysis performed on their saliva and subgingival 
plaque samples. A dentist recorded their oral health status and dental status. Patients with pocket 
depths exceeding 5 mm were taken up in the study. Patients using antibiotics 6 months prior to the 
sampling were excluded from the study. At least 3 ml of non-induced saliva was obtained from each 
person; subgingival plaque was collected in HM medium. Samples were processed within 2 hrs. 
Samples were vortexed vigorously before use. Both the saliva sample and the subgingival sample were 
divided into 4 tubes (750 µl). Two of the tubes were spiked with 4 periodontitis-associated bacteria: P. 
intermedia, A. actinomyctemcomitans, P. gingivalis and F. nucleatum. The final concentration of each 
microorganism in the suspension was 1x108 CFU/ml determined with optical density at 600 nm. Extra 
HM medium was added to the tubes not spiked with the oral bacteria. To one spiked tube 250 µl of B. 
bacteriovorus (OD=2) was added, the other one served as a control receiving 250 µl of pure HM 
medium. The same protocol was carried out for the non-spiked tubes. All 8 tubes were incubated 
aerobically at 37°C for 24 h. Microbiological changes in these communities were monitored via 
selective microbiological plating at 0, 3 and 24 hours and via qPCR and DGGE. 
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2.5 Predation specificity of B. bacteriovorus HD100 
B. bacteriovorus HD100 was harvested on 4 initial prey bacteria: E. coli ML35, Pseudomonas 
fluorescens, Campylobacter jejuni and A. actinomycetemcomitans, as described under ‘strains and 
culture conditions’. B. bacteriovorus HD100 was allowed to grow on these prey bacteria for 4 
generations after which the final Bdellovibrio suspensions were used to prey on all the 4 initial prey 
bacteria, for example the Bdellovibrio culture harvested on E. coli for 4 generations was used to 
predate on E. coli ML35, Pseudomonas fluorescens, Campylobacter jejuni and A. 
actinomycetemcomitans. After 24 h a sample was taken from each suspension. DNA was extracted by 
use of Instagene Matrix (Biorad, Hercules, CA, USA) according to the manufacturer’s instruction after 
which qPCR on B. bacteriovorus HD100 was carried out.  Later, cultures of B. bacteriovorus HD100 
(OD=1) were prepared, grown on E. coli and A. actinomycetemcomitans. In parallel, cultures of P. 
intermedia, P. gingivalis, A. actinomycetemcomitans and F. nucleatum were prepared as described 
under section ‘strains and culture conditions’ and adjusted to a concentration of 1x107 CFU/ml. For 
each bacterium, three conditions were prepared in a 24-well plates: (1) bacterium without Bdellovibrio 
(control), (2) bacterium with Bdellovibrio culture grown on E. coli, (3) bacterium with Bdellovibrio 
culture grown on A. actinomycetemcomitans. The 24-well plates were incubated aerobically at 37°C. 
Microbial plating was performed at 0 h and 3 h. Experiments were repeated 3 times at different days. 
 
2.6 Alternative electron acceptors for Bdellovibrio 
The predation of B. bacteriovorus HD100 (OD=1) on cultures of A. actinomycetemcomitans (1x109 
CFU/ml) under aerobic or anaerobic circumstances was compared. In addition three conditions were 
included containing cultures of A. actinomycetemcomitans and B. bacteriovorus HD100 combined 
with different concentrations of potassium nitrate (KNO3), 1 mM, 10 mM and 100 mM in the final 
volume. As negative controls cultures of A. actinomycetemcomitans without Bdellovibrio were 
included one incubated aerobically and one incubated anaerobically. Microbial plating was carried out 
at 0 h and 24 h and experiments were repeated 3 times at different days. 
 
2.7 Statistics 
For statistical analysis of the data, the data were log10 transformed to obtain a normal distribution. A 
linear mixed model was built to assess differences between conditions. A correction for multiple 
hypothesis testing was carried out. The significance level was set at p<0.05. Even with a low 
number of patients, satisfactory power was attained 
  
CHAPTER III: Effect of Bdellovibrio bacteriovorus HD100 on multispecies oral communities 
 
66 
 
3. RESULTS 
3.1 Predation efficiency of B. bacteriovorus HD 100 in dual species model 
The influence of the presence of both target (preyed upon by Bdellovibrio) and non-target (not 
attacked by Bdellovibrio) organisms on the predation efficiency of B. bacteriovorus HD100 on A. 
actinomycetemcomitans was analysed in a dual species model, with F. nucleatum, S. mitis, P. 
gingivalis or P. intermedia. A. actinomycetemcomitans significantly (p< 0.001) decreased in numbers 
when Bdellovibrio was added and none of the bacteria interfered with the predation of B. 
bacteriovorus on  A. actinomycetemcomitans (Figure 1). When A. actinomycetemcomitans was mixed 
with F. nucleatum, the log reduction in A. actinomycetemcomitans after 3 hours was lowest in the 
condition using the lowest concentration of F. nucleatum. The biggest decrease was seen with the 
highest concentration of F. nucleatum, a 6.58 log reduction compared to the positive control having a 
log reduction of 5.38 (Figure 1). F. nucleatum was also significantly reduced in the presence of B. 
bacteriovorus (p<0.001): the log reduction was even more pronounced as for A. 
actinomycetemcomitans, dropping to zero in 3 hours for all three starting concentrations (Figure 2). 
For all dual species mixtures a more pronounced reduction in A. actinomycetemcomitans 
concentrations could be observed if the mixture contained a higher concentration of bacteria, as seen 
for F. nucleatum (Figure 1). P. intermedia, P. gingivalis and S. mitis were not predated by B. 
bacteriovorus HD100 (p>0.050) (Figure 2).  
 
 
Figure 1: In vitro dual species experiment: Predation of A. actinomycetemcomitans by B. bacteriovorus HD100 was tested 
in a dual species model with a decoy bacterium: P. intermedia, P. gingivalis, S. mitis or F. nucleatum. Different ratios of 
prey: decoy were used (1:10, 1:1 and 1:0.1). Growth of A. actinomycetemcomitans was monitored over a 3 h period and 
compared with a positive and negative control. Error bars represent standard deviations of the mean (n=3). Statistically 
significant differences (p<0.05) between the control (without Bdellovibrio) and test series are marked with *. CFU: colony 
forming units. 
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Figure 2: In vitro dual species experiment: Predation of A. actinomycetemcomitans by B. bacteriovorus HD100 was tested 
in a dual species model with a decoy bacterium: P. intermedia, P. gingivalis, S. mitis or F. nucleatum. Different ratios of 
prey: decoy were used (1:10,1:1 and 1:0.1). Growth of the decoy bacteria was monitored over a 3h period and compared with 
a positive and negative control. Error bars represent standard deviations of the mean (n=3). Statistically significant 
differences (p<0.05) between the control (without Bdellovibrio) and test series are marked with *. CFU: colony forming 
units. 
 
3.2 Predation efficiency of B. bacteriovorus HD 100 on in vitro bacterial communities 
The effect of B. bacteriovorus HD100 predation on 6-species mixed communities was analysed to 
include the multispecies character of the oral microbiota. Both A. actinomycetemcomitans and F. 
nucleatum showed a significant reduction compared to the negative control (p<0.001) (Figure 3).The 
most pronounced effect was seen on F. nucleatum, with bacterial levels falling to zero after 2-3 hours 
(Figure 3), depending on the B. bacteriovorus concentration. For A. actinomcyetemcomitans (Figure 
3), this effect was slightly slower with bacterial levels falling to zero after 3 hours. For both bacteria 
no significant differences were observed between the two concentrations of B. bacteriovorus HD100 
over the 3h period (p=0.133). 
The other Gram-negative bacteria, P. gingivalis and P. intermedia, were not preyed upon by B. 
bacteriovorus HD100 (p>0.050). For P. intermedia, the control without the predator even showed a 
significantly (p= 0.033) higher log reduction compared to the condition containing B. bacteriovorus 
HD100 (Figure 3). For P. gingivalis, the control without the predator also tended to show (p= 0.16) a 
higher log reduction compared to the condition containing B. bacteriovorus HD100 (Figure 3). The 
levels of the two gram-positive bacteria A. naeslundii and S. mitis remained stable over three hours for 
all three conditions (Figure 3). 
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Figure 3: Effect of B. bacteriovorus HD100 on in vitro multi-species communities: Community was challenged with a 
suspension of B. bacteriovorus HD100 with an OD=1 or OD=2 and compared to a control without Bdellovibrio. 
Concentration of P. intermedia, P. gingivalis, F. nucleatum, A. actinomycetemcomitans, A. naeslundii and S. mitis was 
monitored over 3 h. Error bars represent standard deviations of the mean (n=5). Statistically significant differences (p<0.05) 
between the control (without Bdellovibrio) and test series are marked with *. OD: optical density, CFU: colony forming 
units. 
 
3.3 Effect of Bdellovibrio bacteriovorus HD 100 on ex vivo clinical samples 
The effect of B. bacteriovorus HD100 on ex vivo clinical samples was assessed. Both saliva and 
subgingival plaque samples were retrieved from periodontitis patients. Effects were monitored with 
selective plating (Figure 4) as well as vitality qPCR (Figure 5).  
When looking at the culturing results, the effect of Bdellovibrio was most pronounced for F. 
nucleatum and A. actinomycetemcomitans (Figure 4). Bacterial concentrations were significantly 
decreased compared to the control without B. bacteriovorus HD100 for A. actinomycetemcomitans and 
F. nucleatum in the spiked saliva and spiked subgingival plaque samples (p<0.050). Decreases were 
also visible for the non-spiked samples for F. nucleatum however these were not statistically 
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significant (p>0.05). Bdellovibrio also had an effect on the concentration of P. gingivalis in the spiked 
samples, however the decreases were not significant (p>0.05). For P. intermedia the log reduction in 
the spiked samples over 24 h was significantly higher for the control compared to the condition with 
Bdellovibrio in the subgingival samples (p= 0.045).  
These culturing results were somewhat different from the vitality qPCR results (Figure 5). The vitality 
qPCR results confirmed the results obtained by culturing that F. nucleatum and A. 
actinomycetemcomitans were preyed upon. For F. nucleatum a significant decrease was observed for 
both the spiked saliva samples (p<0.001) as well as the non-spiked subgingival samples (p= 0.038) 
and spiked subgingival plaque samples (p<0.001).  A. actinomycetemcomitans was clearly predated on 
by B. bacteriovorus HD100, with significant decreases in the spiked saliva (p=0.006) and spiked 
subgingival plaque samples (p<0.001). In contrast to the culturing results, P. gingivalis showed a small 
but significant decrease in the non-spiked saliva samples (p=0.003). For P. intermedia no effect of the 
predator was shown (p>0.050).  
The difference in effect on saliva samples and subgingival samples was also evaluated, no significant 
differences with regard to the effect of Bdellovibrio between saliva and subgingival plaque samples 
was seen (p>0.050).  
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Figure 4: The effect of B. bacteriovorus HD100 on ex vivo saliva and subgingival samples with microbial plating: 
Growth of periodontopathogens: P. gingivalis, P. intermedia, F. nucleatum and A. actinomycetemcomitans was monitored 
with culturing techniques at 0 h and 24 h. The effect of B. bacteriovorus HD100 (OD=2) was tested on non-spiked saliva and 
subgingival plaque samples and saliva and subgingival plaque samples spiked with the 4 tested periodontopathogens. The 
effect of the predator was compared to the negative control containing HM medium instead of Bdellovibrio. Error bars 
represent standard deviations of the mean (n=8). Statistically significant differences (p<0.05) between the control (without 
Bdellovibrio) and test series are marked with *. OD: optical density, CFU: colony forming units. 
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Figure 5: The effect of B. bacteriovorus HD100 on ex vivo saliva and subgingival plaque samples with qPCR: Growth 
of periodontopathogens: P. gingivalis, P. intermedia, F. nucleatum and A. actinomycetemcomitans was monitored with 
vitality qPCR at 0 h and 24 h. The effect of B. bacteriovorus HD100 (OD=2) was tested on non-spiked saliva and subgingival 
plaque samples and saliva and subgingival plaque samples spiked with the 4 tested periodontopathogens. The effect of the 
predator was compared to the negative control containing HM medium instead of Bdellovibrio. Error bars represent standard 
deviations of the mean (n=8). Statistically significant differences (p<0.05) between the control (without Bdellovibrio) and test 
series are marked with *. OD: optical density. 
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3.4 Effect of Bdellovibrio bacteriovorus HD 100 on ex vivo clinical samples assessed with 
DGGE 
The effects of B. bacteriovorus HD100 were also assessed with DGGE. Of the 8 different patient 
samples, 1 patient (with the highest numbers of periodontopathogens in non-spiked samples) was 
selected of which community profiles for the different samples, with or without B. bacteriovorus 
HD100, were examined with DGGE (Figure 6 and 7).  
The effect of Bdellovibrio on the community profile is shown in figure 6. The bands indicated by the 
rectangles in figure 6 represent the spiked bacteria (P. intermedia (1), P. gingivalis (2), F. nucleatum 
(3) and A. actinomycetemcomitans (4)), after 24 h the bands representing F. nucleatum (3) and A. 
actinomycetemcomitans (4) disappeared in the condition with Bdellovibrio (red rectangle) whereas 
they were still visible in the control (black rectangle). 
The effect of B. bacteriovorus HD100 on the whole bacterial community was validated when looking 
at the relative band intensities in figure 7 and band numbers table 1. Figure 7 showed that the relative 
band intensities in the presence of B. bacteriovorus HD100 were 82% lower for the non-spiked saliva 
samples, 60% for the spiked saliva samples, 47% for the non-spiked subgingival plaque samples and 
78% for the spiked subgingival plaque samples, compared to the negative control. The shift in the 
community profile in the presence of Bdellovibrio was also noticeable when looking at the band 
numbers in the different conditions (Table 1).   
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Figure 6: The effect of B. bacteriovorus HD100 on ex vivo saliva and subgingival plaque samples with DGGE: Different 
conditions of one patient were put on the gel: non-spiked control sample, non-spiked sample with B. bacteriovorus HD100, 
control sample spiked with P. intermedia (1), P. gingivalis (2), F. nucleatum (3) and A. actinomycetemcomitans(4)  and 
spiked sample with B. bacteriovorus HD100. A DGGE was run for samples taken at 0 h and 24 h. The arrow indicates the 
band representing B. bacteriovorus HD100. The black rectangle indicates the bands of the spiked bacteria without presence 
of Bdellovibrio, the red rectangle indicates bands of the spiked bacteria in presence of Bdellovibrio. 
 
 
Figure 7: Relative band intensities DGGE: The relative average band intensities of the samples treated with B. 
bacteriovorus HD100 were compared to the control without B. bacteriovorus HD100 for: the non-spiked saliva sample, the 
saliva sample spiked with 4 periodontopathogens (P. intermedia, P. gingivalis, F. nucleatum and A. actinomycetemcomitans), 
non-spiked subgingival plaque sample and the spiked subgingival plaque sample. 
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Table 1: Comparison of band numbers for saliva and subgingival plaque samples 
 
Number of bands 
Saliva  
Non-spiked control 18 
Non-spiked + B. bacteriovorus 6 
Spiked control 16 
Spiked + B. bacteriovorus 9 
Subgingival plaque  
Non-spiked control 5 
Non-spiked + B. bacteriovorus 3 
Spiked control 12 
Spiked + B. bacteriovorus 5 
 
3.5 Changing the predation specificity of B. bacteriovorus HD100 
In a first attempt to improve the predation specificity of B. bacteriovorus HD100, 3 bacteria (P. 
fluorescens, C. jejuni and A. actinomycetemcomitans) prone to predation by BALOs were used as 
initial prey beside the standard E. coli. B. bacteriovorus HD100 was grown for 4 generations on these 
prey bacteria, after 4 generations, the B. bacteriovorus concentration was about 1010 bacteria/ml for all 
bacteria. These 4th generation cultures of Bdellovibrio were used to prey on cultures of E .coli, P. 
fluorescens, C. jejuni and A. actinomycetemcomitans. Results showed that the growth of B. 
bacteriovorus HD100 was less when E. coli was used as initial prey (Figure 8 rectangles). This reflects 
that Bdellovibrio grown on E. coli as initial prey was not as efficient in predating on P. fluorescens, C. 
jejuni and A. actinomycetemcomitans. The results for C. jejuni and A. actinomycetemcomitans were 
similar (Figure 8 B and C). However, in subsequent experiments A. actinomycetemcomitans was 
chosen as an alternative to the traditional E. coli because C. jejuni is more difficult to culture. In these 
experiments Bdellovibrio grown on A. actinomycetemcomitans or the traditional E. coli was allowed to 
predate on 4 different periodontopathogens. Results showed that no better predation was achieved on 
P. intermedia, P. gingivalis, F. nucleatum and A. actinomycetemcomitans when A. 
actinomycetemcomitans was used as initial prey in comparison to E. coli (Figure 9). 
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Figure 8: Growth of B. bacteriovorus HD100 on different prey bacteria: Growth of B. bacteriovorus HD100 on different 
prey bacteria, E. coli (A), A. actinomycetemcomitans (B), C. jejuni (C) and P. fluorescens (D), was monitored by quantitative 
PCR. 4 different cultures of Bdellovibrio were tested for their growth on these bacteria. These Bdellovibrio cultures were 
made by growing the predator for 4 generations on E. coli, C. jejuni, P. fluorescens or A. actinomycetemcomitans represented 
by the 4 bars. Error bars represent standard deviations of the mean (n=3). Conditions were E. coli was used as initial prey are 
marked with *.  
 
Figure 9: Testing predation specificity of B. bacteriovorus HD100 by using different initial prey bacteria: The effect of 
B. bacteriovorus (OD=1) was tested on different periodontopathogens with microbial plating: P. intermedia , P. gingivalis , 
F. nucleatum  and A. actinomycetemcomitans . Three conditions were monitored: the periodontopathogens with a negative 
control containing only HM medium, a Bdellovibrio suspension grown on A. actinomycetemcomitans as initial prey, a 
Bdellovibrio suspension grown on E. coli as initial prey. Error bars represent standard deviations of the mean (n=3). CFU: 
colony forming units. 
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3.6 Alternative electron acceptors for Bdellovibrio 
It is known that Bdellovibrio is capable of consuming different substrates instead of oxygen to obtain 
ATP. This is interesting as most periodontopathogens are anaerobic bacteria and thus the oxygen 
requirement of Bdellovibrio is a limitation. Therefore this experiment tested the possible use of 
potassium nitrate (KNO3) as an alternative electron acceptor for Bdellovibrio. Experiments showed 
that Bdellovibrio was not able to prey on A. actinomycetemcomitans when potassium nitrate was 
added in different concentrations (Figure 10). The positive control in aerobic conditions however 
rendered good results (p=0.020).  
 
Figure 10: Use of KNO3 as alternative electron acceptor for B. bacteriovorus HD100: Predation of Bdellovibrio on A. 
actinomycetemcomitans was monitored over 24h under different conditions: with (A) or without (B) the predator under 
anaerobic conditions, with (C) or without (D) Bdellovibrio under aerobic conditions, with Bdellovibrio under anaerobic 
conditions with different concentrations of KNO3: 1 mM (E), 10 mM (F) and 100 mM (G). Error bars represent standard 
deviations of the mean (n=3). CFU: colony forming units. 
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4. DISCUSSION 
Periodontitis is a biofilm-associated infectious disease, which results in the destruction of the tooth or 
implant supporting tissues. At the moment, not one single bacterium could be linked to the onset of the 
disease. However, the proportion of Gram-negative bacteria, like A. actinomycetemcomitans and P. 
gingivalis, has been shown to increase in periodontitis patients (Loomer, 2004; Quirynen et al., 2005). 
Conversely, the Gram-positive part of the oral biofilm exhibits beneficial effects and is necessary for 
maintenance of a healthy balance. In contrary to current treatment protocols, that intend to remove all 
micro-organisms, BALOs only predate on Gram-negative bacteria leaving the Gram-positive part 
unaffected. The feasibility of using predatory bacteria to combat periodontopathogens has already 
been evaluated with positive results on suspensions of planktonic periodontopathogens. However, not 
all periodontopathogens were susceptible to BALO predation. B. bacteriovorus HD 100 had the widest 
prey spectrum, attacking A. actinomycetemcomitans, F. nucleatum, P. intermedia, P. gingivalis and E. 
corrodens, although the effect on P. intermedia and P. gingivalis was very small. This strain was also 
able to predate on single species biofilms of A. actinomycetemcomitans (Van Essche et al., 2009). 
Dashiff and Kadouri (2011) tested another BALO strain, B. bacteriovorus 109J, on this range of 
periodontopathogens. Although no effect was seen on P. gingivalis and P. intermedia, planktonic 
cultures and biofilms of E. corrodens, F. nucleatum and A. actinomycetemcomitans were preyed on by 
B. bacteriovorus 109J. As periodontopathogens are mostly present in the oral cavity as part of a 
complex microbial ecology, it was necessary to validate these positive results on more complex 
bacterial communities. In a first step the effect of the addition of one extra bacterium was examined. 
The presence of target and non-target bacteria could hypothetically change the BALO efficiency by 
e.g. steric hindrance. Furthermore, live decoys can produce extracellular factors such as proteases 
which can influence the susceptibility or growth of the prey and the growth or predation efficiency of 
the predator. A decoy effect was already studied in the past using the non-target Gram-positive 
bacteria A. naeslundii and Bacillus subtilis (Hobley et al., 2006; Van Essche et al., 2011). Van Essche 
and coworkers showed that predation of A. actinomycetemcomitans was not inhibited by presence of 
A. naeslundii (Van Essche et al., 2011). However, Hobley and coworkers (2006) showed that 
predation rate of E. coli was significantly reduced in the presence of B. subtilis.  In the current study, 
besides a non-target Gram-positive S. mitis decoy, the effect of Gram-negative target and non-target 
decoys, on A. actinomycetemcomitans predation by B. bacteriovorus HD100 was investigated. 
Addition of an extra target species will indicate whether B. bacteriovorus will predate on both species 
simultaneously or whether it has a preference for a certain species. It is possible that B. bacteriovorus 
first scouts for F. nucleatum, and later when supplies of this bacterium are exhausted preys upon other 
bacteria like A. actinomycetemcomitans. The presented dual species experiments illustrated the 
previously indicated predation of A. actinomycetemcomitans and F. nucleatum by B. bacteriovorus 
HD100. In contradiction with earlier single species experiments P. gingivalis and P. intermedia were 
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no targets for the predator, however the effect noticed in previous experiments was only small. The 
Gram-positive S. mitis was also not predated on by B. bacteriovorus. Presence of target and non-target 
decoy species did not inhibit the predation of B. bacteriovorus. Even more when concentrations of 
target and non-target species increased a faster and stronger predation of A. actinomycetemcomitans 
was observed. It confirms that B. bacteriovorus prefers environments with a high bacterial 
concentration (Keya & Alexander, 1975; Kadouri & O’Toole, 2005).  When looking at mixes of F. 
nucleatum and A. actinomycetemcomitans it was clear that the predator targeted both species 
simultaneously and did not display a prey preference. However, predation on F. nucleatum went 
slightly faster. 
 
Since the oral microbial ecology is not a 2-species community, the next step was to examine the 
predation efficiency of B. bacteriovorus on 6-species planktonic communities containing target and 
non-target species. Similar to the 2-species community experiments, B. bacteriovorus HD100 was able 
to completely eradicate A. actinomycetemcomitans and F. nucleatum in a 3 hour time span and 
predation of F. nucleatum was faster than predation of A. actinomycetemcomitans. Concentrations of 
Bdellovibrio, higher than 1010 bacteria/ml increased the predation rate only marginally and not 
statistically significantly. The numbers of P. gingivalis and P. intermedia seemed to decrease more in 
the negative control than in the presence of Bdellovibrio. One possible explanation could be the 
aerobicity of the system, as P. intermedia and P. gingivalis are both strictly anaerobic bacteria, 
however the 2-species experiment was also conducted under aerobic circumstances and no effect was 
observed. The fact that numbers of both bacteria are decreasing in the control can also be due to 
bacterial interactions, in this 6-species model. For example, several strains of A. naeslundii have 
already been observed to inhibit growth of P. gingivalis (Tenorio et al., 2011). Besides a decrease in 
the control of P. gingivalis of P. intermedia, it was observed that the concentrations of these two 
bacteria in the presence of Bdellovibrio did not decrease as much as in the 2-species model, 
additionally the numbers of S. mitis and A. naeslundii tended to increase slightly.  It could be that an 
inhibitive effect of A. actinomycetemcomitans or F. nucleatum on these species, under normal 
circumstances without Bdellovibrio, disappears when A. actinomycetemcomitans and F. nucleatum are 
preyed on by the predator. Another plausible explanation is that by the predation of these two species, 
compounds (e.g. cellwall components) are released that are used as nutrients for the other species in 
the community.  
 
Based on the above mentioned experiments, it seems that even in relative simple 6-species 
communities B. bacteriovorus HD100 can be effective in reducing its target prey species. However, it 
also became clear that since such simple 6-species communities also behave as small ecological 
systems, the effect of predation is not only reflected in the disappearance of the target species but also 
in a community shift (higher concentrations of P. intermedia, P. gingivalis, A. naeslundii and S. mitis). 
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Therefore, the effect of Bdellovibrio on highly complex multi-species communities and ecologies had 
to be tested.  Furthermore, it could be that the presence of saliva interacts with the predation efficiency 
of B. bacteriovorus, as saliva is a highly complex solution of organic and inorganic components that 
may affect the interaction of predators with periodontopathogens. As a model, ex vivo clinical 
subgingival plaque and saliva samples of periodontitis patients were used.  Results differed between 
the two used techniques: microbial plating and qPCR. Looking at the results for microbial plating B. 
bacteriovorus predated on F. nucleatum and A. actinomycetemcomitans. For P. intermedia results 
were similar to those of the 6-species community experiments, in the ex vivo experiments the decrease 
in the control was even significantly higher than the decrease in the samples with Bdellovibrio, this 
effect was not seen in the vitality qPCR data. This can be explained by the presence of viable but 
nonculturable (VBNC) bacterial cells. It has long been assumed that bacteria were dead when they 
were no longer able to be cultured. However, several bacteria have been shown to enter into a viable 
but nonculturable (VBNC) state under certain circumstances. When in this state, bacteria have a very 
low metabolic activity and do not divide, however they have the ability to resuscitate from this state 
and become culturable again. For the qPCR assay samples were extracted with PMA to distinguish 
between live and dead bacteria as with normal qPCR dead bacteria are also amplified (Loozen et al., 
2011; Sánchez et al., 2012). As an extra control samples extracted without PMA were also assessed 
with qPCR (data not shown). When relating this with the presence of VBNC, qPCR will show the 
proportion of both viable culturable cells (VBC) and VBNC cells as the assay is based on membrane 
integrity. The culturing technique on the other hand will only show the VBCs. So it seems that the 
difference that is illustrated between P. intermedia in the culturing and qPCR results is due to an 
increase of VBNC cells in the control condition.  
When looking at the rest of the qPCR results, similar to the culturing results both F. nucleatum and A. 
actinomycetemcomitans were attacked by the predator. Additionally, P. gingivalis decreased 
significantly in response to B. bacteriovorus in the non-spiked saliva samples. However, as this was 
performed in saliva, the decrease in P. gingivalis can be caused by a pH drop. A community profile for 
one patient was set-up with DGGE, results confirmed outcomes seen with culturing and qPCR. Bands 
representing the spiked bacteria, F. nucleatum and A. actinomycetemcomitans clearly disappeared in 
the presence of Bdellovibrio. However, it was also obvious that a shift occurred in the whole 
community with the addition of Bdellovibrio, several members of the community decreased in the 
presence of Bdellovibrio whereas some bands showed a higher intensity when Bdellovibrio was 
present. 
Overall, B. bacteriovorus HD100 decreased F. nucleatum and A. actinomycetemcomitans in all tested 
models. However, it was clear that the efficiency of predation of Bdellovibrio decreased when the 
complexity of the system increased. The duration of the experiment can play a role here, it can be that 
Bdellovibrio needs more time to scout, find and attach to their prey as there is a higher culture density 
in saliva and subgingival plaque samples. However, sampling only took place after 24 hours which 
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should give the predator enough time to attack their prey. This was illustrated in a study by Kadouri 
and colleagues (2005) working on E. coli biofilms, no additional reduction of biofilm was seen after 
the first 24 hours, neither when using higher concentrations of the predator. Another explanation for 
the lack in predation can be found in the physiological settings. The interaction between a predator and 
its prey in physiological settings depends on a range of variables that may require extensive 
optimization to obtain results (Van Essche et al., 2011). For example the physiological state of the 
prey bacteria. As the strict anaerobes are unable to survive in the aerobic conditions in which the 
predation experiments were conducted B. bacteriovorus HD100 may have problems to attack those 
non-viable bacteria. However, it has been illustrated that B. bacteriovorus is able to prey on 
metabolically inactive host cells (Varon & Shilo, 1968; Dashiff & Kadouri, 2011). Another possibility 
in this category is a pH effect (Crothers & Robinson, 1971), however the pH of the suspensions was 
measured (data not included) and did not decrease significantly over 24 hours. A final hypothesis why 
predation of Bdellovibrio was less pronounced in clinical samples can be found in the fact that the oral 
cavity is an oral ecosystem that can harbour over 700 different species, of which many can be possible 
targets and all of them interact with each other. The more complex the model the more the aerobicity 
of the environment is going to be affected and a more anaerobic environment will be created. 
Bdellovibrio are strict aerobic bacteria, what may also partially explain the decrease in efficiency in 
more complex models. With this in mind we tried to improve the attack skills of B. bacteriovorus 
making them more adapted to specific oral pathogens and their environment in two ways. The first 
hypothesis was that Bdellovibrio can be conditioned to prey on a certain microorganisms. In order to 
elucidate this Bdellovibrio was grown on different prey bacteria, besides the normal prey bacterium E. 
coli. However, the predation efficiency of Bdellovibrio on periodontopathogens was not enhanced by 
using a different initial prey bacterium (Figure 8 and 9). A second way was by searching other electron 
acceptors for the predator to make it more resistant to an anaerobic environment thereby increasing its 
prey efficiency. Genome sequence indicates that Bdellovibrio could reduce the nitrite or nitric oxide 
that is produced in the periplasm of their prey to nitrogen and in that way gain energy in the form of 
ATP (Sockett & Lambert, 2004). This option was tested in some preliminary experiments so far with 
no positive results (Figure 10).  
 
In conclusion, the effect of Bdellovibrio did not seem to be restricted to the removal of target bacteria, 
but changes in the overall ecology of the different models tested were also observed. Furthermore, the 
efficiency of predation decreased when complexity of the models increased. However, B. 
bacteriovorus was able to attack F. nucleatum, an important bacterium in the development of oral 
biofilms, and A. actinomycetemcomitans, an important pathogen in aggressive periodontitis, even 
when present in ex vivo clinical samples. These effects still have to be validated in in vivo models to 
see the impact of Bdellovibrio on the whole bacterial ecology.  
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CHAPTER IV: Do probiotics offer opportunities to manipulate the periodontal 
oral microbiota? 
 
1. INTRODUCTION 
The interest in probiotics and the modulation of the microbiota for restoring and maintaining health 
has gained a lot of interest over the past decade. The term “probiotic” is a relatively new word and is 
currently used to name bacteria with beneficial effects for humans and animals. As an antonym of the 
term “antibiotics”, it was introduced in 1965 by Lilly and Stillwell as “Substances produced by micro-
organisms which promote the growth of other micro-organisms” (Lilly & Stillwell, 1965). However, 
the use of micro-organisms to promote health is very ancient and can even be traced back to the 
classical Roman literature where food fermented with micro-organisms was used as a therapeutic 
agent (Plinius secundus maior 77 A.D.). Since 1965, several definitions for probiotics have been 
proposed (Parker, 1974; Fuller, 1989; Havenaar & Huis In't Veld, 1992; Naidu et al., 1999; Schaafsma 
1996; Schrezenmeir & de Vrese, 2001). The currently used consensus definition of probiotics was put 
forward by the World Health Organization, and the Food and Agriculture Organization of the United 
States. They defined probiotics as “Live micro-organisms which, when administered in adequate 
amounts, confer a health benefit on the host” (http://www.who.int/foodsafety/fs_management/en/probi
otic_guidelines.pdf). The changing definition mirrors the rapid developments in our understanding and 
use of micro-organisms in human conditions and diseases. The definition will surely have to be further 
adapted as scientists rediscover events taking place at the interface between mucosal surfaces and the 
microbiota, and  interactions of probiotic micro-organisms with the host (Böhm & Kruis, 2006). 
There are a number of reasons why probiotic research has become a hot topic in medicine. Despite 
over 50 years of antibiotics, infectious diseases remain a major health problem, with gastroenteritis 
killing a child every 15 s. Hospital infection rates are not declining, multi-drug resistant bacteria 
continue to emerge as the antibiotic pipeline dries up, and pathogenic micro-organisms are being 
linked with induction or worsening of many chronic diseases. Add to this the alarming spread of 
infectious diseases, plus the pending threat of a deadly flu pandemic, and worried consumers, 
governments, scientists and industries are looking for new approaches to health restoration and 
retention. Science itself is playing a major role, with an ever-growing number of studies providing 
tangible evidence that probiotics can alleviate some disease processes (Reid et al., 2006). 
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Currently, well-established probiotic effects are: 1. Prevention and/or reduction of duration and 
complaints of rotavirus-induced or antibiotic-associated diarrhea as well as alleviation of complaints 
due to lactose intolerance (Majamaa et al. 1995; Buydens & Debeuckelaere 1996; Cremonini et al. 
2002; Hawrelak et al. 2005). 2. Reduction of the concentration of cancer-promoting enzymes and/or 
putrefactive (bacterial) metabolites in the gut (Goldin & Gorbach, 1984; Haskard et al., 2001; 
Ouwehand et al., 2002). 3. Prevention and alleviation of unspecific and irregular complaints of the 
gastrointestinal tracts in healthy people (de Vrese & Schrezenmeir, 2008). 4. Beneficial effects on 
microbial aberrancies, inflammation and other complaints in connection with: inflammatory diseases 
of the gastrointestinal tract, Helicobacter pylori infection or bacterial overgrowth ( Vanderhoof et al., 
1998; Gionchetti et al., 2000; Felley et al., 2001; Gaon et al., 2002; Ishikawa et al., 2003b). 5. 
Normalization of passing stool and stool consistency in subjects suffering from constipation or an 
irritable colon ( Niedzielin et al., 2001; Ouwehand et al., 2002; Koebnick et al., 2003). 6. Prevention 
or alleviation of allergies and atopic diseases in infants (Isolauri et al., 2000; Kalliomaki et al., 2001; 
Isolauri, 2003; Ogawa et al., 2006; Forsythe et al., 2007). 7. Prevention of respiratory tract infections 
(common cold, influenza) and other infectious diseases as well as treatment of urogenital infections. 
Insufficient or at most preliminary evidence exists with respect to cancer prevention, a so-called 
hypocholesterolemic effect, prevention or therapy of ischemic heart diseases or amelioration of 
autoimmune diseases (e.g. arthritis) (Agerbaek et al., 1995; Rafter, 1995; Reid et al., 1995; Reid, 
2001; Naruszewicz et al., 2002; Baharav et al., 2004; de Vrese et al., 2005, de Vrese et al., 2006).  
In contrast to the beliefs of some physicians the oral cavity is not a confined compartment within the 
human body. Anatomically, the oral cavity is connected to the nasopharynx, the larynx, the tonsils, the 
middle ear through the Eustachian tube and the gastrointestinal tract. Physiologically it is connected 
with the whole body and by this, the oral cavity is influenced by and influences general health. 
Consequently, dentists are confronted with similar healthcare problems as physicians. Since the oral 
microbiota is at least as complex as the gastro-intestinal or vaginal microbiota and dental biofilms are 
considered to be difficult therapeutic targets (Socransky & Haffajee, 2002), the encouraging effects of 
probiotics in different fields of healthcare, have resulted recently in the introduction of probiotics for 
oral healthcare (Meurman, 2005; Teughels et al., 2008). Today, several clinical studies on the effects 
of probiotics in different fields of oral healthcare have been published such as: halitosis ( Henker et 
al., 2001; Burton et al., 2006; Kang et al., 2006b), oral candidiasis (Ahola et al., 2002; Hatakka et al., 
2007) and tooth decay ( Nase et al., 2001; Montalto et al., 2004; Nikawa et al., 2004; Caglar et al., 
2005b; Caglar et al., 2006; Caglar et al., 2008; Caglar et al., 2009; Stecksen-Blicks et al., 2009; Cildir 
et al., 2009).  Probiotics have also been introduced in the field of periodontal healthcare. The reason 
why probiotics might provide opportunities for periodontal healthcare can be related to the current 
view on the aetiology of plaque-related periodontal inflammation. This aetiological view considers 
three factors that determine whether disease will develop in a subject (Slots & Rams, 1991; Socransky 
& Haffajee, 1992; Wolff et al., 1994): a susceptible host, the presence of pathogenic species and the 
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reduction or absence of so-called “beneficial bacteria”. Since it is difficult to influence the host 
response, traditional periodontal therapies focused on the reduction of the bacterial threat (Salvi & 
Lang, 2005). This globally applied treatment strategy is based on a mechanical subgingival 
debridement (eventually including periodontal surgery to reduce the depth of the periodontal pocket), 
in combination with improved oral hygiene (Haffajee et al., 2003). This shifts the subgingival 
microbiota to a less pathogenic composition, which is characterized by high proportions of Gram-
positive aerobic species and low proportions or preferably absence of periodontopathogens ( Ximenez-
Fyvie et al., 2000b; Roberts & Darveau, 2002). Unfortunately, it is currently unclear to which 
proportions pathogens need to decrease or Gram-positive aerobic species need to increase to consider 
a subgingival biofilm as being not pathogenic. Although reductions in the total subgingival microbiota 
of up to 2-log values can easily be achieved, a recolonization primarily by less pathogenic bacteria 
towards baseline numbers occurs within weeks (Harper & Robinson, 1987; Goodson et al., 1991; 
Maiden et al., 1991).  The shift towards a less pathogenic microbiota is only temporary, with a re-
establishment of a more aggressive microbiota within weeks to months (Mousques et al., 1980; 
Magnusson et al., 1984; van Winkelhoff et al., 1988; Wade et al., 1992; Quirynen et al., 2005). The 
dynamics of this recolonization process depends on the level of oral hygiene, the efficacy of the 
subgingival debridement and residual probing pocket depths (Magnusson et al., 1984; van Winkelhoff 
et al., 1988; Sbordone et al., 1990; Pedrazzoli et al., 1991; Petersilka et al., 2002).  The temporary use 
of antibiotics or antiseptics, either locally or systemically, does not really improve the long-term effect 
of periodontal therapy (Quirynen et al., 2002). Therefore, some authors have started to focus on the 
third aetiological factor for plaque-related periodontal inflammation: “the reduction or absence of so-
called beneficial bacteria”. From a theoretical point of view, restoring these reduced numbers of 
beneficial bacteria via probiotics may be of considerable interest in the prevention and treatment of 
plaque related periodontal diseases. 
It is however important to realize, as outlined below, that probiotic microorganisms do not act 
exclusively by affecting the microbiota. They can also exert effects either by modulating 
immunological parameters, epithelial permeability, and bacterial translocation, or by providing 
bioactive or regulatory metabolites (de Vrese & Schrezenmeir, 2008). The latter effects are appealing 
for periodontal healthcare since current evidence shows that the destruction of the periodontium is 
substantially mediated by the host and driven by the bacterial challenge (Sanz et al., 2005). Therefore, 
probiotics may not only suppress the emergence of endogenous pathogens or prevent the 
superinfection with exogenous pathogens, but they might also protect us through the promotion of a 
beneficial host response (Roberts & Darveau, 2002). 
Surprisingly, back in 1954, although not called probiotics at that time, a beneficial effect of lactic acid 
bacteria on inflammatory infections of the oral mucosa was reported (Kragen, 1954). Noteworthy are 
also some anecdotal Russian reports from the nineties, on the use of probiotics in the treatment of 
periodontitis ( Pozharitskaia et al., 1994; Grudianov et al., 2002; Volozhin et al., 2004). Next to the 
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scientific introduction of probiotics, commercial exploitation almost immediately followed with 
claimed beneficial effects on periodontal health. Given the potent paradigm shift that this phenomenon 
of oral probiotics can give rise to in the field of periodontal healthcare, it should therefore be based on 
solid clinical evidence.  
 
Purpose 
The purpose of this review was to analyse whether the use of probiotics can influence the periodontal 
microbiota. In order to answer the focused question "Can probiotics offer opportunities to manipulate 
the periodontal microbiota?"  the possible mechanisms of action of probiotics specifically focusing on 
the periodontal environment were addressed narratively. Additionally, the clinical effects of oral 
probiotics on periodontal health were reviewed systematically. 
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2. POSSIBLE MECHANISMS OF PROBIOTIC ACTION (Narrative Review) 
2.1 Search strategy 
In order to review the possible mechanisms of action of oral probiotics on the periodontal 
environment, a Medline (PubMed) search was performed to identify articles investigating the 
addressed question. The search was restricted till June 30, 2010. A similar search was conducted on 
the ISI Web of KnowledgeSM database. The literature was searched specifically focusing on the 
general working concepts of probiotics where we specifically looked for literature related to the oral 
environment and oral bacteria. Due to the low number of papers that came out of the initial searches, 
the searches were not limited to searches where the word “probiotic” was one of the search terms. A 
variety of search terms were used based on the known mechanisms of probiotic interaction in other 
fields of healthcare (de Vrese & Schrezenmeir, 2008).    
Additional hand searches were performed and included: (1) bibliographies of previous reviews on the 
topic of oral probiotics ( Caglar et al., 2005a ; Meurman, 2005; Meurman & Stamatova, 2007; de 
Vrese & Schrezenmeir, 2008; Teughels et al., 2008; Stamatova & Meurman, 2009a; Stamatova & 
Meurman, 2009b; Bonifait et al., 2009), (2) bibliographies of all publications considered in this 
review, (3) cited reference searches of all publications considered in this review using the ISI Web of 
KnowledgeSM database. 
A priori, this review was restricted to full text peer-reviewed publications dealing with oral microbial 
interactions which could constitute the basis for probiotic periodontal healthcare in the English 
language. Data from in vitro, human and animal studies were evaluated.  
 
2.2 Results 
The mechanisms of probiotic action in the mouth are expected to be similar to those observed in other 
parts of the body. However, it has been suggested that gastrointestinal tract probiotics may need some 
additional properties when used as oral probiotics. For instance, oral probiotic bacteria should adhere 
to and colonize periodontal tissue including hard non shedding surfaces and should become part of the 
biofilm. They should not ferment sugars, which subsequently lowers the pH and can be detrimental, 
resulting in caries  (Meurman, 2005; Caglar et al., 2005a).  Although from a theoretical standpoint, 
this might be plausible, currently there is no evidence to support these suggestions. Moreover, many of 
the gastro-intestinal probiotics exert their effect without colonizing or with only a temporary 
colonization of the host. As soon as their intake stops, the probiotic bacteria are excreted. Even 
without a permanent colonization, it may be anticipated that the repeated daily use of probiotic 
products over a long period of time will support an increased level of the probiotic in the oral cavity. 
The observation that probiotic bacteria do not need to permanently colonize their host in order to exert 
their effects can be attributed to their mechanisms of action.  
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The effects of probiotics can originate from three main modes of action: (1) modulation of host 
defenses including the innate as well as the acquired immune system, (2) production of antimicrobial 
substances against periodontopathogens, (3) competitive exclusion mechanisms. In all likelihood there 
exists not a single probiotic bacterium exhibiting all three principles, at least not to the extent that it 
could be a remedy for prevention or therapy of all types of diseases (Bonifait et al., 2009; 
Oelschlaeger, 2010). Therefore probiotic strains are often used in combination with each other in order 
to increase the number of beneficial effects. Also extrapolating effects exerted on the gastro-intestinal 
microbiota to effects on the oral microbiota, is cumbersome.  Additionally, it is important to realize 
that probiotic bacterial strains can behave differently or induce completely opposite effects which 
make generalizations of strain effects to species effects difficult.  
Ultimately evidence must emerge from clinical studies. While certain modes of actions shown in vitro 
suggest a means, these action mechanisms may be altered or degraded within the oral cavity and 
thereby have little chance of conferring oral health benefits (Reid et al., 2006).   
 
2.2.1 Immune modulation 
Despite the obvious anti-microbial actions of probiotics, they can also act on a wide variety of cells to 
modulate the immune reaction towards anti-inflammatory reaction. Probiotic bacteria or their products 
(e.g. metabolites, cell wall components and DNA) can be recognized by host cells such as epithelial 
cells and immune cells ( Delcenserie et al., 2008; Oelschlaeger, 2010). Increased phagocytic capacity 
of macrophages when challenged with Lactobacillus acidophilus and Lactobacillus casei has been 
reported (Perdigon et al., 2002). It is known that probiotics can regulate the expression of 
phagocytosis receptors in the neutrophils of healthy individuals (Pelto et al., 1998) and enhance 
natural killer cell activity (Takeda et al., 2006). They have also been shown to modulate the immune 
response via the adaptive immunity (Link-Amster et al., 1994; Braat et al., 2004). 
Only few studies have been conducted to determine whether immunomodulation by so-called 
beneficial bacteria also applies to the oral environment. In this regard, several publications have shown 
that certain streptococci, such as Streptococcus cristatus, Streptococcus salivarius, Streptococcus mitis 
and Streptococcus sanguinis can attenuate the IL-8 response induced by periodontopathogens such as 
Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans on epithelial cells (Zhang et 
al., 2008; Cosseau et al., 2008; Sliepen et al., 2009a). The exact regulatory systems are still unclear 
although there are indications that these streptococci can inhibit the nuclear factor κB pathway (Zhang 
et al., 2008; Cosseau et al., 2008). Recently, Della Riccia and coworkers (2007) tested in vivo the 
immunomodulatory effects of Lactobacillus brevis on periodontal disease. The in vivo use of this 
probiotic led to a significant decrease in inflammatory markers in the saliva, such as metalloproteinase 
and nitric oxide synthase activity, prostaglandin E2 and interferon (IFN)-γ levels. No effect was seen 
on IgA levels.  
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2.2.2 Antimicrobial substances produced by probiotics 
Probiotic bacteria can produce a diverse range of compounds that act as antimicrobial agents such as 
lactic acid, hydrogen peroxide, bacteriocins and bacteriocin like inhibitory substances (Gillor et al., 
2008; Gordon, 2009; Oelschlaeger, 2010). 
Short-chain fatty acids such as lactic acids can pass across bacterial cell membranes and acidify the 
cytoplasm which in turn can inhibit bacterial proliferation. In this respect, Sookkhee and coworkers 
(2001) were able to isolate lactic acid bacteria from healthy oral cavities of Thai volunteers and 
showed that they had an antimicrobial activity against Porphyromonas gingivalis and Streptococcus 
mutans. This activity was higher at an acidic pH, indicating that the antimicrobial effect was partly 
mediated by organic acids like lactic acid. This observation was largely confirmed by Kõll-Klais and 
coworkers (2005) who showed higher prevalence of obligatory homofermentative lactobacilli, 
especially Lactobacillus gasseri, among healthy persons when compared to periodontitis persons. 
Homofermentative lactobacilli produce higher concentrations of lactic acid in comparison to 
heterofermentative lactobacilli and induced therefore a more pronounced inhibition of P. gingivalis or 
P. intermedia.  
Various in vitro and in vivo studies have shown that production of hydrogen peroxide by probiotic 
bacterial strains can inhibit the growth of pathogenic bacterial species (Mashimo et al., 1985; 
Tompkins & Tagg, 1986; Makras & De Vuyst, 2006; Falagas et al., 2007). In this regard, Hillman and 
Shivers (1988) showed in a gnotobiotic rat model that the level of A. actinomycetemcomitans 
colonization in these rats was 45 fold lower in animals infected with a hydrogen peroxide-producing S. 
sanguinis strain when compared to rats infected with a hydrogen peroxide-deficient mutant of this S. 
sanguinis strain. In 1993 a study by Vanderhoeven and coworkers also showed that S. mutans, in co-
culture with S. sanguinis, was inhibited more when hydrogen peroxide was added to the mixture 
(Vanderhoeven & Camp, 1993).  
Bacteriocins are ribosomally synthesized cationic peptides with a narrow spectrum of antimicrobial 
activity whereas bacteriocin like inhibitory substances have a broader spectrum (Silva et al., 1987; 
Cintas et al., 2001). Several bacteriocins derived from indigenous oral bacteria have been described  
(Oliveira et al., 1998; Teanpaisan et al., 1998; Hillman et al., 2000; Hillman, 2002; Lima et al., 2002; 
Hillman et al., 2007). S. salivarius produces even two potent bacteriocins, salivaricin types A and B. 
This strain has been used to prevent dental caries caused by Streptococcus sobrinus and S. mutans. 
Salivaricin B was effectively used to treat halitosis caused by Prevotella spp. and Micromonas micra 
(Balakrishnan et al., 2000, Burton et al., 2005; Burton et al., 2006). Additionally a bacteriocin from 
Lactobacillus paracasei HL32 was shown to be able to kill P. gingivalis by changing the cell envelope 
of the pathogen (Pangsomboon et al., 2006). 
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2.2.3 Competitive exclusion 
The competitive exclusion principle also referred to as Gause’s law, states that two species that 
compete for the same resources cannot stably co-exist. One of the two competitors will always have a 
slight advantage over the other that leads to extinction of the second competitor or a shift of this 
species to another niche. The competitive exclusion mechanism used by beneficial bacteria can occur 
on two levels: (1) hindering the adhesion of pathogenic bacteria or (2) competing for the same 
nutrients. 
 
2.2.3.1 Hindering the adhesion of pathogenic bacteria 
The literature points out that antagonistic strains are better adapted to their niche than potential 
pathogens, and can therefore interfere in disease by passively occupying the niche or actively 
restricting the adhesion capability of pathogens to surfaces. However, definitive proof that any of these 
mechanisms occur in vivo, has seldom been given. It has been shown that several bacterial strains, 
mainly streptococci can hinder colonization of periodontopathogens to hard and soft tissue surfaces in 
vitro (Teughels et al., 2007a; Van Hoogmoed et al., 2008a; Sliepen et al., 2008; Sliepen et al., 2009b). 
An alternative way for probiotics to hinder pathogens is the production of biosurfactants that prevent 
adhesion. Van Hoogmoed and coworkers (2000) observed that a biosurfactant generated by S. mitis 
(strains BA and BMS) cells was able to decrease the adhesion of S. mutans but also from several 
periodontopathogens. Interestingly, probiotics have been shown to inhibit adhesion by modifying the 
protein composition of the binding site. In this regard Haukioja and coworkers (2008) have shown that 
certain probiotic strains modify the salivary pellicle protein composition by removing an important 
adhesion protein, salivary agglutinin gp340, which is necessary for adhesion of S. mutans. The latter 
resulted in a lower colonization efficiency of S. mutans. 
 
2.2.3.2 Competition for essential nutrients 
Bacteria can compete for certain essential nutrients or chemicals required for growth and in doing so 
can inhibit the growth of a pathogen (Elli et al., 2000).  As an example P. intermedia utilizes vitamin 
K to grow. However, this resource may be replaced by progesterone or estrogen. The levels of 
progesterone and estrogen in gingival crevicular fluid are greatly increased during pregnancy. This 
may explain the transition from a healthy microbiota to the pathogenic one seen during pregnancy 
gingivitis. Probiotic bacteria, able to outcompete periodontopathogens for uptake of these nutrients, 
could improve oral health. More studies have yet to be performed in this field (Wang et al., 1990; 
Smith & Pippin, 1998).  
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2.2.3.3 Other mechanisms of probiotic action 
The above outlined mechanisms of probiotic action are numerous, however other modes of action 
exist. These are either not applicable for the oral situation or studies have not yet been conducted in 
those areas. One example of a probiotic mechanism that is relevant for improving gastro-intestinal 
health is the enhancement of the mucosal barrier function. Probiotics can influence mucosal cell-cell 
interactions by the enhancement of the intestinal barrier function. Disruption of this epithelial barrier 
is encountered in several conditions including inflammatory bowel disease and autoimmune diseases 
such as Type 1 diabetes.  Enhancement of the barrier by probiotics can benefit the host in such 
diseases (Ng et al., 2009). Additionally, invasion of epithelial cells is an important mode by which 
bacteria exert their pathogenicity. For gut epithelial cells anti-invasive properties of probiotic bacteria 
have already been established. Secreted factors of Bifidobacterium bifidum strain Bb12 interfere with 
invasion of epithelial cells by Salmonella Typhimurium (Botes et al., 2008). These domains have not 
yet been explored in relation to the oral cavity.  
 
2.3 Adverse effects and safety 
Whereas it is important to understand the mode of action of oral probiotics, systemic safety of 
probiotics is even more important. It is obvious that, when probiotics are applied orally, at least a part 
of them will be ingested and can interact with a patient’s systemic health. When ingested orally, 
probiotics are generally considered safe and well tolerated, bloating and flatulence are the most 
frequent side effects (Kligler & Cohrssen, 2008). One theoretical concern associated with probiotics 
includes the potential for these viable organisms to move into the blood stream and cause systemic 
infections. Rarely, probiotic-related bacteremia has been reported (Snydman, 2008).  It is estimated 
that the risk of developing bacteremia from ingested lactobacilli probiotics is less than 1 per 1 million 
users (Borriello et al., 2003). Although no serious adverse events have been described in clinical trials, 
systemic infections associated with specific probiotics have been noted in isolated reports. These 
include, sepsis or endocarditis and liver abscess (Snydman, 2008). Bacteremia due to lactobacilli 
rarely occurs, but predisposing factors include immunosuppression, prior hospitalization, severe 
underlying comorbidities, previous antibiotic therapy, and prior surgical interventions (Salminen et al., 
2004). To date there have been no reports of bifidobacterial sepsis associated with the use of a 
probiotic, supporting the low pathogenicity of bifidobacteria species (Boyle et al., 2006). Fortunately, 
most cases of probiotic bacteremia have responded well to appropriate antibiotic therapy. Recently 
major and minor risk factors for probiotic-associated sepsis have been identified. Major risk factors 
include immunosuppression (including a debilitated state or malignancy) and prematurity in infants. 
Minor risk factors are the presence of a central venous catheter, impairment of the intestinal epithelial 
barrier (such as with diarrheal illness), cardiac valvular disease (Lactobacillus probiotics only), 
concurrent administration with broad-spectrum antibiotics to which the probiotic is resistant, and 
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administration of probiotics via a jejunostomy tube (this method of delivery could increase the number 
of viable probiotic organisms reaching the intestine by bypassing the acidic contents of the stomach). 
Therefore Boyle and coworkers (2006) recommend that probiotics should be used cautiously in 
patients with one major risk factor or more than one minor risk factor. Probiotics should also be used 
cautiously in patients taking immunosuppressants, such as cyclosporine, tacrolimus, azathioprine, and 
chemotherapeutic agents, since probiotics could cause an infection or pathogenic colonization in 
immunocompromised patients.  Additionally, probiotic strains of Lactobacillus have also been 
reported to cause bacteremia in patients with short-bowel syndrome, possibly due to altered gut 
integrity (Kligler & Cohrssen, 2008) and Lactobacillus preparations are contraindicated in persons 
with a hypersensitivity to lactose or milk. No contraindications are currently listed for bifidobacteria, 
since most species are considered nonpathogenic and nontoxigenic (Kligler & Cohrssen, 2008). 
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3. CLINICAL EFFECTS OF ORAL PROBIOTICS ON PERIODONTAL HEALTH 
(Systematic Review) 
3.1 Materials and methods 
3.1.1 Focused question 
Do probiotics alter the periodontal condition or the outcome of periodontal therapy? 
 
3.1.2 Search strategy 
A Medline (PubMed) search was performed to identify all articles investigating the addressed 
question. The search was restricted till June 30, 2010. A similar search was conducted on the 
Cochrane and the ISI Web of KnowledgeSM databases. 
Additional hand searches were performed and included: (1) bibliographies of previous reviews on the 
topic of oral probiotics (Caglar et al., 2005a; Meurman, 2005; Meurman & Stamatova, 2007; de Vrese 
& Schrezenmeir, 2008; Teughels et al., 2008; Stamatova & Meurman, 2009a; Stamatova & Meurman, 
2009b; Bonifait et al., 2009) (2) bibliographies of all publications considered in this review, (3) cited 
reference searches of all publications considered in this review using the ISI Web of KnowledgeSM 
database. 
 
3.1.3 Search terms 
The term “replacement therapy” (also called “bacteriotherapy” or “bacterial interference”) is 
sometimes used interchangeably with “probiotics”. Although both approaches use living bacteria for 
the prevention or treatment of infectious disease, there are some slight differences (Teughels et al., 
2008, Wilson, 2004). Since there is much confusion over the terminology, we did not specifically 
differentiate between probiotic therapies and replacement therapies in this review. Therefore, the 
following MeSH terms and key words were used: "probiotic" AND "periodontal", "probiotic" AND 
"periodontitis", "probiotic" AND "periodontics", "probiotic" AND "gingivitis", "probiotic" AND "oral 
health", "replacement therapy" AND "periodontal", "replacement therapy" AND "periodontitis", 
"replacement therapy" AND "periodontics", "replacement therapy" AND "gingivitis", "replacement 
therapy" AND "oral health", "bacteriotherapy" AND "periodontal", "bacteriotherapy" AND 
"periodontitis", "bacteriotherapy" AND "periodontics", "bacteriotherapy" AND "gingivitis", 
"bacteriotherapy" AND "oral health", "bacterial interference" AND "periodontal", "bacterial 
interference" AND "periodontitis", "bacterial interference" AND "periodontics", "bacterial 
interference" AND "gingivitis", "bacterial interference" AND "oral health",  
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3.1.4 Inclusion criteria 
A priori, this review was restricted to full text peer-reviewed publications dealing with probiotics for 
periodontal healthcare in the English language. Data from both human and animal studies were 
evaluated. If articles reported on case series, at least 5 consecutive cases had to be enrolled. All study 
designs were considered.  
 
3.1.5 Exclusion criteria 
Publications not meeting the inclusion criteria were excluded from the review.  
 
3.1.6 Data extraction 
Article selection was determined by screening of the titles and the abstracts by 2 independent 
reviewers (GL & WT). In case of disagreement between the reviewers, inclusion/exclusion decision 
was made by discussion after screening the full text article. Data was extracted simultaneously by the 
2 reviewers and recorded in a data extraction sheet. If data had to be extracted from graphs, this was 
properly acknowledged in the corresponding table. The heterogeneity of the studies and outcome 
variables rendered a meta-analysis impossible. 
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3.2 Results 
Out of the 160 studies retrieved by the Medline, Cochrane and ISI Web of KnowledgeSM database 
searches, 9 were selected based on the inclusion and exclusion criteria (Hillman & Shivers, 1988; 
Krasse et al., 2006; Teughels et al., 2007b; Nackaerts et al., 2008; Shimauchi et al., 2008; Twetman et 
al., 2009; Mayanagi et al., 2009; Staab et al., 2009; Zahradnik et al., 2009). An additional 5 studies 
(Ishikawa et al., 2003a; Kang et al., 2006a; Matsuoka et al., 2006; Della Riccia et al., 2007; Sugano et 
al., 2007) could be retrieved by searching the bibliographies of the selected papers and by cited 
reference searches. Of these 5 studies, one study (Matsuoka et al., 2006) did not meet the inclusion 
criteria since it was written in Japanese. However, this Japanese paper was identical to an English 
paper (Sugano et al., 2007) but included additional clinical data. Therefore, the Japanese study was 
included in this review but only for extracting the clinical data that accompanied the English paper 
version of the study. This resulted in a retrieval of 14 publications (Hillman & Shivers, 1988; Ishikawa 
et al., 2003a; Kang et al., 2006a; Krasse et al., 2006; Matsuoka et al., 2006; Della Riccia et al., 2007; 
Teughels et al., 2007b; Sugano et al., 2007; Shimauchi et al., 2008; Nackaerts et al., 2008; Twetman 
et al., 2009; Mayanagi et al., 2009; Staab et al., 2009; Zahradnik et al., 2009). 
The retrieved studies were extremely heterogeneous in set-up of the study, the used probiotics, the 
mode of application and outcome measures. This heterogeneity did not allow a meta-analysis.  
Only 7 of the 14 papers revealed or referenced in vitro experiments showing that the probiotic strains 
used had the potency to interact with the oral microbiota (Hillman & Shivers, 1988; Ishikawa et al. 
2003a; Matsuoka et al., 2006; Sugano et al., 2007; Teughels et al., 2007b; Nackaerts et al., 2008; 
Zahradnik et al., 2009). The other studies either did not reveal any form of interaction or based the 
selection of the probiotic strain on general assumptions, not specifically relating to periodontal 
healthcare. 
In only 4 papers, reporting on data from 3 independent studies, probiotics were administered to a 
suppressed oral ecology (either as adjunct to scaling and rootplaning or in germ-free animals) 
(Hillman & Shivers, 1988; Krasse et al, 2006; Teughels et al., 2007b; Nackaerts et al., 2008). 
Of the 14 retrieved papers, 3 papers (Hillman & Shivers, 1988; Teughels et al., 2007b; Nackaerts et 
al., 2008) reported on data from 2 independent animal studies. The general outline of the 3 papers or 2 
studies is shown in table 1. Both studies called themselves “replacement therapy” studies rather than 
“probiotic” studies. Additionally, both studies did not use the rather conventional Lactobacillus spp. or 
Bifidobacterium spp. but used streptococci as effector strains. The use of the selected effector strains 
was supported by a series of in vitro experiments or clinical observations that these strains (1) could 
inhibit the growth of periodontopathogens (Tanzer et al., 1985; Hillman et al., 1985) (2) were 
associated clinically with periodontal health (Liljemark et al., 1984; Wolff et al., 1985; Ximenez-
Fyvie et al., 2000a) (3) or could inhibit the colonization of periodontopathogens towards hard and soft 
tissues (Teughels et al., 2007a; Van Hoogmoed et al., 2008).  
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7 of the 14 retrieved papers reported on data from 6 clinical studies where periodontally healthy or 
gingivitis subjects used probiotics. The general outline of these 7 papers is shown in table 2. The 
papers by Krasse and coworkers (2006) and by Twetman and coworkers (2009) reported on parallel, 
double blind, placebo controlled, randomized clinical studies in which Lactobacillus reuteri strains 
were administered. However, the study of Krasse and coworkers did not reveal which strains were 
used. The papers by Shimauchi and coworkers (2008) and Mayanagi and coworkers (2009) both 
reported on one parallel, double blind, placebo controlled, randomized clinical study in which 
Lactobacillis salivarius WB21 was used as a probiotic. All subjects who volunteered to participate in 
the study were company workers of the company that produced the probiotic tablets. Additionally it 
should be noted that in this study, both the probiotic tablets as the placebo tablets contained xylitol. 
The additional clinical studies which were all open label studies, used either Weisella cibaria CMS1 
(Kang et al., 2006a), L. casei shirota (Staab et al., 2009), or a combination of Streptococcus oralis 
KJ3sm, Streptococcus uberis KJ2sm, and Streptococcus rattus JH145 (Zahradnik et al., 2009). 
It should be noted that in only one of the papers reporting on the effects of a probiotic treatment on 
healthy or gingivitis patients (Krasse et al., 2006), the probiotics were administered as an adjunct to 
conventional plaque removal. 
Of the 14 retrieved papers, 4 papers reported on data from 3 independent clinical studies on 
periodontitis patients. The general outline of these 4 papers is shown in table 3. 3 of the 4 papers used 
the same probiotic strain, Lactobacillus salivarius TI 2711 and came from the same group of 
researchers. The paper of Ishikawa and coworkers (2003a) did not explicitly mention that the patients 
that participated in this study were periodontitis patients. However, we assumed that these were 
periodontitis patients based on the 2 additional papers (Matsuoka et al., 2006; Sugano et al., 2007) 
published by co-authors on the initial Ishikawa paper and based on the use of the same probiotic 
strains. Only the paper of Matsuoka and coworkers (2006) provided data on periodontal disease 
(average PD of 4.5 mm). The paper by Della Riccia and coworkers (2007) mentions that these patients 
were chronic periodontitis patients but do not provide data on periodontal disease. It was a clear 
limitation that for only 1 of the 3 independent studies (or 2 of the 4 papers), data was provided that 
proved that these were real periodontitis patients.  It should be noted that in none of the papers 
reporting on the effects of a probiotic treatment on periodontitis patients, were the probiotics 
administered as an adjunct to conventional scaling and rootplaning.  
 
3.2.1 Microbiological changes 
6 papers reported on microbiological changes induced by probiotic therapies (Table 4). In general, all 
studies showed at least that probiotic application resulted in microbiological changes, even though 
they were not always applied as an adjunct to standard periodontal treatment (scaling or rootplaning). 
Unfortunately, most of the studies did not perform a statistical inter-group analysis. In the gnotobiotic 
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rat model study of Hillman and Shivers (1988), it was shown that the level oral colonization by A. 
actinomycetemcomitans was approximately 1.8 log lower in animals co-infected with S. sanguinis 
KJ3sm and 1.0 log lower in animals co-infected with the revertant of the hydrogen peroxide-deficient 
mutant of KJ3sm than in animals infected only with A. actinomycetemcomitans. Although the 
experiments were repeated in humans, they were never published because the levels of the S. 
sanguinis effector strain decreased continuously following infection until they were undetectable in 
saliva and plaque samples, usually within 5 weeks (Haffajee, personal communication). In the Beagle 
dog model study of Teughels and coworkers (2007b), where no oral hygiene was performed, multiple 
applications of S. salivarius, S. mitis, S. sanguinis resulted in significant microbiological changes in 
subgingival plaque. Significant decreases in the numbers of anaerobic bacteria, black pigmented 
bacteria, Porphyromonas gulae (canine variant of Porphyromonas gingivalis), Prevotella intermedia, 
Campylobacter rectus were noted and a tendency to increased numbers of aerobic bacteria was 
observed. In comparison to scaling and rootplaning alone, multiple subgingival applications of S. 
salivarius, S. mitis, S. sanguinis resulted in a significant additional microbiological reductions of 0.5 
log in anaerobic bacteria, 0.6 log in P. gulae, 0.6 log in black pigmented bacteria and 0.7 log in P. 
intermedia, 12 weeks after rootplaning and without any form of oral hygiene. 
The publication by Mayanagi and coworkers (2009) unfortunately did not allow data extraction. 
However, the authors reported that the numerical sum of five selected periodontopathogenic bacteria 
in the probiotic group was significantly decreased in subgingival plaque after 4 weeks of probiotic 
usage and tended to be lower after 8 weeks when compared to the placebo group.  Using a multivariate 
model adjusting for bacterial counts at baseline, plaque index, and smoking status, the authors 
calculated that the odds ratio for a reduction of Tannerella forsythensis in the probiotic group was 
significantly increased over the course of the study compared to the placebo group. 
Zahradnik and coworkers (2009) detected 2.6 and 2.1 log reductions for respectively C. rectus and P. 
gingivalis in subgingival plaque when subjects were asked to rinse with a mixture of 3 streptococci. 
Although the data were not provided, the authors mention that the probiotic mixture did not influence 
the subgingival P. intermedia numbers. 
When combining the microbiological effects for L. salivarius TI 2711 on untreated periodontitis 
patients, Ishikawa and coworkers (2003a) and Sugano and coworkers (2007) showed that this 
probiotic could reduce the salivary black pigmented bacteria levels with 1.3 log. Additionally, when 
compared to a placebo treatment, additional subgingival reductions of 0.93 log in P. gingivalis levels 
could be achieved.   
 
3.2.2 Changes in plaque index 
5 studies (Krasse et al., 2006; Kang et al., 2006a; Della Riccia et al., 2007; Shimauchi et al., 2008; 
Staab et al., 2009) report on changes in the amount of plaque when probiotics were used (Table 5). 
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Surprisingly, only in the study of Krasse and coworkers (2006), plaque was removed prior to starting 
the probiotic therapy. With the exception of Staab and coworkers (2009), who even found an increase 
in plaque index, all studies report significant reductions on plaque index when compared to baseline 
values. Only 2 studies have performed an inter-group comparison. Krasse and coworkers (2006) found 
no statistically significant differences between placebo and the probiotic groups whereas Shimauchi 
and coworkers (2008) could find a significant difference in favour of the probiotic group but only for 
current smokers. 
 
3.2.3 Changes in gingivitis index 
Of the 4 studies that reported on changes in gingivitis index, 3 studies (Krasse et al., 2006; Della 
Riccia et al., 2007; Shimauchi et al., 2008) report statistically significant decreases in gingivitis index 
when compared to baseline values (Table 5). In contrast, the study by Staab and coworkers (2009) 
shows a statistically significant increase in gingivitis index. Of the 2 studies that performed an inter-
group statistical analysis, only the study by Krasse and coworkers (2006) showed significant 
differences between the placebo and one of the probiotic formulations. 
 
3.2.4 Bleeding upon probing  
All 3 human studies that report on bleeding upon probing show significant decreases when compared 
to baseline values (Table 5) (Twetman et al., 2009; Della Riccia et al., 2007). However, in the study 
by Twetman and coworkers (2009), the authors noticed that as soon as the probiotic intake was 
stopped, the percentage of sites that were bleeding upon probing positive, increased again. Only 1 
study looked for significant inter-group differences. This clinical study (Shimauchi et al., 2008) did 
not detect a statistically significant difference between the probiotic groups and the placebo group. 
However, in the Beagle dog study of Teughels and coworkers (2007b) (not incorporated in table 5) , a 
statistically significant lower bleeding upon probing was observed for pockets that received multiple 
applications of probiotics, when compared to scaled and rootplaned pockets alone (30% vs. 45% 
respectively). This was considered to be remarkable by the authors since in this 12 week study, no oral 
hygiene was provide to the dogs. 
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3.2.5 Probing pocket depth (PD) and clinical attachment level (CAL) 
Of the 2 human studies that reported on changes in probing pocket depth (Matsuoka et al., 2006; 
Shimauchi et al., 2008), only the study by Shimauchi and coworkers (2008) could detect statistically 
significant greater improvements in PD for the probiotic group, but only for current smokers (Table 5). 
Also the Beagle dog study of Teughels and coworkers (Teughels et al., 2007b) failed to show any 
significant inter-group differences in neither PD, nor in CAL improvements. These results were not 
surprising to the authors since no oral hygiene was provided to the dogs during the 12 week duration 
of the study.   
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3.2.6 Inflammatory markers  
In the study of Twetman and coworkers (2009), the focus was predominantly on gingival 
inflammation and the production of pro- and anti-inflammatory cytokines (IL-1b, TNF-a, IL-6, IL-8 
and IL-10). During the 2 weeks of intervention, the gingival crevicular fluid volume decreased 
significantly in the probiotic groups whereas no significant changes were noted in the placebo group. 
The levels of TNF-α and IL-8 decreased also significantly after 1 and 2 weeks respectively, in the 
probiotic group which used the highest dose of probiotics, compared to baseline. However, these 
effects were only temporary and tended to return to baseline values 2 weeks after discontinuing the 
probiotics.  
 
Shimauchi and coworkers (2008) reported mainly on the clinical outcome of the study but also 
analysed salivary lactoferrin levels. The study showed that during the course of the study, for both the 
placebo as the probiotic group, salivary lactoferrin levels decreased significantly from baseline values. 
However, no significant differences were found between both study groups. 
Staab and coworkers (2009), who investigated the effects of a commercially available probiotic milk 
containing L. casei Shirota on gingival health analysed, next to the amount of interproximal plaque 
and plaque index, the papilla bleeding index and polymorphonuclear elastase, myeloperoxidase and 
matrix metalloproteinase-3 in gingival crevicular fluid. At the end of this 8 week study, elastase 
activity was significant lower in the probiotic group when compared to the control group. When 
compared to baseline values, the plaque index and papilla bleeding index increased and amount of the 
matrix metalloproteinase-3 decreased in the probiotic group whereas they did not change in the control 
group. In the 4 day study of Della Riccia and coworkers (2007), using a L. brevis (CD2) lozenge on 
untreated periodontitis patients, significant decreases were seen in nitrite/nitrate, prostaglandine E2 
(PGE2), matrix metalloproteinase and IFN-gamma levels in saliva at the end of the study. 
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3.2.7 Other effects 
Based on the Beagle dog model study of Teughels and coworkers (2007b), Nackaerts and coworkers 
(2008) analysed radiologically the alveolar bone around the teeth that received the positive control 
treatment and the alveolar bone around the teeth that received rootplaning and repeated application of 
the bacterial mixture. These authors observed that the bone density within periodontal pockets treated 
with beneficial bacteria improved significantly after 12 weeks, while this improvement was not 
statistically significant for the positive control pockets. There was also a statistically significant 
increase in the bone level at the end of the study for the pockets receiving beneficial bacteria whereas 
no statistically significant increase was noted for the control pockets. It should be noted that, as 
mentioned before, in these Beagle dog studies, no oral hygiene was provided to the dos during the 12 
week study period. Therefore, these data may not be generalized to more conventional human studies.  
Additionally, in the 4 day study of Della Riccia and coworkers (2007), significant reductions in 
calculus and tooth temperature sensitivity were noted. 
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4. DISCUSSION 
The present review tried to address the question whether probiotics offer opportunities to manipulate 
the periodontal oral microbiota, and by this offer opportunities to prevent or treat periodontal 
infections.  Although there is a clear rationale for using probiotics in periodontal healthcare, the 
possible mechanisms by which probiotics can influence the oral microbiota and periodontal health 
have been only sparsely investigated. They have been based mainly on mechanisms of action observed 
in gastrointestinal indications. The variety of mechanisms on which probiotics can act makes it 
difficult to suggest any form of in vitro test to substantiate any probiotic claim before going into 
clinical testing. Nevertheless, appropriate target-specific in vitro tests that correlate with in vivo tests 
or outcome measures are recommended. In relation to gastro-intestinal probiotics, the World Health 
Organization, suggested in 2002 a combination of tests to verify the gastro-intestinal survival of 
probiotics (resistance to gastric acid and bile, adherence to mucus, human cells or cell lines) and the 
microbiological effect (antimicrobial activity against potentially pathogenic bacteria or the ability to 
reduce pathogen adhesion). Obviously, not all of these recommendations are applicable to probiotics 
for periodontal healthcare. Additionally, these recommendations focus on substantiating an 
antimicrobial effect whereas it is currently known that the anti-inflammatory/immune modulatory 
properties of probiotics are at least as important. Before translating these recommendations to the field 
of periodontal healthcare, it is necessary before clinical testing, to demonstrate that the putative 
probiotic shows at least a beneficial potential (either antimicrobial, anti-inflammatory, immune 
modulatory or any other clinically verifiable outcome measure specific to the periodontal field) at an 
in vitro level. Any additional material supporting the survival of the potential probiotic in the oral 
cavity would be beneficial. These recommendations do not prioritize local safety regulations and 
testing in regards to probiotic use. It should be noted that the currently available testing mechanisms 
are not fully adequate to predict functionality of probiotic microorganisms in the oral cavity. It should 
also be noted that in vitro data available for particular strains are not sufficient for describing them as 
probiotic. Probiotics for human use will require substantiation of efficacy with human trials. 
Several clinical studies were identified that addressed the focused question. These studies could 
mainly be divided in studies directly addressing the issue by providing microbiological outcome 
measures and studies that indirectly addressed the issue by providing clinical outcome measures.   
These studies often utilized small sample sizes and often lacked appropriate randomization, blinding, 
study set-up or control groups. Due to this low quality of some studies, one needs to be careful in the 
interpretation of the data.  
The number of papers that report on real periodontitis outcome measures is low and there is currently 
no (randomized controlled trial) RCT involving periodontitis patients with an appropriate placebo 
control that performed an inter-group statistical analysis. Moreover, low number of studies make inter-
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group comparisons with true placebos or negative controls. This was rather surprising since this is the 
only reliable way of accounting for Hawthorne effects.  
There is also a lot of heterogeneity among studies since different probiotic doses (2x107 – 2x109 
CFU/day), treatment durations (1 day – 12 weeks), models (human, animal) and patient populations 
(healthy, gingivitis, periodontitis), strains, modes of application are being used. Reflecting upon the 
probiotic strains used, it was surprising that some studies lacked strain specification. Since probiotic 
effects are specific to a particular strain, this may have important implications for the interpretation of 
generalizing review data, particularly when strain designations were not provided. In regards to the 
modes of application, the vehicle by which they are ingested or delivered in the oral cavity can also 
influence their therapeutic potential and the oral colonization of a probiotic. The currently available 
data makes it impossible to draw any firm conclusions given the wide variety of delivery vehicles 
(chewing gum, mouth-rinse, tablets etc.). Therefore the results should be interpreted cautiously due to 
all of these methodological limitations.  
Taking into account the above mentioned limitations and generalizing the data provided in both animal 
and human studies reporting on microbiological outcomes of various probiotic treatments, these 
studies report up to 0.55 log reductions in total anaerobic bacteria, up to 0.25 log increases in total 
aerobic bacteria, up to 1.3 log reductions in black pigmented bacteria, up to 1.8 log reductions in A. 
actinomycetemcomitans numbers, up to 2.6 log reductions in C. rectus numbers, up to 2.1 log 
reductions in P. gingivalis numbers, up to 1 log reductions in P. intermedia numbers and up to 0.17 log 
reductions in T. forsythensis. 
When taking a closer look at the clinical findings of the different human studies concerning probiotics 
taking again into account the above mentioned limitations of the studies and warning for 
generalization of the data, it seems that the effects of probiotic bacteria on the periodontal condition 
(plaque index, gingivitis index, bleeding upon probing, probing pocket depth) are much more limited 
in magnitude when compared to the studies reporting on microbiological outcomes.  
Despite these observations, 4 additional considerations can be made based on the reviewed studies and 
in regards to the use of probiotics to improve periodontal health. 
(1) It was surprising for the reviewers that many of the studies tried to induce a microbiological shift 
or a clinical probiotic effect in an already matured oral microbiological environment. Based on our 
knowledge of the effect of antiseptics and antibiotics on established biofilms and nicely demonstrated 
in a recent study by Pham and coworkers (2009), it seems logical that a probiotic will have difficulty 
colonizing the mouth and exerting beneficial clinical effects under those circumstances. Pre-treatment 
to reduce the levels of oral indigenous microbiota, and thereby create more sites for colonization by 
probiotic bacteria, might be a good option but this approach was limited in most of the studies (Krasse 
 et al., 2006; Teughels et al., 2007b; Tsubura et al., 2009). 
(2) The often limited clinical results may be attributed to the use of dietary lactobacilli as probiotics of 
choice for a large number of the studies. Indigenous bacteria offer the advantage of being perfectly 
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adjusted to the human oral ecology. Therefore the existence of probiotics in the indigenous microbiota 
needs exploration and the use of orally derived probiotics can be recommended. Some groups have 
investigated the potential of the indigenous streptococcal population to act as probiotics. The 
importance of this population has already been described by Roos and coworkers for oto-pharyngeal 
infections (Roos et al., 1993; Roos et al., 1996).  
(3) Probiotic therapy should not be seen as a treatment which permanently alters the oral microbiota. 
There are indications that the probiotic effect will only take place as long as the probiotic is applied. 
As soon as the patient discontinues its use, the effect will likely disappear, therefore does not appear to 
sustain a shift to a stable non-pathogenic microbiota. 
(4) Finally, one should realize that probiotics are currently regulated as dietary supplements and not 
subjected to the same rigorous standards as medications. As a result, individuals may obtain a product 
that is ineffective or that contains varying quantities of bacteria. 
 
In conclusion, data suggests that probiotics may offer opportunities to manipulate the oral microbiota 
or, albeit more limited, periodontal health by either direct microbiological interactions or by 
immunomodulatory interactions. However, due to all the limitations discussed above, it is currently 
premature to draw any conclusion on the clinical significance of the statistically significant results. 
Future research needs to encompass better designed clinical trials in larger populations in which we 
urgently need to address following issues: 
- Long term effects of oral probiotics? 
- Specific oral probiotics coming from the oral cavity or general lactobacilli probiotics? 
- Adjunct therapy or mono-therapy? 
- Statistical inter- as well as intra-group comparisons should be made. 
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CHAPTER V: β-methyl-D-galactoside, a potential prebiotic against periodontal 
diseases?  
 
1. INTRODUCTION 
In the oral cavity a dynamic balance exists between the host, the environment and the oral microbiota 
(Marsh, 1994, 2003). A disturbance of this delicate balance can lead to the development of periodontal 
diseases such as gingivitis and periodontitis, one of the most prevalent oral diseases of our time (Paster 
et al., 2001; Aas et al., 2005). Not all oral microorganisms within the oral cavity contribute equally to 
the disease. Improved cultivation techniques resulted in the discovery of associations between specific 
species, so called “key pathogens”, and infectious oral pathologies. However, additional scientific data 
have suggested that such a simple correlation may be an oversimplification. The assembly of smaller 
pieces cannot explain the whole. This has led over the past decade to the introduction of “holism” and 
“system thinking” within oral microbial research by adopting new concepts such as interspecies 
interactions, microbial community, biofilms, poly-microbial diseases etc. Unlike many known 
“medical” pathogens, that are “foreign invaders with specific virulence factors”, the “oral” pathogens 
are part of a normal endogenous microbiota. It is known that the microbial ecology in dental plaque 
biofilms at diseased sites is distinct from that found at healthy sites (Socransky & Haffajee, 1992; 
Marsh, 1994; Paster et al., 2001). Based on microbial culturing and molecular techniques, it seems that 
biofilms in shallow non-inflamed periodontal pockets consist mainly of Gram-positive, saccharolytic, 
and facultative anaerobic bacteria, such as Streptococcus species. The biofilms in inflamed deep 
periodontal pockets consist of a microbiota dominated by Gram-negative and obligate anaerobic 
species (Slots, 1977; Slots & Rams, 1991; Paster et al., 2001). A recent pyrosequencing study by 
Griffen and colleagues (2012) largely confirmed the aforementioned results from an ecological 
perspective. Additionally, it provided a much broader picture of overall community differences 
between biofilms coming from healthy and diseased sites and a much deeper look at community 
complexity.  
The knowledge that distinct bacterial profiles exist in healthy and diseased periodontal pockets might 
offer new opportunities for the prevention and treatment of periodontal diseases by focusing on 
restoring the concentrations of health-associated bacteria, ‘beneficial bacteria’, instead of removing 
the complete microbiota and thus destroying the ecosystem. Although much research has already been 
conducted concerning beneficial bacteria and gastrointestinal health, the role of these species in the 
progression of periodontitis is less obvious. These beneficial bacteria can exert their effect 
conceptually (1) by passively occupying a niche which may otherwise be colonized by pathogens, (2) 
by actively limiting a pathogen’s ability to adhere to appropriate tissue surfaces, (3) by adversely 
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affecting the vitality or growth of a pathogen, (4) by affecting the ability of a pathogen to produce 
virulence factors or (5) by degrading virulence factors produced by the pathogen.  
It has been shown that Streptococcus salivarius, Streptococcus sanguinis and Streptococcus mitis can 
inhibit colonization of Aggregatibacter actinomycetemcomitans on hard as well as on soft tissues 
(Teughels et al., 2007a). Interestingly they can also attenuate the interleukin (IL)-8 response from 
epithelial cells induced by periodontopathogens (Sliepen et al., 2009). In vivo application of these 
species in periodontal pockets of Beagle dogs after root planing also retarded the recolonization of 
periodontopathogens and reduced bleeding on probing (Teughels et al., 2007b). Indigenous 
‘beneficial’ species, like S. salivarius and S. sanguinis, also exert some antagonistic action against 
cariogenic streptococcal species from the oral cavity (Kreth et al., 2005, 2008, 2009; Ogawa et al., 
2011). 
In this respect, prebiotics may be an interesting and new preventive or treatment option by stimulating 
this indigenous beneficial bacterial population. It can be hypothesized that by stimulating the growth 
of specific beneficial oral bacteria, they could acquire a growth benefit over other bacteria thereby 
possibly creating a shift in the microbial ecology. Prebiotics have been defined as selective ingredients 
that allow specific changes, both in the composition and/or activity in the gastrointestinal microbiota 
that confers benefits upon host well-being and health (Roberfroid, 2007). Different compounds are 
able to meet these criteria however, up till now the vast majority of studies on prebiotics have focused 
on inulin, fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS). There are a number of 
reasons why these compounds have attracted the most attention as possible prebiotics. First of all most 
research on prebiotics has been conducted in the gastrointestinal field and these compounds possess 
certain properties that make them excellent candidates for use on the gastrointestinal microbiota.  For 
one they are not sensitive to gastric acid and are not substrates for hydrolytic enzymes in the upper 
digestive tract. Furthermore, with the eye on the food industry both GOS and FOS are stable at high 
temperatures and in an acid environment and the calorific value of these oligosaccharides is very low. 
The beneficial bacteria that serve as targets for prebiotics have been almost exclusively bifidobacteria 
and lactobacilli (Gibson 1999; Bouhnik 2004). It was demonstrated that prebiotics can decrease 
colonic pH and increase the concentration of bifidobacteria (Macfarlane & Cummings, 1999; Van Loo 
et al., 1999). Although most studies have put emphasis on the effect on these bacterial species, 
prebiotics can also exert their effect in different ways. Immune modulation is one possibility. Some 
GOS for example are able to mimic eukaryotic cell surface receptors that virulent bacteria normally 
adhere to as part of the pathogenicity process, thereby decreasing pathogenicity.  GOS and FOS 
fermentation can also lead to increased butyrate production which has been shown to suppress both 
cytokine-induced and constitutive expression of the transcription factor NF-κB in certain cell lines 
(Inan, 2000). Besides immune modulation effects were seen concerning allergies, inflammatory bowel 
disease, rheumatology and cancer. Limited to no research has been conducted concerning the effect of 
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prebiotics on the oral cavity (Devine & Marsh, 2009). Caglar and co-workers (2007) tried to use 
xylitol as a candidate prebiotic to reduce acid production from Streptococcus mutans. The idea of 
using prebiotic approaches to influence biofilm development has been suggested in some articles 
(Bowden & Li, 1997) but has never been attempted. Finding a prebiotic compound specifically 
stimulating the beneficial indigenous streptococcal species would therefore be very interesting. In this 
study, the aim was to screen for and select potential prebiotics that potentially could specifically 
stimulate the growth of indigenous beneficial species in the oral environment, without stimulating the 
pathogenic species. Metabolic stimulation of a range of carbon sources was assessed on some 
beneficial, commensal and pathogenic oral bacteria. The effect of a potential prebiotic substrate on 
species-specific growth was verified. Additionally, the effect of substrate-induced outgrowth of a 
beneficial species on the growth of oral pathogens was verified to assess whether stimulation caused a 
reduction of pathogenic bacteria.  
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2. MATERIALS AND METHODS 
2.1 Strains and culturing conditions  
The pathogenic species Prevotella intermedia ATCC 25611, Aggregatibacter actinomyctemcomitans 
ATCC 43718, Porphyromonas gingivalis ATTCC 33277, Fusobacterium nucleatum ATCC 10953, 
Eikenella corrodens ATCC 23834, beneficial species Streptococcus mitis ATCC 49456, Streptococcus 
sanguinis ATCC 49297,  Streptococcus salivarius TOVE-R, Streptococcus salivarius ATCC 7073, 
Streptococcus salivarius K12, clinical isolate of Streptococcus salivarius, cariogenic species 
Streptococcus mutans ATCC 25175, Streptococcus sobrinus ATCC 33478 and commensal species 
Actinomyces naeslundii ATCC 52655,  Streptococcus gordonii ATCC 49818 and Capnocytophaga 
sputigena ATCC 33612 were used as model organisms for experiments. Bacterial strains were grown 
on blood agar plates (Blood Agar Base II; Oxoid, Basingstoke, UK) supplemented with 5 µg/ml 
haemin (Sigma Chemical Co, St. Louis, MO), 1 µg/ml menadion and 5% sterile horse blood 
(Biotrading, Keerbergen, Belgium). Bacteria were collected from blood agar plates and transferred to 
10 ml brain heart infusion broth (BHI) (Difco Laboratories, Detroit, MI). P. intermedia, P. gingivalis, 
A. naeslundii, F. nucleatum and E. corrodens were incubated overnight at 37°C in an anaerobic 
atmosphere, A. actinomycetemcomitans, S. mitis, C. sputigena, S. mutans, S. salivarius, S. sanguinis, 
S. gordonii and S. sobrinus were incubated overnight at 37°C in a 5% CO2 environment. Bacterial 
concentration was adjusted by measuring optical density (OD) at 600 nm.  
 
2.2 Growth on different energy sources 
Growth on different energy sources was tested for 3 beneficial indigenous bacteria: S. salivarius 
TOVE-R, S. sanguinis and S. mitis, 1 cariogenic bacterium: S. mutans, 3 commensal bacteria: A. 
naeslundii, S. gordonii, C. sputigena and 5 periodontopathogens : P. intermedia, P. gingivalis, A. 
actinomycetemcomitans, E. corrodens by means of phenotype microarrays for microbial cells 
(PM2a™)  supplied by Biolog Inc. (Hayward, USA) according to the manufacturer’s instructions. The 
microarrays are based on redox chemistry, using cell respiration as a universal reporter. After selection 
of the compound β-methyl-D-galactoside, growth curves were established in a rich medium, BHI, for 
S. salivarius (different strains), S. mutans, S. sobrinus and periodontopathogens: P. intermedia, P. 
gingivalis, F. nucleatum and A. actinomycetemcomitans till stationary phase was reached. 20 µl of 
different concentrations of β-methyl-D-galactoside (0.1-0.5-1-5 mg/ml) was added to 200 µl of a 
suspension of the bacterium with a concentration of 1x107 CFU/ml. As positive control D-glucose was 
used instead of β-methyl-D-galactoside, pure sterile BHI was used as negative control. For the 
periodontopathogens only the highest concentration of the compound (5 mg/ml) was tested. 
Experiments were repeated 3 times at different days. 
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2.3 In vitro effect of β-methyl-D-galactoside on periodontopathogens 
Bacterial suspensions of periodontopathogens, P. intermedia, F. nucleatum, A. 
actinomycetemcomitans and P. gingivalis and beneficial species, S. salivarius NIH were prepared of 
which the OD was adjusted to 1x107 CFU/ml. Experiments were carried out in a dual-species model in 
24-well plates containing one periodontopathogen (1 ml) and S. salivarius (1 ml). Different conditions 
were tested: the two microorganisms with or without β-methyl-D-galactoside (200 µl), only the 
periodontopathogen with or without β-methyl-D-galactoside (200 µl). D-glucose (200 µl) was used as 
a positive control, tested in a mixture with the two species and tested on the periodontopathogen alone. 
Both β-methyl-D-galactoside and D-glucose were used at a final concentration of 1 mg/ml. When S. 
salivarius was not added to the mixture, BHI was added to obtain an equal volume. Plates were 
incubated at 37°C in an anaerobic atmosphere. Selective microbial plating was carried out at 0 h, 24 h, 
and 48 h. Selective agar plates were prepared for each bacterium. P. intermedia and P. gingivalis were 
cultured on CDC anaerobe 5% sheep blood agar (Becton Dickinson, Franklin Lakes, NJ). A. 
actinomycetemcomitans on Tryptic soy serum bacitracin vancomycin agar (TSBV), per l: Brain Heart 
Infusion Agar (Oxoid, Basingstoke, UK) supplemented with 5 g yeast extract (Oxoid, Basingstoke, 
UK), 1.5 g sodium fumarate (Sigma Chemical Co, St. Louis, MO), 1 g sodium formiate (Sigma 
Chemical Co, St. Louis, MO) and 0.009 g Vancomycin (Sigma Chemical Co, St. Louis, MO). F. 
nucleatum on crystal violet erythromycin (CVE) agar, per l: 10 g Trypticase (Becton Dickinson, 
Franklin Lakes, NJ), 5 g yeast extract (Oxoid, Basingstoke, UK), 5 g sodiumchloride (Sigma Chemical 
Co, St. Louis, MO), 2 g dextrose (Sigma Chemical Co, St. Louis, MO) and 0.2g L-Tryptophan (Sigma 
Chemical Co, St. Louis, MO) and 15 g agar (Becton Dickinson, Franklin Lakes, NJ) supplemented 
with 5% sterile horse blood (Biotrading, Keerbergen, Belgium), 0.005 g crystal violet (Sigma 
Chemical Co, St. Louis, MO) and 0.004 g erythromycin (Sigma Chemical Co, St. Louis, MO). And 
finally S. salivarius on Phenylethyl alcohol agar (Becton Dickinson, Franklin Lakes, NJ). Besides 
microbial plating results were also analysed with quantitative PCR (qPCR). The DNA of the samples 
was extracted with a DNeasy Tissue Kit (QIAGEN, Maryland, USA) in accordance with the 
manufacturer’s instructions. A qPCR assay was performed on a CFX96 Real-Time System (BioRad, 
Hercules, CA). The Taqman 5’ nuclease assay PCR method was used for detection and quantification 
of bacterial DNA. Primers and probes were targeted against the 16S rRNA gene for P. intermedia, A. 
actinomycetemcomitans, P. gingivalis, F. nucleatum (Boutaga et al., 2005) for S. mutans and S. 
sobrinus primers and probe were targeted against the glucosetransferase gene B and T respectively 
(Yoshida et al., 2003). Taqman reactions contained 12.5 µl qPCR Mastermix Plus (Eurogentec, 
Seraing, Belgium), 4.5 µl sterile H2O,1 µl of each primer and probe and 5 µl template DNA. Primers 
and probes were used at different concentrations depending on the organism. Assay conditions for all 
primer/probe sets consisted of an initial 2 min at 50°C, followed by a denaturation step for 10 min at 
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95°C, followed by 45 cycles of 95°C for 15 s and 60°C for 60 s. Quantification was based on a 
plasmid standard curve. Experiments were repeated 3 times at different days. 
 
2.4 Influence of pH on effect of β-methyl-D-galactoside 
Three different cultures of S. salivarius in BHI were prepared, containing either D-glucose, β-methyl-
D galactoside or no compound and incubated overnight. Bacterial suspensions were centrifuged at 
7000 g for 10 min. after which supernatant was collected and filtered using 0.2/0.8 µm Acrodisk 
syringe filters (Millipore Filter Corporation, Bedford, MA, USA). The pH of each suspension was 
measured after which the supernatant of each condition was divided in half to obtain 6 different 
suspensions. 3 tubes (1 with D-glucose, 1 with β-methyl-D galactoside, 1 without compound) were 
used as positive control as the pH was adjusted to 7.0 with sodium hydroxide (NaOH). To test for a 
pH effect suspensions of 4 periodontopathogens (P. intermedia, F. nucleatum, A. 
actinomycetemcomitans, and P. gingivalis) were prepared and adjusted spectrophotometrically to a 
concentration of 1x107 CFU/ml. Experiments were carried out in a 24-well plate in which 1 ml of the 
periodontopathogen was added to 1 ml of the 6 different supernatant suspensions. pH was adjusted to 
original values to compensate for the buffering effect of the 1 ml bacterial suspension. Plates were 
incubated at 37°C in an anaerobic atmosphere. Microbial plating was carried out at 0 h and 24 h. 
Experiments were repeated 3 times at different days. 
 
2.5 Statistical analysis  
Growth curves were modelled for the different mixtures with non-linear regression and a comparison 
was carried out on the last measurements with pairwise comparisons. For statistical analysis of the 
experiments with β-methyl-D-galactoside, the data were log10 transformed to obtain a normal 
distribution. A linear mixed model was built to assess differences between conditions. A correction for 
multiple hypothesis testing was carried out. Significance level was set at p<0.05. In the experiments 
testing the effect of β-methyl-D-galactoside on the periodontopathogens only the reduction over 48 h 
was assessed. 
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3. RESULTS 
3.1 Growth stimulation to different energy sources  
The phenotype microarray consisted of 95 different carbon sources. These microarrays employ cell 
respiration as a universal reporter. If the phenotype is strongly “positive” in a well, the cells respire 
actively thereby reducing a tetrazolium dye and forming a strong color. If the phenotype is weakly 
positive or negative, respiration is slowed or stopped, and less or no color is formed. Results were 
obtained by measuring the plates with a spectrophotometer reader at an OD of 630 nm. Carbon 
sources specifically stimulating beneficial bacteria could serve as possible prebiotic compounds. The 
phenotype microarray results brought forward one compound, β- methyl-D- galactoside that strongly 
stimulated cell respiration of S. salivarius TOVE-R, a beneficial bacterium, without affecting cell 
respiration of periodontopathogens or cariogenic bacteria (Figure 1). Besides effects on beneficial 
bacteria, the microarray also provided data concerning the effect of these carbon sources on 
pathogenic bacteria. Several compounds were found to selectively stimulate pathogenic bacteria. An 
overview of the numbers of carbon sources stimulating the different groups of bacteria is shown in 
table 1, the complete list containing all carbon sources and their stimulatory effect can be found in 
addendum (Table 1). 
Table 1: Number of stimulatory carbon sources in tested biolog plate for different bacterial groups: Carbon sources 
were regarded as stimulatory if optical density was raised with factor 2 compared with negative control.  
 Number of stimulatory carbon sources 
Pathogenic species 9 
Beneficial species 1 
Both 17 
None 68 
 
After selection of β-methyl-D-galactoside as a selective stimulator of S. salivarius TOVE-R, growth 
curves were carried out with β-methyl-D-galactoside that confirmed the results from the phenotype 
microarray (Figure 2, 3 and 4). For S. salivarius TOVE-R is significant stimulation was observed for 
all concentrations (p<0.001), the best results were obtained with the highest concentration of the 
compound, stimulation of growth reduced gradually with decrease in concentration (Figure 2A). 
Neither S. mutans nor the other cariogenic bacterium S. sobrinus were stimulated in growth by 
different concentrations of β-methyl-D-galactoside (Figure 2B and C) (p>0.05). Next, three extra 
strains of S. salivarius were tested. S. salivarius ATCC 7073 (type strain) did not respond to the 
compound. However ,S. salivarius K12 and the clinical isolate responded to the compound, showing a 
significant increase in growth compared to the control (p<0.001) (Figure 3). When looking at the 
growth curves of the periodontopathogens, no effect of β-methyl-D-galactoside on the growth could be 
demonstrated (Figure 4) (p>0.05).  
CHAPTER V: β-methyl-D-galactoside, a potential prebiotic against periodontal diseases? 
132 
 
 
Figure 1: Biolog phenotype microarray: Absorbance for all tested oral bacteria, after 24 h in a PM2a™ plate (Biolog Inc.) 
in response to the negative control (dark grey bar) and β-methyl-D-galactoside (light grey bar). Cell respiration is correlated 
with OD630 values. OD: optical density. 
 
Figure 2: Growth curves of S. salivarius TOVE-R (A), S. mutans (B) and S. sobrinus (C): Growth was monitored over 10 
h. β-methyl-D-galactoside was present in different concentrations ranging from 0.1 mg/ml to 5 mg/ml in the final suspension. 
BHI without the bacterium was used as negative control. BHI: Brain heart infusion broth. 
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Figure 3: Growth curves of S. salivarius ATCC 7073 (A) S. salivarius clinical isolate (B) and S. salivarius K12 (C): 
Growth was monitored over 24 h. β-methyl-D-galactoside or D-glucose were present at a final concentration of 1 mg/ml. The 
negative control only contained BHI. BHI: Brain heart infusion broth. 
 
Figure 4: Growth curves of P. intermedia (A), F. nucleatum (B), P. gingivalis (C) and A. actinomycetemcomitans (D): 
Growth was monitored over 48 h. β-methyl-D-galactoside or D-glucose were present at a final concentration of 1 mg/ml. The 
negative control only contained BHI. BHI: Brain heart infusion broth. 
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3.2 In vitro effect of β-methyl-D-galactoside on periodontopathogens 
In vitro competition experiments were set-up to examine the indirect effect of the prebiotic compound 
on the concentration of periodontopathogens (Figure 5). For A. actinomycetemcomitans a significant 
decrease (p<0.001) in concentration was observed after 24 h when S. salivarius and β-methyl-D-
galactoside were added compared with the control containing only A. actinomycetemcomitans or only 
A. actinomycetemcomitans and S. salivarius (Figure 5). This could also be observed for all other 
periodontopathogens (p<0.001) (Figure 5). Best results were achieved with P. gingivalis with a decline 
in concentration to zero after only 24 h (Figure 5). F. nucleatum and P. intermedia were the only 
pathogens with concentration levels remaining above zero after 48 h (Figure 5). Significant reductions 
were also illustrated when D-glucose was added to the dual species mixture for all bacteria (p<0.001). 
Presence of S. salivarius alone did not lead to a significant reduction in the concentration of F. 
nucleatum (p=0.998) compared with the control containing only the periodontopathogen (Figure 5). 
For A. actinomycetemcomitans, F. nucleatum and P. intermedia the concentration of the 
periodontopathogen increased even after 24 h when incubated together with S. salivarius. For P. 
gingivalis a significant reduction was also observed when the pathogen was cultured together with S. 
salivarius without an extra carbon compound (p<0.001) compared with the control containing only the 
pathogen. However, as mentioned above, this reduction was significantly lower compared to the 
conditions containing the carbon sources. Besides microbial plating, effects were also assessed with 
qPCR (Figure 6). Results showed no significant decrease in the concentration of any of the pathogens 
when incubated together with S. salivarius and β-methyl-D-galactoside or D-glucose (p=0.9999). 
However, growth was also not observed in contrast with the control containing only the pathogen, 
which points to an effect of the compound. When these results were compared with those of the 
microbial plating, most trends were similar with exception of condition F for P. intermedia were an 
increase is noticed in the microbial plating (Figure 5) in contrast with a decrease in the qPCR results 
(Figure 6).  
In figure 7 the same experiments were repeated for the two cariogenic species, S. mutans and S. 
sobrinus. No reduction was observed when β-methyl-D-galactoside and S. salivarius were present for 
both microorganisms (p=0.9999). S. sobrinus even increased in concentration after 24 h when β-
methyl-D-galactoside was added without S. salivarius, however its numbers decreased again after 48h. 
Growth was also analysed with qPCR (Figure 7). Results were similar, although no reduction was seen 
after 48 h. During the course of the experiments the pH of the different conditions was measured 
(Table 2), these results illustrated that for all experiments the pH was lower when the compound and 
S. salivarius were added to the suspension, even lower than in the presence of D-glucose and S. 
salivarius.  
CHAPTER V: β-methyl-D-galactoside, a potential prebiotic against periodontal diseases? 
135 
 
 
Figure 5: In vitro effect of β-methyl-D-galactoside on periodontopathogens with microbial plating: Numbers of A. 
actinomycetemcomitans, F. nucleatum , P. intermedia and P. gingivalis were monitored at 0 h,24 h and 48 h in response to: 
β-methyl-D-galactoside with (E) or without (D) the presence of S. salivarius and D-glucose with (C) or without (B) S. 
salivarius. Beside the control only containing the periodontopathogen (A), a second control containing the 
periodontopathogen and S. salivarius without addition of carbon source was included (F) Error bars represent standard 
deviations of the mean (n=3). Statistically significant differences (p<0.05) between the control (only pathogen) and test series 
are marked with *. CFU: colony forming units. 
 
Figure 6: In vitro effect of β-methyl-D-galactoside on periodontopathogens with qPCR: Numbers of A. 
actinomycetemcomitans, F. nucleatum, P. intermedia and P. gingivalis were monitored at 0 h,24 h and 48 h in response to: β- 
methyl-D-galactoside with (E) or without (D) the presence of S. salivarius and D-glucose with (C) or without (B) S. 
salivarius. Beside the control only containing the periodontopathogen (A), a second control containing the 
periodontopathogen and S. salivarius without addition of carbon source was included (F). Error bars represent standard 
deviations of the mean (n=3). CFU: colony forming units. 
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Figure 7: In vitro effect of β-methyl-D-galactoside on cariogenic bacteria: Bacteria were monitored at 0 h, 24 h and 48 h 
with microbial plating for S. mutans and S. sobrinus and with qPCR for S. mutans and S. sobrinus. Growth in response to 
different conditions was assessed: β-methyl-D-galactoside with (E) or without (D) the presence of S. salivarius and glucose 
with (C) or without (B) S. salivarius. Beside the control only containing the periodontopathogen (A), a second control 
containing the periodontopathogen and S. salivarius without addition of carbon source was included (F). Error bars represent 
standard deviations of the mean (n=3). CFU: colony forming units. 
 
Table 2: pH values at 24h for all tested bacteria: pH measured in in vitro dual species experiments for different conditions: 
β-methyl-D-galactoside with (E) or without (D) the presence of S. salivarius and D-glucose with (C) or without (B) S. 
salivarius. Beside the control only containing the periodontopathogen (A), a second control containing the 
periodontopathogen and S. salivarius without addition of carbon source was included. (F) 
 pH value 
A B C D E F 
A. actinomycetemcomitans 5.97 5.75 5.14 5.76 4.96 5.72 
P. intermedia 5.8 5.47 4.92 5.67 4.76 5.83 
P. gingivalis 5.75 5.69 5.13 5.78 4.77 5.68 
F. nucleatum 5.83 5.73 4.89 5.71 4.71 5.71 
S. mutans 5.57 4.93 4.85 5.55 4.84 5.41 
S. sobrinus 5.76 5.06 4.95 5.64 4.87 5.6 
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3.3 Influence of pH on effect of β-methyl-D-galactoside 
This experiment was set-up to test whether the decrease in the concentration of periodontopathogens 
in the presence of β-methyl-D-galactoside was due to a pH effect as indicated in the previous 
experiment (Table 2). After the overnight growth of cultures of S. salivarius combined with the 
prebiotic compound, D-glucose (positive control) or physiological water (negative control) the average 
pH was the lowest when S. salivarius was incubated together with β-methyl-D-galactoside. Here an 
average pH of 4.7 was measured compared to an average pH of 4.9 in the case of D-glucose and 5.6 
when no extra compound was added, the results are identical to pH values measured in the in vitro 
experiments (Table 2). To test if this additional decrease in pH value was the cause of the reduction in 
periodontopathogens these cultures of S. salivarius were added to cultures of periodontopathogens 
(Figure 8). Indeed, a significant decrease (p<0.001) in pathogenic bacteria was observed when the pH 
was 4.7 or 4.9 compared to the control containing only the pathogen. Compared to this control, a 
significant reduction (p<0.001) in pathogen concentration was also detected when the pH had a value 
of 5.6 (physiological water), however a statistical significant difference in reduction (p<0.001) was 
illustrated between the pH value of 4.7 (β-methyl-D-galactoside) or 4.9 (D-glucose) and the pH value 
of 5.6 (physiological water). These results mimicked those from the previous in vitro experiments. To 
investigate whether this was solely a pH effect or whether this effect was enhanced by a factor present 
in the supernatant of the culture, extra controls were incorporated, with a manually raised neutral pH 
of 7.0. No significant effect of the neutralized supernatant was demonstrated compared with the 
control (p=0.999). 
 
Figure 8: Influence of pH on effect of β-methyl-D-galactoside: Numbers of A. actinomycetemcomitans, P.intermedia, F. 
nucleatum and P. gingivalis were monitored at 0 h and 24 h. Growth of the control containing only the pathogen (A) was 
compared to growth of the pathogen in combination with supernatant of overnight S. salivarius cultures containing, D-
glucose (B) β-methyl-D-galactoside (D) or physiological water (F). In addition growth of the control was compared to growth 
of the pathogen in combination with supernatant of overnight S. salivarius cultures containing D-glucose (C), β-methyl-D-
galactoside (E), and physiological water (G) of which the pH was raised to 7.0. Error bars represent standard deviations of 
the mean (n=3). Statistically significant differences (p<0.05) between the control (only pathogen) and test series are marked 
with *. CFU: colony forming units. 
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4. DISCUSSION 
With the arrival of the ecological plaque hypothesis, current protocols to treat periodontal diseases are 
being revised. The hypothesis implies that periodontitis develops when certain selection pressures 
disturb the microbial balance in the oral cavity stimulating pathogenic bacteria (Marsh, 1994). 
Alternative ecologically based treatment options aiming towards a stable microbial balance in the oral 
cavity are gradually gaining ground.  One option is to stimulate beneficial indigenous bacteria, thereby 
countering the outgrowth of pathogenic bacteria by use of prebiotics. However, the use of prebiotic 
substrates to restore the balance has been scarcely investigated (Devine & Marsh, 2009). In this study, 
one compound β-methyl-D-galactoside was found to be a potential oral prebiotic. Of the tested oral 
bacteria β-methyl-D-galactoside specifically stimulated S. salivarius in the phenotype microarray 
(Figure 1). S. salivarius is a prominent member of the oral microbiota and an early colonizer of oral 
surfaces (Carlsson et al., 1970). It has excellent potential for use as an oral probiotic (Wescombe et al., 
2012). It has not yet been implicated in either caries or periodontal disease and is most closely related 
to S. thermophilus, a bacterium widely used in the dairy food industry (Delorme, 2008). Furthermore, 
some strains of S. salivarius are found to produce bacteriocin-like inhibitory substances (BLIS), which 
are antimicrobial peptides. S. salivarius K12 is considered to be a particularly good candidate, it 
produces two antimicrobial peptides: salivaricin A2 and salivaricin B, active against Streptococcus 
pyogenes strains (Burton et al., 2006; Masdea et al., 2012). It also has antimicrobial activity against 
bacteria involved in halitosis thereby decreasing oral malodour (Masdea et al., 2012). Furthermore, the 
bacterium is already commercially available as a probiotic and has plenty studies supporting its safety 
(Burton et al., 2006, 2011).  
β-methyl-D-galactoside is formed when glucose and galactose react during acid catalysis. The methyl-
group is covalently linked with the glucose or galactose molecule by a glycosidic linkage (Aguilar & 
Guareño, 2000). After obtaining the phenotype microarray results indicating this compound as a 
possible prebiotic compound, a genetic screening and literature search were performed on all bacteria 
tested in the phenotype microarray to check whether the other tested beneficial and pathogenic 
bacteria had the machinery to import and metabolize β-methyl-D-galactoside (Addendum, table 1). In 
this way the tiniest option that this compound could lead to a stimulation of these oral pathogens could 
be excluded. The uptake and metabolism of β-methyl-D-galactoside by bacteria was first described in 
E. coli. Here the metabolisation of β-methyl-D-galactoside depends mainly on specific enzymes 
implicated in galactose and lactose metabolism. Therefore a first search was carried out on different 
oral bacteria for the presence of a range of lactose and galactose enzymes. Screening for lactose and 
galactose key genes revealed that all investigated beneficial and commensal bacteria can potentially 
use both lactose and galactose. The Gram-negative group lacks any machinery for lactose uptake. For 
P. gingivalis and A. actinomycetemcomitans this does not imply the disability to grow on lactose as 
they can secrete extracellular β-galactosidase. P. intermedia is even unable of processing galactose 
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because no genetic information is present coding for either the Leloir or the tagatose 6-phosphate 
pathway. All other investigated bacteria show the genetic capability to perform the Leloir pathway and 
as such to metabolise intercellular galactose. Additionally, a genetic search was performed for β-
methyl-D-galactoside transport genes, using protein sequences for the different E. coli transporters. 
Search for these transport genes in oral bacteria was done to rule out the possible processing or import 
of β-methyl-D-galactoside by pathogenic microorganisms. Results indicated that 4 from the 
investigated oral microorganisms, i.e. S. salivarius, S. sanguinis, A. actinomycetemcomitans and F. 
nucleatum, are theoretically able to synthesize the required transport proteins to import β-methyl-D-
galactoside. So from the periodontopathogens only A. actinomycetemcomitans is able to metabolize 
both lactose and galactose and import β-methyl-D-galactoside (Addendum table 2). However, this was 
not demonstrated in the phenotype microarray (Figure 1).  
In order to reproduce the conditions in the mouth, the next step was to validate the results of the 
phenotype microarray in a rich medium as the oral cavity is a nutrient rich environment that is ideal 
for supporting microbial growth.  The medium of choice was BHI, this medium contains a range of 
nutrients, including glucose. Growth curves for S. salivarius using a range of concentrations of β-
methyl-D-galactoside confirmed previous results and showed a linear relationship between growth 
stimulation of different strains of S. salivarius and concentration of β-methyl-D-galactoside (Figure 2 
and 3). S. salivarius ATCC 7073 was not stimulated by the compound, this type strain was purchased 
from DSMZ and was isolated from blood from a patient with acute articula rheumatism and thus was 
not of oral origin. Our isolated clinical S. salivarius strain on the other hand responded positively to β- 
methyl-D- galactoside as did the S. salivarius K12 strain (Figure 3). The compound did not stimulate 
pathogenic microorganisms in a rich medium (Figure 2 and 4). This turns β-methyl-D-galactoside into 
an excellent candidate for prebiotic use. As in these experiments no stimulation to the compound was 
observed for A. actinomycetemcomitans in contrast with results found in the genetic screening, 
transcription or translation processes could be in play leading to a non-functional transporter. One last 
test with a minimal medium (own experiment, data not included) was conducted to validate specific 
stimulation of S. salivarius, as growth kinetic experiments were executed in a rich medium containing 
glucose and the medium in the phenotype microarray was provided by the manufacturer, without 
revealing the exact composition. At first this minimal medium was assembled from different anorganic 
macro- and micronutrients supplemented with haemin (iron source) and vitamin K. However, when a 
carbon source like D-glucose was added to the medium no growth could be observed indicating a 
potential nitrogen limitation. Therefore tryptone was added to the medium. The minimal medium 
(supplemented with tryptone) allowed comparison of growth of oral bacteria on different related 
carbohydrates (D-glucose, galactose, lactose and β-methyl-D-galactoside). The medium confirmed the 
results for consumption of β-methyl-D-galactoside. However, for the asaccharolytic bacterium P. 
gingivalis growth was observed in every condition as it uses tryptone as energy source. While some 
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genes for carbohydrate metabolism are found in the genome, P. gingivalis derives its energy from the 
metabolism of amino acids.  
 
To see whether specific stimulation of S. salivarius caused a reduction in pathogenic bacteria, 
competition experiments were carried out (Figure 5, 6 and 7) using two techniques. With microbial 
plating the concentration of all tested periodontopathogens significantly decreased over a 48h period 
when β-methyl-D-galactoside was added to the mixture compared to the control (p<0.001). Same 
results were achieved for the mixture with D-glucose. D-glucose can however not be used as a 
prebiotic compound as it is metabolised by a wide range of bacteria including periodontopathogens, P. 
intermedia and F. nucleatum and cariogenic microorganisms such as S. mutans and S. sobrinus. 
Although this gave a good result in a dual species model, in the oral cavity D-glucose could potentially 
lead to an overgrowth of these pathogens. Significant reductions were not observed when 2 species 
were not supplemented with an extra carbon source except for P. gingivalis. The effect of β-methyl-D-
galactoside was also investigated with qPCR, with this technique no significant reductions in pathogen 
concentrations were observed, only a growth stop was shown. This can easily be explained by the fact 
that DNA from dead bacteria is also amplified with qPCR and thus a reduction from 0h to 24h cannot 
be monitored (Figure 6).  
Similar experiments were also conducted with two cariogenic bacteria: S. mutans and S. sobrinus 
(Figure 7). For the qPCR results the same problem exists as for the periodontopathogens (Figure 8). 
When looking at the culturing results it was noticed that presence of S. salivarius caused a small 
reduction in the S. mutans concentration no extra decrease was observed in the presence β- methyl-D- 
galactoside (Figure 7). S. sobrinus even seemed to be stimulated by β-methyl-D-galactoside (Figure 
7), this was in contrast to the results of the growth curves were no stimulation was seen (Figure 2). 
This can be explained by the presence of viable but not-culturable (VBNC) bacterial cells. It has long 
been assumed that bacteria were dead when they were no longer able to be cultured. However, several 
bacteria have been shown to enter into a viable but nonculturable (VBNC) state under certain 
circumstances. When in this state bacteria have a very low metabolic activity and do not divide, 
however they have the ability to resuscitate from this state and become culturable again. In the growth 
curve experiments results were obtained by measuring the optical density, so both in the control as 
well as the condition containing β-methyl-D-galactoside both the fraction of viable culturable cells 
(VBC) as the VBNC cell fraction were measured. While in the competition experiments only the 
VBCs were able to grow on the blood agar plates. So it is possible that in both experiments the control 
contained the same number of dead cells as the conditions containing β-methyl-D-galactoside but that 
there was a difference in the numbers of VBNC cells and VBCs between the control and the condition 
with prebiotic compound. If that was the case then this difference would not have been noticed by 
growth curves experiments, only by cultivation experiments. This would then explain why the 
stimulation of S. sobrinus by β-methyl-D-galactoside was not picked up in the growth curves. 
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However, as numbers drop again after 48h and the effect was not noticed when S. salivarius was 
present this stimulation does not pose a problem. When discussing VBNC bacteria one could argue 
that the results observed with the culturing techniques could be inaccurate as these cells cannot be 
picked up by this technique and could potentially pose a problem when resuscitated. However, even 
when a part of these bacterial cells would enter this state, they are metabolically inactive in this state 
and therefore not virulent.  
To get a better insight into the mechanisms behind the inhibiting effect of β-methyl-D-galactoside two 
options were explored. As it is known that sugar intake can lead to acid production by Streptococcus 
species and thus to a pH drop, a pH effect was one of the options investigated. However, as S. 
salivarius is known for its bacteriocin production, β-methyl-D-galactoside could stimulate S. 
salivarius to release these antimicrobial compounds. With this in mind the presence of an 
antimicrobial factor in the supernatant of S. salivarius was studied in parallel. Experiments (Figure 8) 
illustrated that the inhibitive effect on periodontopathogens could be ascribed to a pH effect. When a 
culture of S. salivarius was supplemented by β-methyl-D-galactoside an average pH of 4.7 was 
observed after 24h, compared to an average pH of 5.6 when no extra compound was added. The same 
pH fall was noticed when working with D-glucose as substrate. When the periodontopathogens were 
subjected to supernatant of these S. salivarius cultures, reduction in concentration of these pathogens 
was only observed in the cultures supplemented with D-glucose or β-methyl-D-galactoside, with a pH 
around 4.7. A study by Bhattacharjee and colleagues (Bhattacharjee et al., 2011) already established 
that A. actinomycetemcomitans cells rapidly lost viability even at a mildly acidic pH, they observed a 
dramatic decrease in cell viability as pH went below 6. This was confirmed in our results however 
only a small decrease was noticed when the pH reached the value of 5.6 (Figure 8). Takahashi and 
colleagues (2003; 1997) performed several studies on the effect of pH on oral bacteria, like P. 
intermedia, F. nucleatum and P. gingivalis. They established that P. intermedia and F. nucleatum 
could grow between a pH of 5 and 7, whereas P. gingivalis was even more prone to a decrease in pH, 
this bacterium could only grow at a pH between 6.5 and 7. These results are in line with the results of 
this study as P. gingivalis demonstrated the most pronounced effect. However, our results show that 
growth of P. intermedia and F. nucleatum was also affected at a pH of 5.6. This can be due to a 
different set-up of experiments. The fact that the pH is responsible for the drop in periodontopathogens 
also explains why no effect was seen on the cariogenic species as they are both acid tolerant. 
 
Besides one carbon source specifically stimulating a beneficial bacterium, several compounds were 
found specifically stimulating pathogenic bacteria (Addendum, table 1). Several of these carbon 
sources are even being used in the food industry. This information can still be expanded by testing 
more compounds on different pathogenic bacteria and can give an indication of the influence of a 
particular diet on the onset of periodontal diseases. 
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In conclusion, this study was able to discover one potential prebiotic compound, β-methyl-D-
galactoside, leading to an indirect reduction in pathogenic oral bacteria by stimulating different strains 
of S. salivarius, under which S. salivarius K12 an already commercially available probiotic. With that 
in mind the best approach for periodontal therapy would be a synbiotic approach, combining the 
prebiotic compound with the probiotic bacterium S. salivarius for a maximal result. One potential 
danger could be that the consumption of β-methyl-D-galactoside by S. salivarius in the mouth could 
lead to demineralisation of the teeth, however according to a study conducted by Brudevold and 
colleagues (1983) the extent of demineralization is most pronounced for fructose, glucose and sucrose, 
less for maltose and lactose and least for galactose. It is known that galactolysis is less acidogenic 
compared to glycolysis and thus less cariogenic. The next steps are to screen more strains of oral 
bacteria for growth on this compound as well as extrapolating the current results to a multispecies 
biofilm environment and ultimately to in vivo conditions, as the tested bacteria are part of much bigger 
bacterial networks in in vivo dental plaque communities.  
Of course all the steps above have focused on one energy substrate, however much more energy 
sources can be tested thereby setting up an energy profile for bacteria involved in oral health or 
disease that defines which energy sources specifically stimulate either pathogenic or beneficial 
bacteria. This makes it easier to understand metabolic networks between the different bacteria present 
in oral biofilms and would pave the way for nutrition-based treatment options for periodontal diseases. 
 
  
CHAPTER V: β-methyl-D-galactoside, a potential prebiotic against periodontal diseases? 
143 
 
5. REFERENCES 
 
Aas, J. A., Paster, B. J., Stokes, L. N., Olsen, I. & Dewhirst, F. E. (2005). Defining the normal 
bacterial flora of the oral cavity. J Clin Microbiol 43, 5721–5732. 
Aguilar, A. R. & Guareño, E. O. (2000). Thermochemistry of methyl-D-glucopyranosides and methyl-
D-galactopyranosides.  J Chem Thermodyn 32, 767–775. 
Bhattacharjee, M. K., Childs, C. B. & Ali, E. (2011). Sensitivity of the periodontal pathogen 
Aggregatibacter actinomycetemcomitans at mildly acidic pH. J Periodontol 82, 917–925. 
Boutaga, K., Van Winkelhoff, A. J., Vandenbroucke-Grauls, C. M. J. E. & Savelkoul, P. H. M. (2005). 
Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. FEMS 
Immunol Med Microbiol 45, 191–199. 
Bowden, G. H. & Li, Y. H. (1997). Nutritional influences on biofilm development. Adv Dent Res 11, 
81–99. 
Brudevold, F., Tehrani, A., Attarzadeh, F., Van Houte, J. & Russo, J. (1983). Enamel demineralization 
potential of dietary carbohydrates. J Dent Res 62, 1218–1220. 
Burton, J. P., Cowley, S., Simon, R. R., McKinney, J., Wescombe, P. A. & Tagg, J. R. (2011). 
Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a 
randomized, placebo-controlled, double-blind study. Food Chem Toxicol 49, 2356–2364. 
Burton, J. P., Wescombe, P. A., Moore, C. J., Chilcott, C. N. & Tagg, J. R. (2006). Safety Assessment 
of the Oral Cavity Probiotic Streptococcus salivarius K12. Appl Environ Microbiol 72, 3050–3053. 
Caglar, E., Kavaloglu, S. C., Kuscu, O. O., Sandalli, N., Holgerson, P. L. & Twetman, S. (2007). 
Effect of chewing gums containing xylitol or probiotic bacteria on salivary mutans streptococci and 
lactobacilli. Clin Oral Investig 11, 425–429. 
Carlsson, J., Grahnén, H., Jonsson, G. & Wikner, S. (1970). Early establishment of Streptococcus 
salivarius in the mouth of infants. J Dent Res 49, 415–418. 
Delorme, C. (2008). Safety assessment of dairy microorganisms: Streptococcus thermophilus. Int J 
Food Microbiol 126, 274–277. 
Devine, D. A. & Marsh, P. D. (2009). Prospects for the development of probiotics and prebiotics for 
oral applications. J Oral Microbiol 1. 
Griffen, A. L., Beall, C. J., Campbell, J. H., Firestone, N. D., Kumar, P. S., Yang, Z. K., Podar, M. & 
Leys, E. J. (2012). Distinct and complex bacterial profiles in human periodontitis and health revealed 
by 16S pyrosequencing. ISME J 6, 1176–1185. 
Kreth, J., Merritt, J., Shi, W. & Qi, F. (2005). Competition and coexistence between Streptococcus 
mutans and Streptococcus sanguinis in the dental biofilm. J Bacteriol 187, 7193–7203. 
Kreth, J., Zhang, Y. & Herzberg, M. C. (2008). Streptococcal antagonism in oral biofilms: 
Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans. J 
Bacteriol 190, 4632–4640. 
Kreth, J., Merritt, J. & Qi, F. (2009). Bacterial and host interactions of oral streptococci. DNA Cell 
Biol 28, 397–403. 
CHAPTER V: β-methyl-D-galactoside, a potential prebiotic against periodontal diseases? 
144 
 
Macfarlane, G. T. & Cummings, J. H. (1999). Probiotics and prebiotics: can regulating the activities of 
intestinal bacteria benefit health? BMJ 318, 999–1003. 
Marsh, P. D. (1994). Microbial ecology of dental plaque and its significance in health and disease. Adv 
Dent Res 8, 263–271. 
Marsh, P. D. (2003). Are dental diseases examples of ecological catastrophes? Microbiology (Reading, 
Engl) 149, 279–294. 
Masdea, L., Kulik, E. M., Hauser-Gerspach, I., Ramseier, A. M., Filippi, A. & Waltimo, T. (2012). 
Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch 
Oral Biol 57, 1041–1047. 
Ogawa, A., Furukawa, S., Fujita, S., Mitobe, J., Kawarai, T., Narisawa, N., Sekizuka, T., Kuroda, M., 
Ochiai, K. & other authors. (2011). Inhibition of Streptococcus mutans biofilm formation by 
Streptococcus salivarius FruA. Appl Environ Microbiol 77, 1572–1580. 
Paster, B. J., Boches, S. K., Galvin, J. L., Ericson, R. E., Lau, C. N., Levanos, V. A., Sahasrabudhe, A. 
& Dewhirst, F. E. (2001). Bacterial diversity in human subgingival plaque. J Bacteriol 183, 3770–
3783. 
Roberfroid, M. (2007). Prebiotics: the concept revisited. J Nutr 137, 830S–7S. 
Sliepen, I., Van Damme, J., Van Essche, M., Loozen, G., Quirynen, M. & Teughels, W. (2009). 
Microbial interactions influence inflammatory host cell responses. J Dent Res 88, 1026–1030. 
Slots, J. (1977). Microflora in the healthy gingival sulcus in man. Scand J Dent Res 85, 247–254. 
Slots, J. & Rams, T. E. (1991). New views on periodontal microbiota in special patient categories. J 
Clin Periodontol 18, 411–420. 
Socransky, S. S. & Haffajee, A. D. (1992). The bacterial etiology of destructive periodontal disease: 
current concepts. J Periodontol 63, 322–331. 
Takahashi, N. (2003). Acid-neutralizing activity during amino acid fermentation by Porphyromonas 
gingivalis, Prevotella intermedia and Fusobacterium nucleatum. Oral Microbiol Immunol 18, 109–
113. 
Takahashi, N., Saito, K., Schachtele, C. F. & Yamada, T. (1997). Acid tolerance and acid-neutralizing 
activity of Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum. Oral 
Microbiol Immunol 12, 323–328. 
Teughels, W., Kinder Haake, S., Sliepen, I., Pauwels, M., Van Eldere, J., Cassiman, J.-J. & Quirynen, 
M. (2007a). Bacteria interfere with A. actinomycetemcomitans colonization. J Dent Res 86, 611–617. 
Teughels, W., Newman, M. G., Coucke, W., Haffajee, A. D., Van Der Mei, H. C., Haake, S. K., 
Schepers, E., Cassiman, J.-J., Van Eldere, J. & other authors. (2007b). Guiding periodontal pocket 
recolonization: a proof of concept. J Dent Res 86, 1078–1082. 
Van Loo, J., Cummings, J., Delzenne, N., Englyst, H., Franck, A., Hopkins, M., Kok, N., Macfarlane, 
G., Newton, D. & other authors. (1999). Functional food properties of non-digestible oligosaccharides: 
a consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br J Nutr 81, 121–132. 
 
CHAPTER V: β-methyl-D-galactoside, a potential prebiotic against periodontal diseases? 
145 
 
Wescombe, P. A., Hale, J. D. F., Heng, N. C. K. & Tagg, J. R. (2012). Developing oral probiotics 
from Streptococcus salivarius. Future Microbiol 7, 1355–1371. 
Yoshida, A., Suzuki, N., Nakano, Y., Kawada, M., Oho, T. & Koga, T. (2003). Development of a 5′ 
Nuclease-Based Real-Time PCR Assay for Quantitative Detection of Cariogenic Dental Pathogens 
Streptococcus mutans and Streptococcus sobrinus. J Clin Microbiol 41, 4438–4441. 
 
 
 
  
CHAPTER V: β-methyl-D-galactoside, a potential prebiotic against periodontal diseases? 
146 
 
6. ADDENDUM 
Table 1: Stimulative effect of different carbon sources in biolog plate for different groups: Carbon sources were 
regarded as stimulative if OD was raised by factor 2 compared with the negative control. OD: optical density. 
Stimulative effect of different carbon sources PM2a™ plate 
 Pathogenic bacteria Beneficial bacteria Both  none 
Chondroitin Sulfate C    X 
α-Cyclodextrin    X 
β-Cyclodextrin    X 
γ-Cyclodextrin    X 
Dextrin   X  
Gelatin    X 
Glycogen    X 
Inulin X    
Laminarin    X 
Mannan    X 
Pectin   X  
N-Acetyl-D-Galactosamine    X 
N-Acetyl-Neuramine Acid    X 
β-D-Allose    X 
Amygdalin   X  
D-Arabinose   X  
D-Arabitol    X 
L-Arbitol    X 
Arbutin   X  
2-Deoxy-D-Ribose   X  
l-Erythritol    X 
D-Fucose X    
3-O-β-D-Galacto-pyranosyl-D-Arabinose X    
Gentiobiose   X  
L-Glucose    X 
Lactilol   X  
D-Melezitose    X 
Malitol    X 
α-Methyl-D-Glucoside    X 
β-Methyl-D-Galactoside  X   
3-Methyl Glucose X    
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β-Methyl-D-Glucuronic Acid    X 
α-Methyl-D-Mannoside    X 
β-Methyl-D-Xyloside    X 
Palatinose X    
D-Raffinose   X  
Salicin   X  
Sedoheptulosan    X 
L-Sorbose X    
Stachyose   X  
D-Tagatose X    
Turanose    X 
Xylitol    X 
N-Acetyl-D-Glucosaminitol    X 
γ-Amino Butyric Acid    X 
δ-Amino Valeric Acid    X 
Butyric Acid X    
Capric Acid   X  
Caproic Acid    X 
Citraconic Acid    X 
Citramalic Acid    X 
D-Glucosamine   X  
2-Hydroxy Benzoic Acid    X 
4-Hydroxy Benzoic Acid    X 
β-Hydroxy-Butyric Acid    X 
γ-Hydroxy-Butyric Acid    X 
α-Keto Valeric Acid    X 
Itaconic Acid    X 
5-Keto-D-Gluconic Acid   X  
D-Lactic Acid Methyl Ester    X 
Malonic Acid    X 
Melibionic Acid    X 
Oxalic Acid   X  
Oxalomalic Acid   X  
Quinic Acid    X 
D-Ribono-1,4-Lactone    X 
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Sebacic Acid    X 
Sorbic Acid X    
Succinamic Acid    X 
D-Tartaric Acid    X 
L-Tartaric Acid    X 
Acetamide    X 
L-Alaninamide    X 
N-Acetyl-L-Glutamic Acid    X 
L-Arginine    X 
Glycine    X 
L-Histidine    X 
L-Homoserine    X 
Hydroxy-L-Proline    X 
L-Isoleucine    X 
L-Leucine    X 
L-Lysine    X 
L-Methionine    X 
L-Ornithine    X 
L-Phenylalanine    X 
L-Pyroglutamic Acid    X 
L-Valine    X 
D,L-Carnitine    X 
Sec-Butylamine    X 
D,L-Octopamine    X 
Putrescine    X 
Dihydroxy Acetone   X  
2,3-Butanediol    X 
2,3-Butanone    X 
3-Hydroxy 2-Butanone    X 
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CHAPTER VI: Live/dead real-time PCR to assess new therapies against dental 
plaque related pathologies 
 
1. INTRODUCTION 
Oral microbiology has been implicated with pathologies such as tooth decay, endodontic infections, 
gingivitis and periodontitis for a long time (Marsh and Martin, 1999). In order to assess current and 
future treatment protocols directed towards oral pathogens, an accurate quantification of viable 
bacteria is essential. DNA-based methodologies for the detection, identification and quantification of 
specific bacteria in dental plaque offers advantages over culturing techniques (Sanz et al., 2004). One 
drawback of quantitative molecular techniques like real-time quantitative polymerase chain reaction 
(qPCR) is that they are not able to distinguish between live and dead bacteria. Since bacterial DNA is 
only slowly degraded after the loss of bacterial viability, the remaining DNA of already dead bacteria 
still can act as template DNA during PCR reactions. Consequently, oral pathogens killed by 
antimicrobial protocols will still be quantified when a PCR based molecular method is used. This may 
lead to an underestimation of treatment results. A strategy to circumvent this problem is focusing on 
the presence of rapidly degrading RNA instead of DNA. However, working with RNA is more 
technically demanding and RNA molecules are merely an indication of bacterial activity and not of 
abundance. 
Membrane integrity has been a well-established characteristic to discriminate between viable and dead 
bacterial cells. This characteristic is frequently used in the domains of microscopy and flow cytometry 
with live/dead staining using membrane-impermeable or permeant dyes, like propidium iodide, to 
discriminate between living and dead cells (Boulos et al., 1999; Wang et al., 2010). Nogva and 
coworkers (2003) were the first to introduce a similar concept in qPCR procedures to differentiate 
between viable and dead cells. Ethidium monoazide (EMA) is a DNA/RNA intercalating substance, 
which only enters bacterial cells with compromised cell walls and cell membranes. Following 
photoactivation it irreversibly cross-links to the nucleic acids, by converting the azide group into a 
highly reactive nitrine radical that can form a covalent link to DNA. DNA covalently bound to EMA 
cannot be PCR amplified. Thus, when EMA is applied before DNA extraction, only DNA from viable 
cells can be amplified after DNA extraction. Unbound EMA that is left is simultaneously inactivated 
by reacting with water molecules in the solution, forming a hydroxylamine that is no longer capable of 
linking to DNA (Nocker and Camper, 2009). qPCR EMA treatment has been tested on different 
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species like Escherichia coli 0157:H7, Salmonella Typhimurium, Listeria monocytogenes, 
Campylobacter jejuni, with promising results (Nogva et al., 2003;Rudi et al., 2005). However, it was 
shown that EMA is also capable of penetrating viable cells of certain bacterial species resulting in 
partial DNA loss of viable bacteria (Flekna et al., 2007;Kobayashi et al., 2009). Therefore, the focus 
was shifted to an alternative chemical, propidium monoazide (PMA), which does not penetrate cells 
with an intact cell membrane.  PMA has already been used successfully for selective staining of a wide 
variety of dead cell types but also as a more selective alternative for EMA in vitality qPCR reactions. 
Research on PMA-driven inhibition of dead cell DNA amplification has been mostly focused on 
environmental (Nocker et al., 2007;Flekna et al., 2007;Wagner et al., 2008;Lin et al., 2010) or 
respiratory samples (Rogers et al., 2008) with successful results. 
The aim of this study was to prove the effectiveness of both EMA and PMA treatments in combination 
with qPCR on Prevotella intermedia, Streptococcus mutans and Aggregatibacter 
actinomycetemcomitans, three pathogenic bacteria implicated in different oral pathologies. 
This study showed that the combination of EMA or PMA with qPCR, vitality qPCR, could also be a 
means of distinguishing viable from dead bacteria in oral bacterial samples, thereby facilitating the 
assessment of antimicrobial protocols against pathogenic oral bacteria. To our knowledge, this 
methodology has never been explored in the dental field and it could be an added value for scientists 
working in oral microbial research. 
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2. MATERIALS AND METHODS 
2.1 Strains and culture conditions 
Prevotella intermedia ATCC 25611, Streptococcus mutans ATCC 25175, and Aggregatibacter 
actinomycetemcomitans ATCC 43718 were used as model organisms, so that both gram-positive and 
gram-negative bacteria were represented. Bacterial strains were grown on blood agar plates (Blood 
agar base II, Oxoid, Basingstoke, United Kingdom) supplemented with 5 µg/ml of hafoemin (Sigma 
Chemical Co, St. Louis, MO, USA), 1 µg/ml of menadione and 5% sterile horse blood (Biotrading, 
Keerbergen, Belgium). Bacteria were collected from blood agar plates and transferred to 10 ml Brain-
Heart-Infusion (BHI) broth (Difco Laboratories, Detroit, MI, USA). P. intermedia was incubated 
overnight at 37°C in an anaerobic atmosphere, A. actinomycetemcomitans and S. mutans were both 
incubated overnight at 37°C in a 5% CO2 environment. The bacterial concentration was adjusted by 
measuring optical density at 600nm in order to obtain bacterial suspensions with concentrations 
ranging from 1x108 CFU/ml to 1x103 CFU/ml. 
2.2 Stress conditions 
A heat-killing protocol was followed to kill cells prior to EMA or PMA treatment (Talaro, 2007). In 
order to determine the most effective heat-killing protocol, bacterial suspensions underwent heat 
treatment at different temperatures and for different time periods. Absence of viability was checked by 
microbial culturing. Both A. actinomycetemcomitans and P. intermedia suspensions were killed after 
15 min in a heating block at 95°C. For S. mutans viability was lost after 30 min at 95°C. 
2.3 Mixtures of viable and dead cells 
Next to heat-killed suspensions of the selected bacteria, mixtures were made consisting of heat-killed 
cells and viable cells of the same bacterium. Mixtures were prepared with equal volumes of both cell 
suspensions using different concentrations of viable bacteria (103 – 108 CFU/ml) or dead bacteria (103 
– 108 CFU/ml). A mixture containing only viable cells was used as positive control. 
2.4 EMA/PMA cross-linking 
PMA and EMA were purchased from Biotium (Hayward, CA, USA). Both compounds were dissolved 
in 20% dimethyl sulfoxide (DMSO) to produce stock concentrations of 1 mg/ml, down to 50 µg/ml. 
These were stored at -20°C in the dark. Solutions of cross-linkers (10 µl) were added to 90 µl culture 
aliquots in order to obtain final concentrations of the compounds ranging from 5-100 µg/ml. 
Following a 5 min incubation period in the dark, samples were exposed for 10 min to a 650W halogen 
light source placed 20 cm above the samples. The samples were kept on ice during this period, to 
avoid excess heating. Both EMA and PMA were handled as potential carcinogens. 
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2.5 DNA extraction and quantitative PCR 
DNA was extracted from bacterial samples with DNeasy Tissue Kit (QIAGEN, Maryland, USA) in 
accordance with the manufacturer’s instructions. The amounts and quality of extracted DNA were 
estimated by electrophoresis through 1% agarose gel. A quantitative PCR (qPCR) assay was 
performed with a CFX96 Real-Time System (Biorad, Hercules, CA, USA). The Taqman 5’ nuclease 
assay PCR method was used for detection and quantification of bacterial DNA. Primers and probes 
were targeted against the 16S rRNA gene for both P. intermedia (Forward (F):5’-
CGGTCTGTTAAGCGTGTTGTG-3’, Reverse (R):5’-CACCATGAATTCCGCATACG-3’, Probe:5’-
TGGCGGACTTGAGTGCACGC-3’) and A. actinomycetemcomitans (F: 5’-GAACCTTACCTACTC 
TTGACATCCGAA -3’, R: 5’ TGCAGCACCTGTCTCAAAGC3’,Probe:5’AGAACTCAGAGATGG
GTTTGTGCCTTAGGG-3’). For S. mutans (F:5’-GCCTACAGCTCAGAGATGCTATTCT-3’, R:5’-
GCCATACACCACTCATGAATTGA-3’, Probe:5’-TGGAAATGACGGTCGCCGTTATGAA-3’) 
the construction of primers and probe was based upon the glucosyltransferaseB (gtfB) gene. For A. 
actinomycetemcomitans another primer pair was tested, creating a 200-bp fragment (forward: 5’-
CAGGCCTAACACATGCAAGTC- 3’; reverse: 5’-ATTACCGCGGCTGCTGG-3’). 
Taqman reactions contained 12.5 µl Mastermix (Eurogentec, Seraing, Belgium), 4.5 µl sterile H2O, 1 
µl of each primer and probe and 5 µl template DNA.  Primers and probes were used at different 
concentrations depending on the organism. Assay conditions for all primer/probe sets consisted of an 
initial 2 min at 50°C, followed by a denaturation step for 10 min at 95°C, followed by 45 cycles of 
95°C for 15 s and 60°C for 60 s. Quantification was based on a plasmid standard curve. 
 
2.6 Statistics 
Bacterial numbers were log transformed. Differences between conditions were assessed by use of a 
linear mixed model, with the different conditions as fixed factor and the experiments as random 
factors. P-values were calculated and correction for multiple comparisons was carried out according to 
Sidak. The significance level was set at p<0.05.  
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3. RESULTS 
3.1 Effectiveness of EMA and PMA on heat-killed bacterial suspensions 
Different concentrations of EMA and PMA (5-100 µg/ml) were tested on heat-killed suspensions 
containing 5x108 CFU/ml of the selected microorganisms. The positive control was a heat-killed 
suspension of the different bacteria not subjected to treatment. Experiments were repeated 3 times as 
was the qPCR analysis. Figure 1 illustrates that EMA and PMA both signifcantly inhibited PCR 
amplification from dead cells for all three tested bacteria (p<0.001). For P. intermedia and S. mutans 
an average signal reduction of 3.8 log reduction was achieved when EMA was used, while for A. 
actinomycetemcomitans this was a 3.3 log reduction.  The signal reduction was even larger for P. 
intermedia when PMA was used (5 log reduction) however this extra reduction was not significant 
(p>0.050). For S. mutans no difference could be observed between the two compounds. For A. 
actinomycetemcomitans results indicated a non-significant (p>0.050) lower effect of PMA 
corresponding to a reduction of only 2 log. 
 
The largest signal reductions were observed when working with the highest concentrations of the 
compounds. For both S. mutans and A. actinomycetemcomitans the difference in effect between 50 
µg/ml and 100 µg/ml of both compounds was small (p>0.050), whereas results for P. intermedia 
illustrated an additional 1 -2 log decrease when employing 100 µg/ml  EMA or PMA (p<0.001) 
(Figure 1). Because of the larger decreases seen with S. mutans and P. intermedia, these two bacteria 
were chosen as the model organisms for subsequent experiments. 
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Figure 1: Effect of EMA and PMA on heat-killed bacterial suspensions: heat-killed bacterial mixes containing 5 x 108 
CFU/ml of S. mutans, P. intermedia and A. actinomycetemcomitans were subjected to increasing concentrations of EMA (A) 
or PMA (B). Error bars represent standard deviations of the mean (n=3). Statistically significant differences (p<0.05) 
between the control (with PMA or EMA) and test series are marked with *. CFU: colony forming units; PMA: propidium 
monoazide; EMA: ethidium monoazide.  
3.2 Effect of bacterial concentration 
To test whether the compounds had the same effect on different concentrations of heat-killed bacteria, 
bacterial suspensions were made of S. mutans and P. intermedia of 5 x108, 5 x106 and 5 x104 CFU/ml. 
qPCR results were compared to the positive control that did not receive EMA or PMA treatment. For 
S. mutans both concentrations (50 µg/ml and 100 µg/ml) of the compounds gave similar outcomes 
(p<0.001). EMA showed slightly superior effects in comparison with PMA with an average signal 
reduction of 3 log in comparison with 2.5 log for PMA. However, when the bacterial concentration 
was 5 x104 CFU/ml, the signal reduction only reached 1 to 2 log, which was significantly lower 
(p<0.001). The latter was also observed for heat-killed cells of P. intermedia (p<0.001). For this 
bacterium the highest concentration gave the highest signal reduction with a log reduction of 4-5 for 
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EMA and 3-4 for PMA. EMA again showed the best results (Figure 2), however the difference with 
PMA was non-significant (p>0.050). 
 
Figure 2: Effect of EMA and PMA on different concentrations of heat-killed bacterial suspensions: Heat-killed 
bacterial mixes of P. intermedia (A) or S. mutans (B) were subjected to 50 or 100 µg/ml EMA or PMA. Error bars represent 
standard deviations of the mean (n=3). Statistically significant differences (p<0.05) between conditions are marked with *. 
CFU: colony forming units; PMA: propidium monoazide; EMA: ethidium monoazide. 
3.3 Effect of EMA and PMA on viable cells 
Although the above outlined results illustrated that EMA treatment resulted in the largest signal 
decrease, it has been reported that EMA can also penetrate viable cells of certain bacteria. Therefore, 
the effects of both EMA and PMA treatment on viable cultures of P. intermedia and S. mutans were 
tested and compared to the signal reduction for the corresponding heat-killed suspensions and positive 
controls (Figure 3). Results for P. intermedia indicated that EMA inhibited DNA amplification from 
viable cells significantly by 1 to 2 log (p<0.001), whereas no effect was seen for PMA. For S. mutans, 
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a small non-signficant (p>0.050) log reduction of 0.5 -1.0 on amplification of viable cells was 
demonstrated for PMA, and for EMA this reduction reached up to 2 log (Figure 3) (p<0.001). Because 
of the strong inhibitive effect of EMA on amplification of viable cells all subsequent experiments were 
conducted with PMA at a concentration of 100 µg/ml. 
 
Figure 3:Effect of EMA and PMA on viable cells: Heat-killed and viable bacterial suspensions of P. intermedia and S. 
mutans were subject to 100 µg/ml PMA (A,C) or EMA (B,D). A comparison was made with positive controls that did not 
receive PMA or EMA treatment. Error bars represent standard deviations of the mean (n=3). Statistically significant 
differences (p<0.05) between conditions are marked with *. CFU: colony forming units; PMA: propidium monoazide; EMA: 
ethidium monoazide. 
3.4 Effects of PMA on mixtures of viable and heat-killed cells 
In order to determine the effectiveness of PMA to selectively detect viable cells, in the presence of 
dead cells, various mixtures comprising viable and dead cells were evaluated (Table 1). For the 
treatment to be effective in preventing DNA amplification from dead cells, it would be expected that 
the amount of amplified DNA would correspond to the percentage of viable cells in the sample. Table 
1 demonstrates a linear relationship between the quantification cycle value (CQ) value and the number 
of viable cells, as long as the ratio of dead cells to viable cells was less than 4 (log values) and the 
concentration of heat-killed bacteria did not reach 1 x108 CFU/ml. In these occasions the CQ values 
differed significantly from those from the other conditions (p<0.001).  
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Table 1: PMA assays on varying ratios of viable and dead cells: Mixtures of viable and dead cells of P. intermedia and S. 
mutans were subjected to treatment with 100 µg/ml PMA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results are displayed as average Cq values (n=3), standard deviations and linear regression coefficients are indicated. 
 
3.5 Influence of amplicon size 
Because of these promising results for S. mutans and P. intermedia, the question was raised as to why 
the results gained with A. actinomycetemcomitans (Figure 1) were less effective. We hypothesized that 
because the signal decrease observed after EMA or PMA treatment is partly due to PCR inhibition, the 
amplicon size may be important for achieving better results. For both S. mutans and P. intermedia, a 
fragment of more than 120 basepairs (bp) was generated after qPCR, whereas the amplicon size for A. 
actinomycetemcomitans was only 82 bp. Therefore the differences in signal reduction may be 
associated with fragment length. 
Accordingly, A. actinomycetemcomitans samples treated with various concentrations of PMA 
underwent qPCR with two different sets of primers, amplifying fragments of different lengths. Results 
showed a significant (p=0.008) additional signal decrease of 1 log occurred for A. 
actinomycetemcomitans when primers amplifying a larger fragment of the genome were used (Figure 
4). 
 
  Cq value with a viable cell density of 
Dead cell 
density 
(log10CFU/ml) 
8 log10 
CFU/ml 
6 log10 
CFU/ml 
4 log10 
CFU/ml 
3 log10 
CFU/ml R
2 
P. intermedia     
0 18.90 ± 0.67 23.06 ± 0.54 28.97 ± 0.04 30.66 ± 0.31 0.9929 
3 18.73 ± 0.03 22.69 ± 0.30 28.99 ± 0.15 30.25 ± 0.91 0.9937 
4 18.76 ± 0.54 23.09 ± 0.01 30.06 ± 0.14 32.70 ± 0.78 0.9893 
6 18.44 ± 0.32 23.11 ± 0.15 28.47 ± 0.06 28.96 ± 0.30 0.9791 
8 18.07 ± 0.57 22.77 ± 0.07 25.79 ± 0.27 27.58 ± 0.31 0.9896 
S.  mutans     
0 19.42 ± 0.41 27.53 ± 0.26 33.07 ± 0.92 35.54 ± 0.49 0.9878 
3 19.85 ± 0.33 27.54 ± 0.42 32.09 ± 0.15 34.08 ± 0.20 0.9813 
4 20.15 ± 0.78 27.81 ± 0.45 33.13 ± 0.44 34.97 ± 0.99 0.9832 
6 20.07 ± 0.65 27.79 ± 0.21 31.59 ± 0.43 34.79 ± 0.57 0.9784 
8 19.43 ± 0.65 24.68 ± 0.24 27.60 ± 0.68 29.05 ± 0.75 0.9761 
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Figure 4: Influence of amplicon size on effectiveness of PMA treatment: After treatment of a heat-killed suspension of A. 
actinomycetemcomitans (5 x 108 CFU/ml) with different concentrations of PMA, qPCR was performed with two different 
primer sets amplifying fragments with different length, 82 bp and 200 bp. Error bars represent standard deviations of the 
mean (n=3). Statistically significant differences (p<0.05) between conditions are marked with *. Bp: base pair; CFU: colony 
forming units; PMA: propidium monoazide. 
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4. DISCUSSION 
In agreement with previous reports introducing the application of EMA/PMA in combination with 
qPCR (vitality qPCR) to differentiate between viable and dead bacterial cells, the efficacy of these 
DNA-intercalating dyes in selecting against DNA from dead cells was confirmed. Both compounds 
demonstrated their ability to inhibit DNA amplification from dead cells (Figure 1 and 2). However, 
both EMA and PMA also decreased DNA amplification from viable cells. For PMA this effect was 
small and could only be demonstrated for S. mutans (Figure 3). 
 
To test the effect of EMA/PMA on amplification of viable cells overnight cultures of the bacteria were 
used. It is well accepted that overnight cultures also contain fractions of dead cells. Based on that, the 
log decrease in amplification of viable bacteria that was observed could be attributed to the effect of 
the compounds on the dead cell fraction. With this mind, for P. intermedia, EMA seemed to be the 
most effective compound, as the observed log decrease was not observed for PMA (Figure 1 and 2). 
This is in line with previous studies by Chang et al. (2010) and Chen and Chang (2010), working with 
Legionella pneumophila, that pointed to EMA as a superior compound. They attributed the lesser 
effects of PMA to lower penetration efficiency of PMA compared with EMA for heat-killed cells. 
However, PMA should be considered as the superior compound for the tested oral bacteria, based on 
the results gained for S. mutans (Figure 3C and D). Firstly, a log decrease was seen in PCR 
amplification levels from viable cells after treatment with PMA. This decrease could be attributed to 
the effect of PMA on the fraction of dead cells present, and therefore the efficiency of PMA on heat- 
killed cells can be assured. This effect was not noticeable for P. intermedia. This is presumably 
because the fraction of dead cells in overnight cultures of S. mutans is much higher than the fraction of 
dead cells in a similar culture of P. intermedia. 
Secondly, the log decrease seen after EMA treatment of viable cells was much greater and cannot be 
attributed solely to presence of dead cells. It seems that EMA had an effect on amplification of viable 
cells. 
 
These results are in accordance with results from previous studies using EMA (Nocker et al., 
2006;Flekna et al., 2007;Wagner et al., 2008;Yáñez et al., 2011). EMA is excluded by viable cells by 
means of efflux pumps and these pumps can have different substrate specificities according to the 
specific microorganism. Some bacteria can therefore better exclude EMA than others (Kobayashi et 
al., 2009). In this way EMA cannot be trusted to solely enter bacteria with decreased membrane 
integrity. This property may however be exploited in the future with regard to cell activity. EMA can 
also enter dead bacteria that are metabolically inactive and have an intact membrane, whereas PMA 
will only enter cells that are membrane-compromised. In this regard one can potentially distinguish 
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between the physiological states of bacteria, using PMA as a marker for intact cells and EMA as a 
marker for active cells. 
 
One possible reason why PMA does not seem to affect viable cells is the higher charge of the PMA 
molecule and the greater impermeability of the compound through the intact cell membrane (Nocker et 
al., 2006). Both P. intermedia and S. mutans responded well to treatment with PMA. The highest 
concentrations of the compound demonstrated the strongest inhibition of dead cell DNA amplification. 
The signal decrease observed for P. intermedia was superior to the reduction seen for S. mutans. When 
a higher concentration of the compound (100 µg/ml) was used an additional signal decrease was 
observed for P. intermedia. For S. mutans no difference in signal reduction was seen between the 
different concentrations of PMA. Optimal assay conditions such as concentrations of the compounds 
and light exposure time may depend upon the targeted bacterial species. This may explain why P. 
intermedia had a better response towards the compounds. 
 
When working with mixtures of viable and dead cells in different ratios a linear relationship was 
illustrated between the CQ value and the number of viable cells, CQ values decrease with increasing 
number of viable bacteria. This was also demonstrated by Pan and Breidt (2007) who observed a loss 
in linearity when the number of viable cells was less than 1 x103 CFU/ml. From the results of both 
studies it can be concluded that the minimum number of DNA copies that are available for qPCR 
analysis and the number of dead cells in a mixture of viable and dead cells are two factors limiting the 
range of the assay. In order for the assay to work efficiently, viable cells should be present in numbers 
greater than 1 x103 CFU/ml, and the ratio of dead cells to viable cells should not be greater than 4. For 
oral microbiology, this limitation should not pose a major problem since the range in which the assay 
is effective is in accordance with the concentrations of viable bacteria found in clinical samples. 
 
One way to optimize the PMA assay is to take into account the length of the DNA fragment that will 
be amplified. As was shown for A. actinomycetemcomitans, qPCR targeting a longer DNA fragment 
(200 bp) resulted in an additional log decrease compared to qPCR amplifying a shorter DNA fragment 
(82 bp). Soejima and coworkers (2008) demonstrated that high concentrations of EMA led to breaks of 
double-stranded DNA. So the results seen after qPCR amplification of a longer DNA fragment may be 
explained by the increase in cleavage sites for PMA in a larger amplicon (Soejima et al., 2007). Thus 
for a sensitive live-dead qPCR quantification, choice of primers and amplicon length is crucial. 
 
One issue concerning the PMA qPCR concept is that the principle is based on membrane integrity as a 
viability criterion. In a model described by Nocker and Camper (2009) three viability criteria were 
discussed: culturability, metabolic activity and membrane integrity. In this model, cells that were alive 
passed all three criteria. The problem lies however with intact cells that have already lost detectable 
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respiration and metabolic activity. The speed by which cells lose metabolic activity and membrane 
integrity depends on the causative agent of cell death. For assessing certain treatment applications it 
would be desirable to also exclude metabolically inactive cells. In this case PMA treatment could be 
supplemented with a molecular viability assay based on biological activity. Alternatively, an assay 
could be set-up using EMA in combination with PMA, since EMA is also able to enter membrane-
intact bacterial cells. 
 
In summary, this study showed that EMA and PMA are able to inhibit DNA amplification from dead 
cells. However, as EMA also exerted an effect on amplification of viable cells only PMA could be 
utilized to discriminate between three strains of live or dead oral bacteria. In future the assay needs to 
be further assessed for a number of different oral bacteria, and its applicability in complex mixed 
cultures needs to be proven. Furthermore, validation studies on clinical samples should be carried out. 
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CHAPTER VII: General discussion 
The main focus of this work was to investigate alternative treatment options for periodontitis focusing 
on the oral microbiota, as periodontal diseases are recognized to occur when the ecological balance in 
the oral cavity is disturbed leading to increases in pathogenic species and reductions in beneficial 
bacteria. During the last 4 years, the major accomplishments of this work were: 
1. An exploration of the oral microbiota, which reinforced the idea of a microbial shift when 
going from health to periodontitis and put emphasis on the many bacterial interactions that 
form the oral microbial ecosystem. (CHAPTER II) 
2. Assessment of the effect of B. bacteriovorus HD100 on oral communities. (CHAPTER III) 
3. Systematic review of the effect of probiotics on periodontal disease. (CHAPTER IV) 
4. Identification of a potential prebiotic compound specifically stimulating beneficial oral 
bacteria. (CHAPTER V) 
5. Establishment of a new technique to distinguish between live and dead oral bacteria by use of 
propidium monoazide (PMA) and quantitative polymerase chain reaction (qPCR) (CHAPTER 
VI). 
The importance of the findings will be briefly discussed in the following paragraphs and suggestions 
for future work will be made. 
Defining the problem 
Periodontal diseases such as periodontitis and gingivitis are some of the most prevalent diseases 
worldwide. Besides these oral manifestations persistent inflammation of the oral tissues can also lead 
to systemic diseases such as diabetes and cardiovascular disease (Zarco et al., 2012). Good treatment 
measures for oral diseases are therefore of vital importance. Currently periodontal therapy is focused 
on removal of the whole oral microbiota. This is based on earlier beliefs concerning the aetiology of 
these infections, only focusing on the oral microbiota as possible cause for periodontal disease. 
Conventional treatment combines subgingival mechanical debridement, scaling and root planing, with 
oral hygiene improvement and is in some cases supplemented with antiseptics or antibiotics. Although 
these procedures can lead to an improvement of the periodontal status and a reduction in inflammation 
and the number of pathogenic bacteria, this positive evolution is often only temporary. Recolonization 
of the periodontal pockets frequently occurs (Harper & Robinson, 1987; Magnusson et al., 1984). 
Several reasons exist for the ineffectiveness of this therapy such as the fact that several pathogens can 
invade periodontal tissues, the incomplete removal of dental plaque especially in severe periodontitis 
or the upcoming resistance towards antibiotics and antiseptics (Quirynen et al., 2002). Moreover 
periodontal diseases develop when a complex biofilm called dental plaque accumulates on oral 
surfaces and antibiotics are unable to reach all microorganisms present in this biofilm. Thus a life-long 
need for (re)treatment arises, creating a serious socio-economic problem. Because current treatment 
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protocols are not optimal, new options are investigated. In order to find a new treatment it is necessary 
to understand underlying mechanisms leading to the inflammatory response in periodontal tissues. In 
the early days people thought that the amount of dental plaque was a measure for the degree of 
periodontitis, this hypothesis was described as the ‘non-specific plaque hypothesis’(Theilade, 1986). 
However, with the improvement of research techniques, our knowledge concerning the aetiology of 
periodontal diseases has also extended. Nowadays periodontal diseases are regarded as polymicrobial 
diseases. Several microorganisms have already been implicated in the disease and the most well-
known are the ‘red complex’ bacteria however with the arrival of new sequencing techniques several 
former unculturable species could also be associated with health or disease (Griffen et al., 2012; 
Kumar et al., 2003; Socransky et al., 1998). Although the microbial aspect is very important in the 
aetiology of periodontal diseases, the immune response triggered by this microbial presence is equally 
important. Several new hypotheses have already been proposed trying to combine the host factor and 
bacterial factor. In 2003 Marsh proposed the ecological plaque hypothesis in which the oral cavity and 
its microbiota are regarded as an oral ecosystem that is in equilibrium with the host and the 
environment under healthy conditions (Marsh, 2003). The theory implies that a change in the 
environment affecting the host or oral microbiota could lead to a shift in the balance and thus disease. 
In 2010 this theory was further elaborated by Darveau, he describes periodontitis as a disruption of 
tissue homeostasis, in which both pathogenic as well as beneficial bacteria, in a protective way, play a 
role and inflammation is critical but a secondary event (Darveau, 2010). Hajishengallis and coworkers 
(2012) recently proposed the ‘keystone pathogen concept’ in which they imply that presence of certain 
low-abundance microbial pathogens can inflict inflammatory disease by remodeling a normal 
homeostatic microbiota into a dysbiotic one. They proposed Porphyromonas gingivalis to be such a 
keystone pathogen as it is able to rearrange the oral microbiota by triggering certain immune factors. 
Although this concept has merit, several cases can be presented where P. gingivalis was present and 
no periodontitis was seen and vice versa. 
For the moment the exact events leading to periodontitis are still not fully identified, although it is 
clear that several factors play an important role: the host (immune response), the oral microbiota (both 
beneficial and pathogenic bacteria) and the environment. It is also established that these factors are in 
symbiosis during health and that periodontitis arises when a shift occurs in this host-microbiota 
ecosystem. So, although disease can be treated by targeting the pathogens, changes in the number of 
beneficial bacteria or interfering with the host immunity and environment are also options especially 
when looking at long term prevention of the disease. 
Some options with regard to the immune response and resolving of inflammation have already been 
elaborated. Preclinical studies already tested the possibility of active and passive immunization 
directed against P. gingivalis with some success (Booth et al., 1996; Page et al., 2007). Furthermore, 
resolution of inflammation by resolvins has been tested in animal models and is showing potential. 
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Resolvins are a class of proresolving lipid mediators, that inhibit neutrophil infiltration an important 
player in inflammatory processes during periodontitis (Van Dyke, 2007; Serhan et al., 2008). 
The search for alternative treatment options was the main aim of this research. However, the focus was 
not put on the host immune response but on the primary etiological factor in periodontitis: the oral 
microbiota. 
Exploration of the oral microbial ecosystem  
In a first part of this PhD thesis an elaborate exploration of the subgingival biofilm community was 
conducted, to get a better insight in the complexity of the oral microbiota. The complexity of the oral 
microbial ecosystem has been recognized for a long time. More than 700 species can reside in the oral 
cavity and this number keeps on increasing with the development of new bacterial identification 
techniques (Aas et al., 2005; Paster et al., 2001, 2006). The oral microbiota can consist of three types 
of bacteria: pathogenic bacteria, beneficial bacteria and neutral or commensal bacteria. Additionally 
there seems to be an association between the concentration of Gram-negative bacteria and 
periodontitis (Paster et al., 2001; Slots, 1977). Presence of high numbers of Gram-positive bacteria on 
the other hand is correlated with a healthy situation.  In the past several research groups have already 
attempted to define specific bacteria associated with periodontitis and those associated with health 
(Socransky et al., 1998). Nevertheless past research on this topic has always been conducted on a 
relatively small study population. This study was conducted on a large group of 6308 patients with 
different periodontal conditions going from health to severe periodontitis. Besides information 
concerning the probing pocket depth (PD), the numbers and presence of 20 oral bacteria were 
examined in this patient group. The large number of patients increased the power of the study and 
made it possible to look at a range of pocket depths instead of categorizing them into three groups: 
deep, intermediate and shallow as was done in previous studies. The combination of the information 
concerning pocket depth and bacterial numbers made it possible to correlate certain bacteria with 
periodontitis and others with a healthy periodontium.  
Even more important was the fact that this large dataset allowed to investigate the shifts in the oral 
community when going from deep to shallow pockets and vice versa. Results indicated that the 
concentration of several pathogens decreased when the concentration of bacteria with low prevalence 
in deep pockets increased. Heat maps also indicated the negative and positive correlations between the 
different bacteria and especially the clear negative correlation between Gram-negative and Gram-
positive species (data not shown). The large part of these correlations were significant, an indication 
that the dental plaque biofilm consist of a delicate network of bacteria were bacterial interactions play 
a crucial role. Multiple ways of interaction are possible between oral bacteria: metabolic interactions, 
cell-cell signalling, co-aggregation (Hojo et al., 2009). Digging deeper into these interactions can be 
very useful as in that way it will allow us to predict shifts in the community species composition and 
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thus changes from oral health towards oral disease. Further in this research, several options were 
investigated to shift the oral microbiota back to a healthy community by focusing on bacterial 
interactions.  
Targeting the Gram-negative (pathogenic) component of the oral microbial ecosystem 
We first attempted to target the periodontal pathogens without affecting the beneficial and commensal 
oral microbiota as is done in current therapies. For this Bdellovibrio bacteriovorus HD100, a predator 
of Gram-negative bacteria was used. Previous research already indicated that several 
periodontopathogens are Gram-negative bacteria as was confirmed in our large scale study, and 
therefore this predator would be an excellent therapy against periodontitis. By suppressing the Gram-
negative component, virulence will decrease in the dental plaque biofilm leading to a decrease in 
immune response. However, it will also give the Gram-positive beneficial species the chance to 
flourish in that way restoring the healthy balance in the oral community.  
In contrast to other biological agents such as bacteriophages, B. bacteriovorus and other Bdellovibrio 
and like organisms (BALOs) display a very non-specific predation. They have been shown to attack 
Gram-negative bacteria from various genera, such as Escherichia, Pseudomonas, Salmonella, 
Helicobacter, Campylobacter and many more (Dwidar et al., 2012; Markelova, 2010). Although this 
broad spectrum activity has many benefits especially for infections of polymicrobial nature, it also 
implies that they could disturb the natural flora in the gastrointestinal tract for example. However, 
research on poultry indicated that although the action of Bdellovibrio led to a microbial shift in 
gastrointestinal flora this did not affect the overall wellbeing of the animals (Atterbury et al., 2011). 
With regard to periodontal diseases previous research demonstrated the predation of B. bacteriovorus 
on several oral pathogens, such as Aggregatibacter actinomycetemcomitans, Fusobacterium 
nucleatum, Eikenella corrodens and Prevotella intermedia (Dashiff & Kadouri, 2011; Van Essche et 
al., 2011). In order to use Bdellovibrio as a biological agent against periodontitis it was necessary to 
verify whether the same results could be obtained for multispecies communities because of the 
polymicrobial character of the disease. In our study a dual species model was the starting point, then 
switching to a six species model and finally the effect of Bdellovibrio was tested on ex vivo clinical 
samples.  
 
In our dual-species model decoy microorganisms also included other Gram-negative bacteria (target 
and non-target). It could be concluded that predation of A. actinomycetemcomitans was not inhibited 
by presence of decoy microorganisms neither Gram-positive nor Gram-negative. Furthermore, when 
both A. actinomycetemcomitans and F. nucleatum, both target species, were present in the same 
suspension, Bdellovibrio was able to significantly predate both of them simultaneously, although the 
predation rate for F. nucleatum was faster. These experiments also illustrated that there was no 
predation of P. intermedia when A. actinomycetemcomitans was present in contrast with earlier single 
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species experiments, however effects then were rather small. Similar results were observed in the six 
species model and experiments with ex vivo clinical samples. In these latter experiments, levels of 
both F. nucleatum and A. actinomycetemcomitans were significantly decreased in the presence of the 
predator, however the effects were not as pronounced as in the other in vitro experiments (Van Essche 
et al., 2009, 2011). Furthermore, shifts in the non-target species were noticed when Bdellovibrio was 
present, such as smaller decrease in P. gingivalis and P. intermedia and slight increases in 
Streptococcus mitis and Actinomyces naeslundii compared to the negative control. Overall it could be 
concluded that the predation efficiency of Bdellovibrio decreased when the complexity of the system 
increased. Two tracks were followed trying to make Bdellovibrio more adapted to the oral microbiota 
and environment. The first idea was to shift the predation specificity of the predator toward important 
oral pathogens. Experiments showed that Bdellovibrio grown on E. coli, the initial prey that was used 
throughout the course of the experiments to get pure cultures of Bdellovibrio, did not grow as good on 
cultures of several tested Gram-negative bacteria. It seemed that when the predator was grown on A. 
actinomycetemcomitans as initial prey, it was better in attacking the tested Gram-negative bacteria. 
However, when this was tested on our periodontopathogens no extra effect could be observed even not 
on A. actinomycetemcomitans itself. The second trail was based on the increased anaerobicity in the 
more complex community models. To circumvent the aerobic nature of Bdellovibrio, alternative 
electron acceptors were tested, so far without positive results.  
 
Overall, the experiments confirmed that Bdellovibrio can still predate in the presence of saliva, this 
makes it easier with the eye on application of the predator in the mouth. Second, although Bdellovibrio 
did not prey on all tested periodontopathogens, it did attack F. nucleatum and A. 
actinomycetemcomitans two important bacteria implicated in the disease. These bacteria are also 
present in less anaerobic parts of the oral cavity, which would circumvent the problem of aerobicity. 
However, it was shown that besides the predation of A. actinomycetemcomitans and F. nucleatum, 
presence of the predator also seemed to influence the ecology in the community. So it is important to 
test the effect of Bdellovibrio in in vivo models, to clarify the effects of the predator on the whole oral 
ecology.  
 
Future studies could focus on the genome of Bdellovibrio, thereby making the predator more potent. 
It is known that several Gram-negative periodontopathogens contain lipopolysaccharides (LPS) in 
their outer membrane that elicit strong immune responses. By introducing a gene for LPS-binding 
protein in the genome of B. bacteriovorus, the predator would be able to bind to several Gram-
negative pathogenic bacteria by means of LPS. This could make it easier to guide B. bacteriovorus in 
a certain prey direction. As the genome of B. bacteriovorus is being further unravelled and the 
mechanisms behind its predation are become more concrete, other ways to manipulate this predator 
can be investigated (Sockett, 2009). Lambert and coworkers (2003) already described an assay in 
CHAPTER VII: General discussion 
172 
 
which they compared predation by B. bacteriovorus containing targeted mutations in genes involved 
in chemotaxis. Results indicated that Bdellovibrio uses a chemotaxis system in order to sense 
appropriate prey bacteria. As more exact genes involved in this chemotaxis system are being 
identified, assays can be developed targeting these genes in order to improve chemotaxis towards 
certain prey bacteria.  
 
Boosting beneficial part of the oral microbial ecosystem 
In the same way that an increase in the pathogenic component can lead to a disrupting of the symbiosis 
and thus disease, a decrease in beneficial species can shift the oral microbiota away from a healthy 
situation. By stimulating this beneficial microbiota the oral ecosystem can regain equilibrium. One 
direct way of replenishing this beneficial component is the use of probiotics. Probiotics are already 
being used in the gastro-intestinal area for a long time and it is known that they can exert their effect 
not only by affecting the microbiota but also by modulating the immune system. Several studies 
concerning probiotics and periodontal diseases have already been conducted. However, these studies 
were very heterogeneous in set-up with regard to used probiotic bacteria, patient groups, mode of 
application and outcome measures. Therefore a systematic review of the literature on probiotics in the 
oral cavity was performed in order to get a better idea of the mechanisms of action of probiotics in the 
oral cavity and their clinical effects on oral health and more specifically on periodontitis respectively.   
With regard to the clinical effects of probiotics on oral health only 14 studies from the 160 that were 
retrieved, were included in the set. Even these 14 studies were very diverse in set-up, there were 11 
human studies and 3 animal studies and of these 14 studies 6 reported on the microbiological effect, 
whereas 8 reported on the clinical effects. Moreover the studies often lacked appropriate 
randomization, blinding or true negative controls. Therefore the data that were retrieved from these 
studies made it very difficult to draw definite conclusions.  However, keeping all these shortcomings 
in mind, best results were observed when looking at the microbiological outcomes.  Reductions up to 2 
log could be observed for several periodontopathogens, whereas effects on the clinical conditions were 
not that evident. It could be concluded that most of the results from probiotic intervention studies for 
the management of periodontal diseases showed no extreme effects.  
Several considerations could be made. First of all, better designed clinical trials in larger populations 
are necessary to truly assess the action of certain probiotic bacteria. Another explanation for the 
minimal effect of probiotics could be the lack of pretreatment in most studies. Although removal of 
the existing microbial ecology might be difficult in the gastro-intestinal tract, is it easier to achieve in 
the oral cavity. This can be done by means of scaling and root planning, oral hygiene measures and 
antiseptics. Elimination of the existing microbial ecology, will simplify the colonization of probiotic 
bacteria. When comparing a study of Roos and co-workers (2001) to a study of Tano and co-workers 
(2002) evidence could be found of the beneficial effect of pretreatment. Both studies had similar set-
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ups, looking at the recurrence of otitis media in children. Roos and co-workers (2001) used a 10 day 
antibiotic pretreatment prior, this led to a significant lower recurrence of otitis media in contrast to the 
study of Tano and co-workers (2002) were no significant difference was observed between the placebo 
group and the probiotic group.  
Furthermore, the minimal effect observed in some studies could be due to the use of Lactobacilli as 
probiotics. In the gastro-intestinal field both lactobacilli and bifidobacteria are the probiotics of choice 
and thus in most studies concerning periodontitis and probiotics these bacteria have been chosen. 
These probiotic bacteria have already gone through the necessary safety tests which will also have 
contributed to the motivation of using gastro-intestinal probiotics. However, when looking at oral 
health, these bacteria have a high cariogenic potential. Lactobacilli are highly acidogenic and produce 
short chain carboxylic acids from the fermentation of sucrose. Several studies have been conducted 
investigating the cariogenic potential of lactobacilli. A study by Fitzgerald and co-workers (1980) 
illustrated that only 3 of 50 Lactobacillus strains isolated from dental plaque of school children 
induced significant caries activity in hamsters. It also has been speculated that in contrast to 
Streptococcus mutans, lactobacilli are more related to caries progression than to the initiation of a 
caries lesion (Edwardsson, 1974; Maltz et al., 2002). However, this does not imply that lactobacilli are 
incapable of causing caries under favourable environmental conditions (Fitzgerald et al., 1981; 
Matsumoto et al., 2005). It seemed that those studies employing orally derived probiotics displayed 
better results. The Streptococcus species especially play an important role here. This group of oral 
bacteria is numerically predominant in the oral cavity and is particularly well adapted to colonize both 
hard and soft tissues. Furthermore, oral streptococci are among the first bacteria to colonize the 
newborn infant (Pearce et al., 1995) as well as newly erupted teeth (Brailsford et al., 2005) and 
cleaned tooth surfaces (Li et al., 2004). A number of streptococcal species have been shown to have 
potential as probiotic candidates.  Roos and co-workers (2001) used two Streptococcus sanguinis, two 
Streptococcus mitis and one Streptococcus oralis strain to look at the recurrence of otitis media in 
children. The group treated with probiotics showed a significantly reduced recurrence of the disease. 
Additionaly, S. mitis, S. sanguinis and Streptococcus salivarius exhibited effects on the colonization of 
particular oral pathogens and on the immune response induced by periodontopathogens (Sliepen et al., 
2009; Teughels et al., 2007a). These bacteria were used successfully in replacement therapy executed 
in Beagle dogs (Teughels et al., 2007b). S. salivarius especially has emerged as an important probiotic 
bacterium. Strain K12, the prototype S. salivarius probiotic, is already commercially available and has 
been implicated in the control of several bacterial infections such as caries, halitosis and otitis media 
(Wescombe et al., 2009, 2012). Instead of using extra-oral probiotics it would be indeed be more 
logical to directly refill low concentrations of indigenous beneficial bacteria. These indigenous 
beneficial bacteria have some advantages over other probiotic bacteria. They are already incorporated 
CHAPTER VII: General discussion 
174 
 
in the oral ecosystem and biofilm structure. In this way they don’t have to compete for binding sites to 
remain viable in the mouth.  
With this in mind the focus was shifted to prebiotics. Theoretically, prebiotics could enhance the 
growth of beneficial bacteria already present in the mouth. In our study, the aim was to screen for and 
select potential prebiotics that stimulate specifically indigenous beneficial species in the oral 
environment and to assess whether this stimulation can cause a reduction of pathogenic bacteria. One 
carbon source β-D-methyl-galactoside was selected that specifically stimulated different strains of the 
beneficial indigenous bacterium S. salivarius, under which S. salivarius K12. The indigenous 
bacterium S. salivarius is very interesting as it has been shown to exhibit several probiotic properties. 
It is able to decrease IL-8 production from epithelial cells induced by periodontopathogens (Sliepen et 
al., 2009), moreover it inhibited colonisation of A. actinomycetemcomitans on hard and soft tissues 
(Teughels et al., 2007a). The fact that S. salivarius K12 was also stimulated is very attractive as this 
strain is already commercially available and oral delivery of this bacterium in a food-based carrier has 
already been established as being safe (Burton et al., 2006, 2011). The bacterium was first introduced 
to counter Streptococcus pyogenes infection and by now has already an expanded repertoire of health 
promoting applications, such as downregulation of the innate immune responses of human epithelial 
cells and reduction of oral volatile sulphur compound levels (Guglielmetti et al., 2010). Furthermore, 
the study of lantibiotics produced by S. salivarius is one of the exceptional studies in which 
researchers have mixed in vitro studies with studies in humans with success (Power et al., 2008; Ross 
et al., 1993; Tagg et al., 1983).  
In this study it was observed that β-D-methyl-galactoside, by stimulating S. salivarius, indirectly led to 
the reduction of several key periodontopathogens. Additional experiments revealed that this was 
probably due to a pH effect. In the future, this effect still has to be validated on dental plaque biofilm 
communities and in in vivo models. The microbial ecology in the oral cavity comprises of a complex 
network of bacteria that all interact which each other. This implies that the pH effect observed in a 
two-species model can be buffered in a larger community. Takehashi and co-workers (1997)(1997) 
already observed that P. intermedia and F. nucleatum are able to produce bases that buffer the 
environment thereby sustaining growth of P. gingivalis. However, the prebiotic compound could also 
exert its effects in different ways that were not tested in our experiments. A first option is competitive 
exclusion; by increasing the numbers of S. salivarius this bacterium will be able to colonize spots first 
available for periodontopathogens (Teughels et al., 2007a). Another option could be an immunological 
effect, it is known S. salivarius can reduce IL-8 levels induced by periodontopathogens (Sliepen et al., 
2009).  
In our two-species set-up a stimulatory effect was seen on Streptococcus sobrinus. However, when S. 
salivarius was present this cariogenic bacteria was not stimulated by the prebiotic compound. With 
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that in mind the best approach for periodontal therapy would be a synbiotic approach, combining the 
prebiotic compound with the probiotic bacterium S. salivarius for a maximal result.  
 
Besides results concerning stimulation of beneficial oral bacteria, the phenotype microarray also 
provided some data concerning the specific stimulation of pathogenic oral bacteria by certain carbon 
sources. This is interesting data as several from the carbon sources identified as stimulators of our 
tested pathogenic bacteria are being used as food ingredients or preservatives. Trying to diminish the 
consumption of these carbon sources could therefore have a possible beneficial effect on the oral 
microbiota. Of course only a limited range of oral bacteria and carbon sources has been tested in this 
study.  
Future research could focus on the nutritional requirements and metabolic networks of pathogenic 
and beneficial oral bacteria thereby manipulating the bacterial composition in the oral cavity. In the 
past some research has already been conducted concerning nutritional influences on periodontal 
diseases. Van der velden and coworkers (2011) presented a review concerning the relationships 
between micronutrients and periodontitis in humans. They recommended a daily intake of natural 
antioxidants, vitamin D and calcium to help prevent and treat periodontitis. Several studies have also 
been conducted concerning the relationships of carbohydrates and biofilm formation (Bowden & Li, 
1997). Beckers and van der Hoeven conducted a study on the effects of diet regimens of sucrose or 
glucose on the cell number doubling times of S. mutans and Actinomyces viscosus in oral biofilms in 
gnotobiotic rats. Results indicated that the diet did not influence early stage of biofilm formation 
(Beckers & Van der Hoeven, 1982; Beckers & van der Hoeven, 1984). De jong et al. (1984) later 
confirmed that dietary carbohydrates influence the numbers of S. mutans and A. viscosus in 28 day old 
plaque in rats. They concluded that sucrose diets favoured the retention of S. mutans and A. viscosus 
and enhanced plaque formation. The effect of N-acetylglucosamine on the growth of S. sobrinus and 
S. mutans has also been explored. S. sobrinus was unable to ferment N-acetylglucosamine in the 
presence of glucose, therefore in these circumstances S. mutans out-competed S. sobrinus. The 
opposite was true when these species were grown on glucose alone (Homer et al., 1993). Attempts 
also have been made to better understand the metabolic activities of the oral microbiota. Mazumdar 
and coworkers (2009) already set up a metabolic network model for P. gingivalis, most of the used 
information was derived from the sequenced genome of the bacterium. They demonstrated that 
although P. gingivalis is able to secrete succinate, propionate and butyrate as products of amino acid 
catabolism, the bacterium specifically produces only butyrate and propionate. One explanation could 
be that succinate is also secreted by several other oral microorganisms as a catabolic by-product and is 
then used by P. gingivalis to produce ATP. This is an indication that metabolic networks are 
depending on bacterial interactions. Takahashi and coworkers (2010) focused on metabolomics, the 
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comprehensive identification and quantification of metabolites in biological systems, of supragingival 
plaque and oral bacteria implicated in caries, in order to elucidate the sugar metabolic system.  
Future studies can further explore the oral ecosystem and its metabolic networks in biofilm and in vivo 
models. Validation in in vivo models is crucial as bacteria can behave in different ways when grown in 
complex communities. An example of the complexity of analyzing the role of the oral microbiota in 
vivo is presented by Palmer and co-workers (2006) and Chalmers and co-workers (2008) investigating 
the interaction between Streptococcus and Veillonella. Palmer (2006) used an enamel chip model to 
test the interactions between these two genera in humans. They demonstrated changes in the 
predominant phenotype of Veillonella strains during early development of dental plaque. Chalmers 
and coworkers (2008) then tried to grow these microbiota colonizing enamel chips in enrichment 
medium to reconstruct the model in vitro. However, the Veillonella strain present in vivo could not be 
cultured in vitro and a laboratory strain was used instead, which was clearly not equivalent to it. 
Authors suggested that these strains probably had a nutritional requirement that may be satisfied only 
by growing together with a Streptococcus in saliva.  
Development of essential research tools in periodontal research 
In this study one technique was established, that will contribute to further research on the oral 
microbiota and the influence of certain treatments on the complex oral community. This technique 
optimized the normal qPCR assay by combining it with propidium monoazide (PMA) to distinguish 
between viable and dead bacteria and is referred to as vitality qPCR. This technique will make the 
assessment of a treatment much easier. The technique also has another advantage. The method is 
based on the disrupted cell membrane of dead bacteria. However, besides viable bacteria and dead 
bacteria a third category of bacteria exists: the viable non-culturable bacteria. These bacterial cells 
have an intact cell membrane but they are unable to grow or divide and thus cannot be picked up with 
culturing methods. Bacteria in this state can still be resuscitated and thus potentially pose a danger 
(Oliver, 2005, 2010). With the establishment of the vitality qPCR, it will be easier to reveal the VBNC 
part of an oral community, by comparing results gathered with culturing methods, showing only the 
VB cells, with results from vitality qPCR, showing both dead cells and VBNC cells. The technique 
already proved to be valuable in the study in CHAPTER II concerning Bdellovibrio bacteriovorus 
HD100, when comparing results from both techniques. 
Main conclusion 
The first chapter emphasized the microbial shift from health to disease and showed that inter-bacterial 
relationships can play an important role in the onset of the disease. Several microorganisms correlated 
with health suppressed oral pathogens. The treatment options tested afterwards were based on this 
concept of microbial dysbiosis. In a first attempt the Gram-negative pathogenic bacteria were targeted 
CHAPTER VII: General discussion 
177 
 
immediately with the use of B. bacteriovorus HD100 in order to shift the balance towards the 
beneficial side. In a second attempt the beneficial bacteria were directly stimulated by means of pre-
and probiotics. 
Overall, pro- and prebiotics show the best potential as future treatment option for periodontitis, in a 
synbiotic approach. Although B. bacteriovorus HD100 was able to predate on F. nucleatum and A. 
actinomycetemcomitans, it also led to shifts in the oral community that should be elaborated further. 
The combination of probiotics and prebiotics offers many advantages. It has been illustrated before 
that several indigenous oral bacteria contain beneficial characteristics and especially the streptococcal 
species have showed to be very interesting. In our study one compound was discovered that 
specifically stimulated S. salivarius and thereby indirectly inhibited all tested periodontopathogens. 
This shows huge potential as a new treatment option for periodontitis. Probiotic bacteria are already 
being used in the treatment of periodontal diseases. S. salivarius K12 is already commercially 
available in part because of its bacteriocin producing abilities. A combination of this probiotic strain 
together with the prebiotic compound could lead to superior effects. This investigation is still in its 
infancy and has a lot of growth potential, testing the compound in biofilm models and in vivo models 
and by expanding the number of energy sources and oral microorganism. 
While in this research some bacterial interactions and metabolic networks have been elucidated, future 
research should further clarify the complex bacterial networks present in dental plaque biofilm 
communities. Energy profiles can be set-up for a wide range of oral bacteria, by use of metabolomics 
and metagenomics. These metabolic networks can lead to the further exploration of nutrient 
approaches to shape the dental plaque biofilm communities. It should also be kept in mind that besides 
these microbial metabolic networks the dental plaque biofilm community is also shaped by a person’s 
genetic make-up and immune response however this is beyond the scope of this research.
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